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Abstract 
Membrane proteins are the gateways into cells and therefore a critical part of pharmaceutical 
research. Membrane proteins, in fact, have been shown to be the target of over 50% of all 
medicinal drugs. The development of drugs that acts on membrane proteins, however, has 
been limited by the lack of high resolution structural data. This lack of information results 
from a lack of a generic method to extract active membrane proteins from the cell membrane.  
 
We have developed a novel styrene maleic acid (SMA) / lipid particle system termed SMALP 
that preserves the structural and functional integrity of membrane proteins. We have 
optimised this system and used it to solubilise two membrane proteins with different 
architectures and functions. The first, human adenosine 2a receptor (A2aR), is a G-protein 
coupled receptor, a 7 transmembrane helix protein that is involved in cell signalling, whereas 
the second, FtsZ-interacting protein A (ZipA), is a protein involved in bacterial cell division 
that contains a single transmembrane domain.  
 
In this project, standardised purification protocols were developed that produced pure 
proteins without the need to add any detergents. The subsequent biophysical characterisation 
that included circular dichroism, mass spectrometry and sedimentation velocity analytical 
ultracentrifugation indicated that these purified SMALP solubilised proteins were natively 
folded once encapsulated. The activities of both proteins were then tested and shown to be 
close to that expected for the intact proteins in the cell membrane. Taken together these data 
suggest that the SMALP system offers the solution to membrane protein purification into the 
future.  
 
Keywords: Membrane proteins; SMALP; Human adenosine 2a receptor; FtsZ-interacting 
protein A; Detergent; Biophysical characterisation 
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CHAPTER 1: Introduction 
 
1.1 Why Study Membrane Proteins 
At the present time, the biggest challenge to our understanding of the structure and 
functionality of membrane proteins is the lack of a simple and universal protocol for 
extracting membrane proteins from the native membrane environment while at the same time 
maintaining their native structures and functions. Membrane proteins are extremely important 
for human biology research as they are central to a wide range of biological processes 
including signal transduction, molecular transport, cell division and respiration [1]. The 
human genome project has shown that over 30% of genes encode for membrane proteins, and 
these membrane proteins are the targets for over 50% of the marketed pharmaceuticals [2, 3]. 
The development of drugs, however, has been limited by the lack of atomic level structural 
information.  
 
The first high resolution protein structure, myoglobin, was reported in 1960 [4]. However, the 
first membrane protein structure was solved after a further 26 years [5], and since then a 
relatively small number of membrane protein structures have been solved (compared to total 
protein structures, Figure 1-1) [6, 7]. To date, there are nearly 65,000 protein structures 
solved by X-ray crystallography, nuclear magnetic resonance (NMR) or electron microscopy 
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(EM), but only approximately 1% these structures are membrane proteins. (All known protein 
structures: 64,353; membrane proteins: 717) [6, 7].  
 
 
Figure 1-1. The chart shows the number of total protein structures (red) and membrane protein structures 
(blue) resolved from 1976 to 2010. The number of total protein structures is accumulated to ~ 65,000 in 
2010, but the number of membrane protein structures is only 717. Within the figure of 717, it is 
noteworthy that only 261 represent truly unique membrane protein structures.  
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The main reason which makes membrane proteins extremely difficult to study is their low 
solubility in water, which leads to instability when extracted from the cell membrane. 
Moreover, only few membrane proteins are naturally abundant [8, 20]. This results in 
challenges at all levels including protein expression, purification and analytical study for 
membrane proteins.  
 
In this chapter, we will describe the current challenges and review the current approaches for 
membrane protein study. We have also illustrated a novel system, styrene maleic acid lipid 
particle (SMALP), which offers a new route for membrane protein study. Furthermore, we 
describe two membrane proteins with different architectures and functions which we have 
successfully applied to this novel system, SMALP. The first, human adenosine 2a receptor 
(A2aR) contains 7 transmembrane helices and belongs to G-protein coupled receptors (GPCRs) 
family. The second, FtsZ-interacting protein A (ZipA) is a bacterial cell division protein that 
contains a single transmembrane domain.  
 
1.2 Membrane Proteins and Lipids 
Membrane proteins can be classified to two main categories according to how easily they are 
removed from the membrane. The first, peripheral membrane proteins: as they can be isolated 
by changing the ionic strength or the pH. The second, integral membrane proteins: require 
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disruption of the membrane using chemical agents such as detergents [8]. Whichever 
extraction technique is used, it is clear that the removal from biological membrane has a 
significant influence on structure and function of membrane proteins. Phospholipids, 
sphingolipids and sterol are the main components found in the biological membrane [8]. 
Numerous reports have shown these lipids protect the hydrophobic regions of the membrane 
proteins, increase protein structural stability, control insertion and directly influence the 
function of membrane proteins [8, 12-17]. 
 
The lipids in a membrane can be classified into three types according to their positions and 
functions with respect to membrane proteins. The first, the bulk, forms the major part of the 
lipid bilayer which provides a special milieu for membrane proteins. The lipid bilayer is 
thought to provide a specific lateral pressure for membrane proteins [13, 14]. Moreover, the 
lipid makeup of a membrane also effects the folding of a membrane protein. Work by Booth 
et al. has shown that the lateral pressure of lipid bilayer influences the folding of a membrane 
protein [15, 16]. The second type of lipids is called the annular lipids; these lipids encircle 
and directly contact the proteins and have been thought to affect the function of membrane 
proteins [8]. In addition to the bulk and annular lipids, there is a third type of lipids called 
lipid cofactors. Lipid cofactors are often found bound tightly to a cleft or in between the 
subunits of the membrane proteins. These lipids are directly involved in the function of the 
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membrane proteins. For example, Ca
2+
-ATPase requires phosphatidylinositol-4-phosphate 
and cholesterol for acetylcholine receptor [17, 18]. It is therefore clear that an ideal solution 
to the problem of membrane protein extraction would maintain these lipids around the chosen 
membrane protein. 
 
Furthermore, White and Wimley proposed a four-step thermodynamic model to describe 
membrane protein folding (for α-helix membrane proteins) including partitioning, folding, 
insertion and association (Figure 1-2) [19]. The hydrophobic side chain can provide enough 
free energy for partitioning. While the ∆G (standard transfer free energy) of the partitioning 
of the folded peptide is smaller than (more negative) the partitioning of the unfolded peptide, 
the partitioning could induce the folding to α-helix. The insertion of the α-helix is affected by 
its rotational degrees of freedom and the space [8, 19]. Finally these helices assemble by 
packing together. 
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                                                                                                                                               [19] 
Figure 1-2. Four-step thermodynamic model for membrane protein folding.  
The model describes the energetics of the partitioning, folding, insertion, and association of α-helix. The 
process can go through an interface path, a water path, or a combination of both. The ∆G symbol 
represents the standard transfer free energies. w= water, i = interface, h = hydrocarbon core, f = folded, u = 
unfolded, and a = association. For example, the standard free energy of transfer from water path to 
interface path of a folded peptide is represented as ∆Gwif [19].  
 
 
1.3 The Current Challenges and Approaches for Membrane Protein Study 
Membrane proteins have proved difficult to be investigated due to their natural low 
abundance and their amphipathic nature which tends to lead to aggregation in aqueous buffer 
[20]. In addition, the requirement to use detergent as an extraction agent from the cell 
membrane often leads to the striping of lipids from the protein, can alter its activity. The 
imbedding of membrane proteins in lipids also limits the use of many techniques used for 
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further functional and structural studies [8, 20]. In this section, we describe current challenges 
in membrane protein study and recent approaches to membrane protein expression, 
purification and analytical studies. Figure 1-3 shows the standard flow chart of membrane 
proteins study from designing the primers to the characterisation of proteins. 
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Figure 1-3. Flow chart showing the standard process of membrane proteins study from designing the 
primer to the characterisation of protein. 
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1.3.1 Membrane Proteins Expression  
The current challenges on expression of membrane proteins are mainly low protein 
expression yield, cellular toxicity, protein misfolding and aggregation. These result in a 
significant impact on the final purification yield and protein quality [11, 21]. To overcome 
these expression problems, it is important to choose the right expression system for each 
particular membrane protein [11]. Membrane proteins have been successfully expressed in 
several of expression systems, such as bacteria (e.g. Escherichia coli and Lactococcus lactis) 
[22-24], yeasts (e.g. Pichia pastoris and Saccharomyces cerevisiae) [25, 26], insect cells (e.g. 
Baculovirus) [27], mammalian cells [28], and cell free systems [29]. The proteins purified 
from these sources have been successfully used for functional and structural studies. 
Choosing a suitable expression system should consider several factors including the 
expression yield, post-translational modifications and the lipid composition of cellular 
membranes [21]. Furthermore, it should be understood that establishing an expression system 
to obtain the high quality and yield of membrane protein is usually difficult, therefore, it can 
take several months to a year to establish a satisfying expression system. 
 
For example, expression of membrane proteins by bacterial cells such as E. coli is simple, 
quick, inexpensive, and a large number of constructs can be screened, however, most post-
translational modifications of recombinant eukaryotic membrane proteins require eukaryotic 
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systems for protein expression [8, 12]. Moreover, membrane proteins are embedded in a 
complex and dynamic lipid bilayer, and the components of the lipids are different for 
bacterial and eukaryotic cells. Therefore, consideration should be given to the lipid 
composition when choosing an expression system for membrane proteins. 
 
Additionally, in most of traditional eukaryotic culture systems, the protein yield is extremely 
low, e.g. the flask culture of yeast cells. This can be mitigated by using a bioreactor which 
maximises cell densities and hence increases the yield of the target protein. For example, the 
expression level of human adenosine 2a receptor (A2aR) is approximately 0.2 mg of protein 
per litre of flask culture. By growing A2aR in a bioreactor results in up to 10 times biomass, 
therefore, the expression level per litre of bioreactor culture can be increased to 2 mg of 
protein. This level of protein is sufficient for many functional and structural studies [25, 30]. 
 
1.3.2 Membrane Protein Purification  
Membrane proteins can be purified by a range of chromatographic methods such as affinity 
column, ion-exchange and gel filtration. However, before application to a chromatography 
column, for membrane proteins, the first step is to remove proteins from their cell membrane 
using a chemical agent such as detergent. Unfortunately, this step often leads proteins to lose 
their native function. This issue can sometimes be mitigated by the addition of specific lipids 
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during the purification which stabilise membrane proteins and maintain their activity. For 
example, the presence of cholesterol can increase the activity of some mammalian membrane 
proteins [11, 21, 31-33]. In addition, temperature and pH are also important factors for the 
stability of purified membrane proteins, most of purified membrane proteins are stable at 
4°C, pH 6 - 8. Additions of glycerol and protease inhibitors can also stabilise these purified 
membrane proteins [20]. Furthermore, once the complex process of purification has been 
completed, many functional and structural studies of membrane proteins require the 
reinsertion of the purified membrane protein into a mimic native membrane environment, 
termed model systems. Achieving this process in the presence of detergent presents a larger 
challenge than the purification itself. Here, we illustrate a number of current methods for 
producing of membrane proteins including using detergents and model systems.  
 
Current Methods for Studying Membrane Proteins: Detergents and Model Systems 
There are a wide range of methods in the literature that use detergents and several model 
systems, such as the use of liposomes, amphipols, nanodiscs, and bicelles which allow 
membrane protein study in vitro in a native-like membrane environment [8-10, 35-37]. 
Detergent is the most common tool to extract membrane proteins from their cell membranes 
and prevent protein aggregation [20]. However, detergents also remove lipids from 
membrane proteins resulting in loss of its biological activity. Inserting proteins into a model 
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system can provide proteins a native-like membrane environment for their structural and 
functional studies [8].  
 
Detergents 
Detergents are amphiphilic molecules and water soluble surfactants, these have been widely 
used to solubilise membrane proteins in aqueous solutions [8]. A variety of detergents have 
been used to solubilise membrane proteins, including ionic detergents such as sodium 
dodecyl sulfate (SDS) and cyltrimethylammonium bromide (CTAB) and non-ionic 
detergents: Triton X-100, octyl ß-D-glucoside (OG) and n-dodecyl-ß-D-maltoside (DDM) 
[148, 149]. Ionic detergents bind to the hydrophobic parts of membrane proteins disrupting 
ionic and hydrogen bonds due to their charge. Some ionic detergents, such as SDS usually 
denature proteins by binding to each side chain. Non-ionic detergent, for example, Triton X-
100 has aromatic ring that interferes with some biophysical studies such as circular dichroism 
(CD) [8]. So far, no single detergent has been shown to be satisfactory for all membrane 
proteins. It is therefore an essential and time-consuming part of the purification process to 
test several different detergents and select an effective solubilising, non-denaturing detergent 
prior to use [20].  
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The mechanism of most detergent to solubilise membrane protein involves micelle formation 
[20]. The solubilisation action of membrane proteins by detergents is strongly related to the 
critical micelle concentration (CMC). Below the CMC (low concentration), detergent 
penetrates the lipid bilayer but does not form micelles. As the concentration increases above 
the CMC (high concentration), the detergent disrupts the bilayer and results in mixed micelles 
(Figure 1-4) [8, 150]. Detergent micelles are commonly used for study membrane proteins, 
although they lack a lipid bilayer [47, 151]. Maintaining the micelles structure, however, 
requires careful control of the experimental conditions within narrow limits, and this is often 
not possible during the purification and further biophysical studies of membrane proteins. 
 
 
 
14 
 
 
Figure 1-4. Solubilisation of membrane proteins by detergents. Detergents are used to solubilise membrane 
protein from their cell membrane. (A) Initially, the membrane protein is in the native membrane. (B) While 
low concentration of detergent is added (lower than CMC), some detergent molecules bind to the 
membrane without forming mixed micelles. (C) As more detergent is added (higher than CMC), it leads to 
the formation of mixed micelles containing the protein, lipids and detergent molecules.  
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Model systems: Liposomes, Amphipols, Nanodiscs and  Bicelles 
1.Liposomes 
Liposomes are the most common model systems used in membrane proteins studies. A 
liposome is a closed spherical vesicle containing an aqueous core enclosed in lipid layer [37, 
152]. Liposomes can be classified as multilamellar vesicles (MLVs) contain an ―onion‖ like 
arrangement of membrane layers and unilamellar vesicles containing a single bilayer (Figure 
1-5) [153]. Unilamellar vesicles are also classed by size including small unilamellar vesicles 
(SUVs), large unilamellar vesicles (LUVs) and giant unilamellar vesicles (GUVs) [154-157]. 
 
(A)                                                                                                              (B) 
Figure 1-5.  Different type of liposomes 
Liposomes can be classified to two major types depending on whether they have single or multi bilayers. 
(A) Multilamellar vesicles (MLVs): the size is up to 10 μm. (B) Unilamellar vesicles include SUVs, LUVs, 
and GUVs and the size varies from 20 nm to 300 μm. 
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MLVs can be prepared by simply shaking a dried lipid within an aqueous solution and have 
been previously used in many enzyme and peptide binding studies. SUVs are vesicles with a 
diameter of 20 ~50 nm and can be easily made by sonicating MLVs [8, 34]. Although SUVs 
are very simple to prepare, it is often difficult to incorporate proteins due to the excessive 
bilayer curvature. LUVs (diameters between 100 nm and 5 μm) can be prepared from induced 
fusion of SUVs by freeze-thaw cycles. LUVs have more encapsulated lipid and a lower 
curvature than SUVs, but also are fragile and often have a heterogeneous size distribution [8, 
34]. GUVs can to be prepared by different methods, including the use of Teflon disks (§ 
2.5.7), LUVs fusion or Electroformation - Pt Wire [34]. In general, GUV preparation is more 
complicated than preparation of SUVs and LUVs. GUVs are very large vesicles with 
diameter between 5 μm to ~300 μm and hence have a very low surface curvature, they can 
also be visualised by optical microscopy, however, the large size also makes them very 
fragile [8]. Table 1-1 summarises the advantages and disadvantages of the methods for GUVs 
preparation. 
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Teflon disk 
Advantages Most of the GUVs are unilamellar 
Disadvantages It is hard to remove vesicles from the substrate surface 
LUVs fusion 
Advantages Very simple method 
Disadvantages The size of GUVs is relatively small, ~10 μm 
Electroformation - Pt Wire 
Advantages GUVs size is well controlled 
GUVs are unilamellar 
Disadvantages Only a few GUVs can be prepared per experiment since only small 
amounts of lipids can be used for each sample  
Requires many hours to clean the chamber 
Table 1-1: Advantages and disadvantages of different methods for GUVs preparation 
 
2.Amphipols 
Amphipols are amphipathic polymers that allow membrane proteins to be solubilised in 
aqueous solutions (polymers with strongly hydrophilic backbone and grafted with 
hydrophobic chains) [35, 36]. These amphipathic polymers are short chain polymer, which 
must be flexible, highly soluble in water and also able to be adsorbed onto the hydrophobic 
transmembranes segments of membrane proteins. They can retain the lateral pressure of 
membrane proteins, increase protein stability and maintain their native state [37]. There are 
several amphipathic polymers that have been used for the study of membrane proteins so far, 
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these include A8-35 and PC-amphipol [36-39]. A8-35 is the most studied amphipol since it 
has been developed by Tribet et al. in 1996 (Figure 1-6). It has been applied to numerous 
membrane proteins including GPCRs [35, 36, 40, 41]. Although useful, the major drawback 
of these polymers is their requirement of detergent usage to solubilise the target proteins from 
their cell membrane before being added the polymer [37]. 
 
 
                                                                                                                                   [35] 
Figure 1-6. A8-35: the most studied amphipathic polymer used for membrane protein studies. 
 
 
3.Nanodiscs 
Nanodiscs are a novel model system for supporting membrane proteins during studies which 
has been developed in the last decade. It is proposed that membrane proteins incorporated 
into nanodiscs may avoid the aggregation and purification problems associated with other 
systems [9, 10]. The nanodisc is a 10 nm diameter disc structure composed of phospholipids 
and membrane scaffold proteins (MSPs) (Figure 1-7). In order to incorporate membrane 
proteins to nanodiscs, the membrane protein of interest is first solubilised in a detergent such 
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as Triton X-100. The mixture of MSPs stock solution and lipid are then added into the sample. 
The detergent is removed and the protein can be purified using a general purification 
procedure. The nanodisc contains the purified target protein which can then be used to further 
analytical studies. In practice, MSPs may interfere with some analytical investigations, for 
example their proteinaceous nature means that they have disruptive signals in techniques such 
as CD [9, 42]. 
 
 
                                                                                                                               [9] 
 
                            
Figure 1-7. Model of a nanodisc (cutaway view)  
The nanodisc is a nanometer scale soluble bilayer structure which consists of phospholipids (blue) and 
encircled by a 200 amino acid scaffold protein (orange) containing the target protein (purple)                                                                                                                                   
[9]. 
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4. Bicelles 
Bicelles are self-assembled disc-like structures which are usually made of two lipids. Bicelles 
can be formed from phospholipids which contain the combinations of head-group/acyl chain  
that favour the form of the curved bilayers, for example, the mixtures of 1,2-Dihexanoyl-sn-
Glycero-3-Phosphocholine (DHPC) and 1,2-Dimyristoyl-sn-Glycero-3-Phosphocholine 
(DMPC). The diameter of the bicelle is usually between 5 - 40 nm depending on the DMPC: 
DHPC ratio (Figure 1-8) [43-46].  Previous study on bicelles has shown that biophysical 
studies of membrane proteins can be performed on this system [46]. This system, however, 
still requires using detergents to solubilise the membrane proteins from their biological 
membranes. Table 1-2 summarises the advantages and disadvantages of these current 
methods for membrane proteins study. 
 
 
Figure 1-8. Cross section representation of the central planar bilayer of a bicelle.  
The bicelle is formed by the long-chain phospholipid (DMPC) and it is surrounded by the of short-chain 
phospholipid (DHPC) that protects DMPC hydrophobic tails from water [46].  
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Detergents 
Advantages Size homogeneity 
Disadvantages Lateral pressure is decreased 
Detergent sometimes leads to activation of unfolded protein 
Native lipid is disrupted 
Concentrations below CMC results in membrane protein aggregation 
Liposomes 
Advantages Provide native lipid environment 
Maintain lateral pressure 
Disadvantages Size heterogeneity 
One side of the membrane protein is inaccessible to the bulk solvent  
Requires detergent solubilisation of membrane protein prior to formation 
Amphipols 
Advantages Size homogeneity 
Maintain membrane lateral pressure 
Disadvantages Requires detergent solubilisation of membrane protein prior to formation 
Nanodiscs 
Advantages Size homogeneity 
Provide native lipid environment 
Maintain lateral pressure                                                                   
Disadvantages Membrane scaffold proteins (MSPs) may interfere with the functional 
and structural studies 
Require detergent solubilisation of membrane protein prior to formation 
Bicelles 
Advantages Suitable for many biophysical studies of membrane proteins 
Disadvantages Require detergent solubilisation of membrane protein prior to formation 
Limited choice of lipid combinations 
Table 1-2: Advantages and disadvantages of detergents and model systems for membrane protein studies. 
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1.3.3 Analytical Studies 
To study the native structure and function of membrane proteins in vitro, membrane proteins 
are generally prepared in the detergent micelles or in the model systems such as those 
discussed above. However, no single system has been universally satisfactory for all 
techniques used to characterise membrane proteins. This is mainly due to interference with 
the signals produced by the subsequent analytical studies. In addition, maintaining the protein 
in the micelles or a model system requires careful control of experimental conditions (e.g. pH 
and temperature) [8, 20], within narrow limits and it is often not possible to achieve this 
during the subsequent analytical studies. Therefore, different detergents or model systems are 
often required for different functional and structural studies of the same membrane protein. 
Table 1-3 summarises current hurdles for membrane protein studies. 
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Expression 
Most membrane proteins are naturally low in abundance 
Tend to aggregate  
 
 
Purification 
Need to solubilise using detergent 
Need insertion to a model system to maintain their native structure 
and function for further study 
Low yields 
 
Analytical Study 
Detergents and model systems may interfere with the signals of 
analytical studies 
Rapid degradation, and aggregation 
Table 1-3. A summary of current hurdles for membrane protein studies. 
 
1.4 A Novel Membrane Protein Study Method: Styrene Maleic Acid Lipid 
Particles  
As described above, many methods have been used to produce monodispersed preparations 
of membrane proteins. These include the use of the detergent micelles and the model systems. 
However, all these methods require the use of detergents to solubilise proteins from the cell 
membrane, and hence the striping away of their native lipids. Furthermore, no single method 
has been universally satisfactory to study and characterise these membrane proteins. It is 
therefore important to develop a novel system which can be used to produce membrane 
proteins, ideally keeping them in their native environment without adding any detergents as 
well as being suitable for most techniques used to characterise membrane proteins.  
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Styrene maleic anhydride polymer is an anionic hypercoiling polymer (Figure 1-9) [48]. The 
only anionic polymers that have been found to hypercoil are polyacids containing carboxylic 
acid pendant groups either in the form of acrylic acid or maleic anhydride (requires 
hydrolysing to maleic acid). Styrene pendant groups provide a hydrophobic moiety, which 
together with maleic acid form a hypercoiling polymer [48]. 
 
 
                                                                                                                              [48] 
Figure 1-9. Styrene maleic anhydride  
Prior to use, maleic anhydride requires hydrolysing to maleic acid. Styrene pendant groups provide a 
hydrophobic moiety and together with maleic acid they form a hypercoiling polymer [48]. 
 
 
In the presence of lipids, styrene maleic acid (SMA) polymer self assembles to form a 
polymer-lipid nanostructure (Figure 1-10) [48,158]. This lipid-polymer nanostructure 
disassociates at pH 4 due to the pH-dependence of the ionization of the maleic groups within 
the polymer (Figure 1-11) [158]. The polymer-lipid particle is formed again when pH 
increases to 8. This polymer-lipid nanostructure was termed ―Lipodisq‖ and it has been 
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developed by Malvern Cosmeceutics Ltd for use in hydrophobic pharmaceutical delivery 
systems [49].  
 
 
 
                                                                                                                                    [158] 
                           (A) 
        
                                  
 [48] 
                          (B) 
 
Figure 1-10.  
(A) The cartoon of styrene maleic acid/DLPC (lipid) 
(B) Cryo-TEM electron micrograph (x 120,000) of styrene maleic acid/DLPC particles. The diameter of 
this nano-disc structure is 10 nm [48]. 
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                                                                                                                                          [158] 
Figure 1-11. The addition of SMA polymer into a 2% lipid (1, 2-dimyristoyl-glycero-3-phosphocholine, 
DMPC) aqueous solution, makes it form SMA/DMPC nanostructure and hence becomes clear. This lipid-
polymer nanostructure disassociates at pH 4. The SMA/DMPC nanostructure forms again when pH 
increases to 8. 
 
Knowles et al. have recently applied this SMA/lipid nanoparticle system, termed SMALP, to 
bacterial membrane proteins, PagP and bacteriorhodopsin (bR) [49]. The empty SMALP has 
been shown with average 9.0 ±1.1 nm diameter estimated by dynamic light scattering (DLS). 
The size of SMALP was slightly larger when PagP was incorporated into SMALP, with an 
average diameter of 11.2 ±1.4 nm as estimated by DLS. It is clear that SMALP is flexible and 
may be able to incorporate with different architectures of proteins. Additionally, the 
subsequent biophysical experiments the proteins have shown proteins were folded, 
thermostable and active. For example, CD spectroscopy has shown that proteins were 
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correctly folded within SMALP and more thermostable than protein within detergent (Figure 
1-12) (Figure 1-13) [49].  
 
 
 
 
                                                                                                                                               [49] 
 
Figure 1-12. Far UV CD of (A) purified SMALP-PagP and (B) purified SMALP-bR. Both of samples 
showed a folded structure. The CD spectrum of purified SMALP-PagP showed a minimum at 218 nm and 
shoulders at 222 and 208 nm, consistent with the expected β-barrel and α-helical structures The CD 
spectrum of purified SMALP-bR showed a minimum at 222 nm and shoulder at 208 nm, consisting with 
the expected high α-helical components [49]. 
 
 
 
 
28 
 
 
 
 
 
[49] 
Figure 1-13. CD spectrum of the thermal stability experiment. 218 nm CD unfolding profiles for PagP in 
SMALP (grey line), liposomes (red line), and detergent (β-octylglucoside, (β-OG)) (orange line).The data 
showed β-OG-PagP denatured at 84°C, both purified SMALP-PagP and liposomes-PagP maintained fold 
state at 84°C. It showed that PagP in SMALP offers corresponding stability to liposomes-PagP and a better 
stability to detergent-PagP [49].  
 
These preliminary studies showed that SMALP offers a solution to preserve the integrity of 
transmembrane proteins and form a thermostable and soluble nanoparticle which is suitable 
for their biophysical studies in the lipid environment. It is clear that SMALP may provide a 
solution to other more challenging membrane proteins, such as G-protein coupled receptors. 
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1.5 Target Protein Selection: Human Adenosine 2a Receptor, a GPCR 
1.5.1 G-Protein Coupled Receptors 
The G-protein coupled receptors (GPCRs) are the largest family of membrane proteins in the 
human genome with over 1000 unique members, and have been shown to have vital roles in 
maintaining normal function in humans [50, 51]. These proteins are implicated in diverse 
acute and chronic diseases ranging from HIV infection to Parkinson’s disease. GPCRs are 
integral membrane proteins, embedded within the cellular plasma membrane with 7 
transmembrane helices linked by extracellular and intracellular loops [52].  
 
GPCRs bind to a wide variety of extracellular ligands including peptides and small 
molecules. The receptors are activated by agonists while neutral antagonists prevent 
activation by agonists. In addition to agonists and neutral antagonists, a third type of ligand, 
the inverse agonist, reduces the activity of GPCRs by inhibiting their constitutive activity [12, 
52]. The neutral antagonist ―blocks‖ the action of the agonist or inverse agonist without 
altering the existing conformation of the receptor. Agonist-activated receptors undergo a 
conformational change which results in their intracellular interaction with G-proteins which 
are involved in downstream cellular signalling [12, 52]. These G-proteins are trimers made of 
α, β, and γ subunits (known as Gα, Gβ, and Gγ) (Figure 1-14). Moreover, GPCRs also 
interact with other proteins apart from G-proteins, in particular, β-arrestin, can bind to 
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phosphorylated GPCRs, and prevent further coupling of the receptor to G protein [53]. β-
arrestin is thought to play an important role in agonist-mediated desensitisation of GPCRs, 
and leads to the mitigation of cellular responses to stimuli such as hormones, 
neurotransmitters, etc.  (Figure 1-15) [54-56,160]. 
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Figure 1-14. GPCRs signalling pathway.  
(1) Ligand (agonist) does not bind to the receptor. (2) Ligand binds to the receptor which causes a 
conformational change of the receptor and results in activation of the trimeric G-protein. (3) and (4) GDP 
is released and GTP binds to the trimeric G-protein. (5) While GTP binds to the trimeric G-protein, the G-
protein dissociates into two parts, G alpha and G betagamma. (6) The GTP has been hydrolysed to GDP 
and Pi by the GTPase activity of the alpha subunit, the separated two parts of the G-protein can  recombine 
again and restart a  new signalling cycle (back to(1)) [159]. 
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Figure 1-15. (1) The GPCR is activated by agonist. (2) The G-protein dissociates into two parts, G alpha 
and G betagamma (see above, Figure 1-14). (3) The receptor is phosphorylated by a G protein-coupled 
receptor kinase (GRK). (4) β-arrestin can bind to phosphorylated GPCR, which prevents further coupling 
of the receptor to G protein (desensitisation) (5) Internalisation and (6) dephosphorylation. (7) The receptor 
is ready for the new cycle (back to (1)) [160]. 
 
GPCRs are central to cellular signalling and thus these receptors have emerged as desirable 
targets for the pharmaceutical research. In fact, approximately 40% of pharmaceuticals on the 
market are targeted to GPCRs [2]. However, merely six crystal structures of GPCRs have 
been discovered in this largest class of membrane proteins: rhodopsin, β2-adrenoceptor, β1-
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adrenoceptor, A2aR adenosine receptor, CXCR4 chemokine receptor and Dopamine D3 
receptor [57-63]. The first crystal structure of GPCR was rhodopsin, it is a molecule of the 
retina which is responsible for light detection. Rhodopsin consists of the opsin apoprotein and 
the 11-cis-retinal. It is activated while light causes photoisomerisation of the 11-cis-retinal 
(the inverse agonist of the receptor) to all-trans-retinal (an agonist of rhodopsin). This makes 
the protein ―inflexible‖ as it is held in an inactive state bound to 11-cis retinal [58]. In other 
cases, receptors had been ―locked‖ by binding to an antagonist or plus other modifications. 
For example, the A2aR is bound to its antagonist ZM241385, and for the β2-adrenoceptor, 
intracellular loop 3 is replaced with T4 lysozyme [57, 60]. Although it became possible to 
obtain GPCRs crystal structure in the last decade, however, it is still a big challenge to obtain 
the crystal structure of GPCRs without any modifications.  
 
1.5.2 Human Adenosine 2a Receptor 
Adenosine receptors play an essential role in local regulatory processes in humans such as 
control of cerebral blood flow and respiration. Four subtypes of human adenosine receptors 
have been identified (A1R, A2aR, A2bR, and A3R) [64-66]. The human adenosine 2a receptor 
(A2aR) is a GPCR and one of adenosine receptors found in humans. Until today, the first and 
the only crystal structure of human adenosine receptors is A2aR, which was solved by Jaakola 
et al. in 2008 (Figure 1-16) [57].  
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A2aR binds to ligands present in the extracellular domain and then changes shape leading to 
the activation of an intracellular G-protein. This activation has been summarised in a two-
state model. State one represents the active state and state two represents the inactive. A2aR is 
activated by agonists such as 2-chloroadenosine, and blocked by antagonists such as caffeine 
[161]. A2aR is abundant in polymorphonuclear leukocytes, blood vessels, and platelets. A2aR 
is found in high concentrations in the central nervous system and is expected to have a 
therapeutic effect in central nervous system (CNS) disorders such as Parkinson’s disease [67]. 
Clinical evidence suggests that coffee drinkers have a lower risk of Parkinson's disease [68]. 
Therefore, understanding the binding mechanism of A2aR with its ligands and obtaining A2aR 
crystal structure without any modifications should help drug discovery for these diseases. 
35 
 
 
                                                                                      
[57]  
Figure 1-16. Human adenosine 2a receptor bound to an antagonist (ZM-241385). The resolution of the 
structure is 2.6Å . The third cytoplasmic loop of the receptor was replaced with lysozyme from T4 
bacteriophage. In addition, the C-terminal tail (Ala317–Ser412) was removed to improve the likelihood of 
crystallization. The transmembrane domain of A2aR is colored brown (helices I to VIII), and the T4L is in 
cyan. ZM241385 is colored blue. Five lipid molecules bound to the receptor are in red, and four disulfide 
bonds are colored yellow. The intracellular loops are colored blue, and the extracellular loops are in green. 
PDB identifier: 3EML [57]. 
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1.6 Target Protein Selection: FtsZ-Interacting Protein A, a Bacterial Cell 
Division Protein 
1.6.1 Bacterial Cell Division Proteins 
Cell division is the critical mechanism by which a cell divides into two or more daughter cells 
in all living organism. In prokaryote cells, cell division occurs by a process called binary 
fission which starts with DNA replication. The single, circular DNA replicates by 
semiconservative replication. The chromosome replicates resulting in two identical 
chromosomes. The actual physical division process then proceeds. The cell elongates, two 
identical chromosomes separate into daughter cell [12]. In the E. coli cells, several cell 
division genes have been identified in temperature-sensitive mutants these have been named 
Fts genes, filamentous temperature sensitive. Fts genes such as FtsA, FtsB, FtsL, FtsI, FtsQ, 
FtsN, FtsW, FtsK and FtsZ are believed to be involved in cell division [69-71]. 
 
Apart from the Fts proteins there are also more than 5 other proteins have been identified that 
play a role during cell division of E. coli cells [72-74]. The protein encoded by FtsZ gene is 
called FtsZ protein, the first protein appears at the division site (in the middle of the bacterial 
cell) where FtsZ protein assembles into FtsZ-ring (§ 1.6.2, symbol § represents ―describe in‖). 
In the last decade, numerous pieces of evidence have suggested FtsZ-ring drives cell division 
by which FtsZ-ring creates enough force in constricting the cytoplasmic membrane [72-75]. 
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Two proteins, ZipA and FtsA, are important for formation of FtsZ-ring by directly interacting 
with FtsZ [75]. ZipA is an integral inner-membrane protein (§ 1.6.3). FtsA, although a 
cytoplasmic protein, has been found to contain an amphipathic helix that forms a labile 
anchor to the membrane [76]. It has been observed that the FtsZ-ring can form while either 
ZipA or FtsA protein is absent, however, FtsZ-ring can not form if both of proteins are absent 
[75]. Another protein, ZapA, has also been shown to be an FtsZ binding protein that can 
stabilise FtsZ-ring [77]. 
 
The localisation of FtsZ-ring is regulated by three proteins, MinC, MinD and MinE. These 
three proteins prevent the formation of FtsZ-ring away from the mid-cell (Figure 1-17) [78, 
162]. MinC has been shown to inhibit the formation of FtsZ-ring and is found at its highest 
concentration at the poles and the lowest at mid-cell [79, 80]. MinC is active only while 
bound to MinD as free MinC remains in the cytoplasm and is unable to prevent FtsZ 
assembly. MinD belongs to a family of bacterial ATPase that binds to the membrane by its C-
terminal amphipathic helix only while it is bound to ATP. The third Min protein, MinE has 
been shown to prevent the formation of MinC/D complexes at mid-cell. MinE can displace 
MinC from the MinC/D complex [81-83]. Consequently, MinC is unable to prevent FtsZ 
from forming the FtsZ-ring and then allows the cell to divide in the middle of the cell. MinE 
is able to stimulate the ATPase activity of MinD which results in MinD dissociating from the 
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membrane. MinD can then rebind to membrane at the opposite pole where MinE 
concentration is the lowest, MinC then bind to MinD to start of the new cycle.  
 
 
Figure 1-17. The localisation of FtsZ-ring regulated by MinCDE proteins.  
In the Escherichia coli cell, positioning of the FtsZ-ring is regulated by three proteins, MinC, MinD and 
MinE. MinD-ATP binds to the cell membrane and it also binds MinC to form the MinC/D complex which 
prevents the formation of FtsZ-ring. MinE has been shown to prevent the formation of MinC/D complexes 
at mid-cell. Consequently, FtsZ-ring forms at mid-cell which then allows cell to divide in the middle of the 
cell [162]. 
 
After the FtsZ-ring has been formed, the remaining proteins involved in cell division are 
recruited; all these proteins are predicted to contain either single or multiple transmembrane 
spaning helices (apart from AmiC, amidase required for cell division). However, the 
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functions of some of these proteins are still not clear. Table 1-4 summarises 15 proteins are 
required for cell division of the E. coli cell. 
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Protein Function 
FtsZ-ring associated  
1. FtsZ Tubulin homologue ; forms FtsZ-ring  
2. ZipA Stabilises FtsZ-ring; serves as a membrane 
anchor for FtsZ-ring  
3. FtsA It belongs to the actin superfamily; stabilises 
FtsZ-ring 
4. ZapA Stabilises FtsZ-ring 
Regulator of the location of FtsZ-ring   
1. MinC FtsZ inhibitor 
2. MinD Required to activate MinC; a family of 
bacterial ATPase 
3. MinE Min topological regulator ; prevents the 
formation of MinC/D complexes at mid-cell 
Proteins involve in “late” cell division  
1. FtsK Chromosome partitioning; acts as a DNA 
motor 
2.FtsW Division and Sporulation proteins 
3. FtsI Division specific transpeptidase 
4. FtsN It is only found among gamma-
proteobacteria ; unknown function 
5. FtsQ Unknown function 
6. FtsL Unknown function 
7. FtsB Unknown function 
8. AmiC  Amidase required for cell division 
Table 1-4: At least 15 proteins are required for cell division of E. coli cell. These proteins include 
cytoplasmic, integral inner-membrane proteins and enzymes. These proteins can be classified into three 
groups according to their function, including FtsZ-ring associated, regulator of the location of FtsZ-ring 
and the proteins involved in ―late‖ cell division [72-74]. 
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1.6.2 Filamentous Temperature Sensitive Protein Z 
Filamentous temperature sensitive protein Z (FtsZ) is a GTPase protein, essential for cell 
division [84, 85]. It exists in most of the major groups of bacteria and Euryarchaeal branch of 
the archaea [86-88]. It is a highly conserved protein among the prokaryotes with only a few 
exceptions [89-91]. FtsZ has also been found in eukaryotic cells, for example, it is involved 
in the division of chloroplasts and mitochondria [92, 93]. 
 
The first crystal structure of FtsZ has been solved by Lowe and Amos in 1998 (Figure 1-18) 
[94]. FtsZ consists of four main protein domains, and these domains include the N-terminal 
region, a highly conserved core segment, a variable spacer and a C-terminal conserved 
domain. The N-terminal region is variable, and the function of this region is not clearly 
understood. Following the N-terminal region lies a conserved core segment which contains a 
tubulin-like motif of 7 amino acids responsible for GTP binding and hydrolysis. Flanking this 
are two independent N-terminal and C-terminal regions called Nt core and Ct core. The Nt 
core binds to the bottom portion of the adjoining monomer in an FtsZ protofilament, and the 
Ct core binds to the top portion of the adjoining monomer in the protofilament [94, 95]. 
Following the core segment is a variable spacer, but its function is still not clear. Finally, a C-
terminal conserved domain, although this domain is not required for assembly, it is an 
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essential part for the interaction with other FtsZ-ring associated proteins such as ZipA, FtsA 
and ZapA which are important for stabilising FtsZ- ring [96, 97]. 
 
 
                                                                                                                                                     
[164]                                             
Figure 1-18. The structure of FtsZ. The protein consists of four main protein domains including the N-
terminal region, a highly conserved core segment, a variable spacer and a C-terminal conserved domain.  
PDB identifier: 1FSZ 
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1.6.3 FtsZ-Interacting Protein A 
FtsZ-interacting protein A (ZipA) is an integral inner-membrane protein that contains an N-
terminal membrane anchor which has been identified by Hale and de Boer in 1997 [100]. 
ZipA consists of 328 amino acids with a predicted molecular weight of 36.4 kDa. ZipA plays 
an essential role in the assembly of the FtsZ-ring by anchoring the FtsZ protein to the 
membrane during cell division (Figure 1-19). Its importance is reflected by the fact that cells 
depleted of ZipA can grow, but can not divide [100]. 
 
 
Figure 1-19. Representation of ZipA binds to the FtsZ-ring. 
The periplasmic domain and transmembrane segment (N-terminal) acts as a membrane anchor for FtsZ-
ring. The P/Q domain is unfolded and serves as flexible linker for FtsZ-ring to the membrane. The globular 
domain of ZipA (C-terminal) has been shown to bind to the C-terminus of FtsZ. 
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ZipA contains five regions [99]: a short periplasmic domain (amino acids 1 to 6) followed by 
a hydrophobic transmembrane segment (amino acids 7 to 28) which serves as a membrane 
anchor for FtsZ-ring. The removal of this N-terminal region of the protein results in a soluble 
ZipA [100]. The third region is a highly charged region (amino acids 29 to 85) which has 
been shown to block membrane transport and prevent further export of the protein [100,101]. 
The fourth region (amino acids 86 to 185) is a proline/glutamine rich domain named P/Q 
domain. The P/Q domain is the largely an unfolded polypeptide and plays a role as flexible 
linker that tethers FtsZ-ring to the membrane [100,102]. Immediately following P/Q domain 
lays a globular domain (amino acids 186 to 328). The globular domain of ZipA has been 
shown to bind to C-terminus of FtsZ [103-107]. The atomic structure of C-terminal has been 
solved and reveals this region to contain 3 -helices motifs and 6 -sheets (Figure 1-20) 
[104,105].  
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                                                                                                   http://www.pdb.org/pdb/home/home.do 
Figure 1-20. Crystal structure for the C-terminal domain of ZipA 
The complex with a 17 residue C-terminal domain of FtsZ [105]. The Resolution of the structure is 1.95 Å . 
PDB identifier: 1F47 
 
1.6.4 The FtsZ-ZipA Interaction 
ZipA protein has been shown to stabilise FtsZ-ring at the membrane in the early stages of cell 
division. In the last decade, several reports have described the interaction between FtsZ and 
ZipA [107,108,110,111]. Ray and Chaudhuri and Hale et al. have shown that ZipA stabilises 
FtsZ polymers and that ZipA can induce bundling of FtsZ polymers [110,111]. Liu et al. 
found no evidence to suggest that ZipA affect FtsZ GTPase activity [107, 146].  
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Recent studies of the FtsZ-ZipA interaction have been carried out using methods that probe 
the GTPase activity of FtsZ as well as the structure of FtsZ by electron microscopy and 
sedimentation assays [107,110-112]. However, the information from these techniques does 
not fully address all aspects of the FtsZ-ZipA interaction.  
 
Linear dichroism (LD) is a spectroscopic technique that can be used to characterise the 
interaction between FtsZ and ZipA. Previous studies have reported that LD can be used to 
measure the changes of rigidity or length of FtsZ polymers when FtsZ interacts with other 
proteins [113]. LD can be used in describing the orientations of biomolecules in ordered 
arrays [114]. LD is defined as the difference in absorbance between parallel and 
perpendicular linearly polarized light with respect to an orientation axis [115]. This can be 
used to determine the angle and the length of FtsZ polymers in the presence/absence of ZipA. 
 
1.7 Objectives 
Membrane proteins present critical targets in biological research. However, the development 
of drugs that acts on membrane proteins has been limited by the lack of data on their structure 
and function. This is partly due to low expression level of most membrane proteins. 
Nevertheless, the major problem for membrane protein studies is the requirement of detergent 
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to extract from the native membrane, which often results in a loss of native structure and 
function. In this project we explore the use of a novel extraction reagent (SMA) for extraction 
of membrane proteins. This reagent negates the need of detergents and preserves the lipid 
annulus around the protein. In order to examine the applicability of the technique we use the 
reagent to purify two structurally and functionally diverse membrane proteins, A2aR and 
ZipA. Finally, we can use these purified SMALP membrane proteins for the subsequent 
characterisation studies. 
 
1.8 Aims 
1. Expression and purification of SMALP and detergent solubilised A2aR 
An A2aR expression plasmid obtained from Dr. Niall Fraser (University of Glasgow). This is 
transferred to Pichia pastoris strain X-33 for protein expression. In order to obtain large 
quantities of protein, a bioreactor culture was used to grow A2aR. The SMALP system is then 
used to solubilise A2aR and compared to an established system using detergent. 
  
2. Characterisation of A2aR 
Purified SMALP-A2aR and purified DDM-A2aR (pure A2aR solubilised by SMALP or DDM 
methods and then purified by standardised purification protocols) was studied using the 
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ligand-binding assay, circular dichroism (CD) and sedimentation velocity analytical 
ultracentrifugation (svAUC). These experiments can be used to characterise A2aR within 
SMALP, and also assess the advantages and disadvantages of the SMALP method compared 
with detergent solubilised sample. 
 
3. Cloning, expression and purification of  ZipA  
A ZipA construct was made and the protein solubilised using the SMALP method as well as 
previous protocol used to purify A2aR.  
 
4. Characterisation of ZipA, the interaction studies between FtsZ and ZipA 
The structure of purified SMALP-ZipA (pure ZipA solubilised by SMALP method and then 
purified by standardised purification protocols) will be characterised using CD and svAUC. 
This material will then be used for studying the FtsZ-ZipA interaction. 
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CHAPTER 2: Materials and Methods 
 
2.1 Materials 
Unless stated otherwise all chemicals used in this project were purchased from Sigma-
Aldrich (Dorset, UK) and Fisher Scientific (Leicestershire, UK). 
 
2.1.1Reagents for Protein Expression  
Synthetic oligonucleotides used for PCR reactions and primer DNA sequencing reactions 
were synthesized by Alta biosciences (University of Birmingham, UK). GoTaq Flexi DNA 
Polymerase was purchased from Promega (Southampton, UK). Restriction enzyme, PmeI, 
was purchased from NEB (Hitchin, UK). DNA loading buffer and Hyperladder I (ranging 
from 200 to 10,000 bp) were purchased from Bioline (London, UK). The pET 101/D-TOPO 
plasmid vector, One Shot
®
 TOP10 Chemically Competent E. coli and One Shot
®
 BL21 Star
™
 
(DE3) Chemically Competent E. coli were purchased from Invitrogen (Paisley, UK). FtsZ 
expression plasmid was kindly provided from Dr. Raul Pacheco-Gomez (University of 
Birmingham, UK). A2aR expression plasmid was obtained from Dr. Niall Fraser (University 
of Glasgow, UK). Pichia pastoris strains X-33 was kindly provided from Dr. Roslyn Bill 
(Aston University, UK). QIA quick gel extraction kit and QIAprep
®
 Spin miniprep kit were 
purchased from Qiagen (Crawley, UK). LB medium and antibiotics, Ampicillin, used in E. 
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coli culture were purchase from Sigma-Aldrich (Dorset, UK). Isopropyl-β-D-
thiogalactopyranoside (IPTG) was purchase from Bioline (London, UK). BMMY/BMGY 
media used in yeast culture containing yeast extract and peptone were purchased from Merck 
(Feltham, UK), yeast nitrogen base without amino acids, biotin and antibiotics, Zeocin, were 
purchased from Invitrogen (Paisley, UK),  glycerol and methanol were purchased from Fisher 
Scientific (Leicestershire, UK).  
 
2.1.2 Reagents for Protein Purification  
Styrene maleic anhydride was supplied by Malvern Cosmeceutics Ltd. (Malvern, UK). DDM 
detergent was purchased from Sigma-Aldrich (Dorset, UK). All lipids were purchased from 
Avanti polar lipids (Alabaster, USA). Ni-NTA agarose was purchased from Qiagen (Crawley, 
UK). Colorplus prestained protein marker was purchased from NEB (Hitchin, UK). Instant 
blue was purchased from Expedeon (Harston, UK). Silver stain kit and BCA protein assay 
reagent were purchased from Thermo scientific (Northumberland, UK). CBQCA protein 
quantitation kit was purchased from Invitrogen (Paisley, UK). For western blotting: 6xHis 
Monoclonal antibody was purchased from Clontech (Saint-Germain-en-Laye, France), rabbit 
anti-A2aR receptor antibodies was purchased from Thermo scientific (Northumberland, UK), 
anti-mouse or rabbit IgG HRP-conjugated , ECL western blotting detection solution and 
autoradiography film were purchased from GE Healthcare (Buckinghamshire,UK). 
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 2.1.3 Reagents for Protein Characterisation 
GTP was purchased from Sigma-Aldrich (Dorset, UK). EnzChek®  Phosphate Assay Kit was 
purchased from Invitrogen (Paisley, UK).  
 
2.2 Methods: Expression and Purification of A2aR 
2.2.1 Yeast Strains, Transformation and Expression Screening 
A glycosylation deficient version of human adenosine 2a receptor (A2aR) expression plasmid 
was obtained from Dr. Niall Fraser (University of Glasgow). The N-linked glycosylation site 
at Asn154 in A2aR was changed to Gln in order to decrease overglycosylation due to yeast 
has a tendency to hyperglycosylate. The A2aR gene was excised by digestion with EcoRI and 
NotI before being cloned into the Pichia pastoris expression vector pPICZαA (Invitrogen) 
(Figure 2-1). The construct contained an N-terminal Flag-tag followed by a 10xHis-tag which 
can be used for the protein purification (Figure 2-2) as well as a Zeocin selection marker [25].  
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pPICZαA- 3593 nucleotides 
5  ´AOX1 promoter region: bases 1-941 
5  ´AOX1 priming site: bases 855-875 
α-factor signal sequence: bases 941-1207 
Multiple cloning site: bases 1208-1276 
c-myc epitope: bases 1275-1304 
Polyhistidine (6xHis) tag: bases 1320-1337 
3  ´AOX1 priming site: bases 1423-1443 
AOX1 transcription termination region: bases 1341-1682 
TEF1 promoter: bases 1683-2093 
EM7 promoter: bases 2095-2162 
Sh ble ORF: bases 2163-2537 
CYC1 transcription termination region: bases 2538-2855 
pUC origin: bases 2866-3539 (complementary strand) 
                                                                                                          http://www.invitrogen.com 
 
 
Figure 2-1.The Pichia pastoris expression vector pPICZαA  
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Figure 2-2 Diagram of the A2aR fusion protein, the protein contains a Flag-tag and a 10xHis-tag in the N-
terminal. 
 
The plasmid was linearized with the restriction endonuclease PmeI. It was then purified and 
concentrated to 0.5 - 1 μg DNA/μl using a centrifugal vacuum concentrators (Labconco), and 
used to transform into Pichia pastoris wild type strain X-33 by electroporation, as described 
by Cereghino et al. [116]. 20 transformants were cultured in BMGY medium (1% yeast 
extract, 2% peptone, 1.34% yeast nitrogen base without amino acids, 0.00004% biotin, 1% 
glycerol, 0.1 M phosphate buffer, pH 6) containing 100 g/ml Zeocin. The cells were grown 
at 30°C and 220 rpm overnight to yield an optical density at 600 nm (OD600) of 2 - 10. 200 l 
of 80% glycerol was added to 0.8 ml of the cell cultures and the mixture was stored at -80°C. 
Clones were then screened for production of A2aR by inducing production in 3 ml BMMY 
medium (BMGY containing 0.5% methanol instead of 1% glycerol) at 30°C and 220 rpm 
with an initial OD600 of 1 in 24-well uniplates (Whatman). Protein production was maintained 
by addition of methanol (to a final concentration of 0.5% (v/v)) at 24 hours and 48 hours of 
post-induction. Samples were collected by centrifugation at 13,000 rpm for 3 minutes in a 
bench microcentrifuge (Labnet, Model 16M) at 6 hours, 24 hours and 54 hours of post-
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induction to analyse production yields and determine the optimal harvest time by Western 
blotting.  
 
2.2.2 Large-scale Flask Culture 
Five litres of A2aR expressing cells were routinely grown as 10 x 500 ml cultures. The frozen 
stock glycerol culture was used to inoculate to 50 ml of BMGY medium containing 100 
g/ml Zeocin at 30°C, 220 rpm until OD600 between 2 and 6. A 500 ml conical flask 
containing BMGY was then inoculated with 25 ml of the initial culture and grown at 30°C 
and 220 rpm until OD600 reached a value between 8 and 12. The cells were centrifuged at 
6,000 x g in a Beckman JA-10 rotor for 20 minutes, and the pellet was then resuspended in 
500 ml BMMY with 10 mM theophylline for induction. This was further incubated at 22°C 
and 220 rpm. At the 12 and 24 hours of post-induction, 0.5% methanol was added to the 
culture. The cells were harvested by centrifuging at 6,000 x g in a Beckman JA-10 rotor for 
20 minutes at the 36 hours of post-induction. The pellet was then washed once with 10 mM 
Tris-HCl buffer, pH 8. 
 
2.2.3 Bioreactor Culture 
A bioreactor, also known as a fermentor, allows precise regulation of pH, carbon source and 
the aeration that in return allows maximising cell densities and expression of the target 
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protein. Several factors should be considered carefully before optimizing the protocols such 
as pH, dissolved oxygen, the level of methanol for induction. For example, a large amount of 
methanol can induce cytotoxic effects and thus decrease the expression level [117]. The 
osmotic stress happens during high cell density which can adapt cell response mechanisms, 
e.g. change in the component of lipid [118]. Bioreactor cultures may yield up to 10 times 
more biomass compared to flask cultures and then increase the expression level of protein 
[25, 30].  
 
Methods 
The frozen glycerol stock culture was used to inoculate to 50 ml of BMGY containing 100 
g/ml Zeocin at 30°C, 220 rpm which was grown until an OD600 between 2 and 6 was 
reached. 50 ml of this culture was used to inoculate a 1 litre fermentor (Applikon) containing 
basal salts medium (BSM) 26.7 ml 85% H3PO4, 0.93 g CaSO4, 18.2 g K2SO4, 14.9 g 
MgSO47H2O, 4.13 g KOH, and 40.0 g glycerol in 1 litre and 4.35 ml PTM1 trace salts 
(PTM1 (filter-sterilized) consists of 6.0 g CuSO45H2O, 0.08 g NaI, 3.0 g MnSO4H2O, 0.2 g  
Na2MoO42H2O, 0.02 g H3BO3, 0.5 g CoCl2, 20.0 g ZnCl2, 65.0 g FeSO47H2O, 0.2 g biotin 
and 5.0 ml H2SO4 in 1 litre)
 
to a starting at OD600 of 0.3. The fermentation was run in fed-
batch mode at 30
o
C, and pH was maintained at 5.0 using undiluted (28%) ammonium 
hydroxide. Dissolved oxygen (DO) was maintained above 20% saturation by adjusting 
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agitation rate and pure oxygen supply. When the initial glycerol (40 g/l) in batch phase was 
depleted, as indicated by an abrupt increase in DO reading, a 50% (w/v) glycerol solution 
containing 1.2% (v/v) PTM1 was fed at a feed rate of 30 ml/hr for 4 hours. Glycerol feed was 
terminated and a 3 hours starvation period was initiated in order to ensure complete glycerol 
consumption. During the final hour of starvation the temperature was at 30
o
C or reduced to 
22
o
C and allowed to stabilise. Theophylline was added into the culture with a final 
concentration of 10 mM to increase A2aR expression. The induction phase is then started, in 
which 100% methanol or mixture of 60% sorbitol and 40% methanol containing 1.2% (v/v) 
PTM1 was fed at a programmed initial feed rate of 1.92 ml/hr for 17 hours to allow culture 
adaptation to methanol. When a steady DO rate and fast DO spike time was obtained, 
indicative of adaptation to methanol utilisation the feed rate was increased to 3.96 ml/hr for 
the remainder of the fermentation. The entire methanol fed-batch phase lasts approximately 
40 hours with a total of approximately 125 ml methanol fed per litre of initial volume. The 
cells were then harvested by centrifuging at 6,000 x g in a Beckman JLA-8.1 rotor and 
washed once with 10 mM Tris-HCl buffer, pH 8.
 
 
2.2.4 Yeast Membrane Preparation 
All work involving membrane preparation was carried out at 0 - 4°C to preserve protein 
integrity. Typically 10 g of cells were suspended in 50 ml ice-cold breaking buffer (5% 
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glycerol, 2 mM EDTA, 50 mM Tris-HCl, pH 7.4, 0.2% protease inhibitor cocktail set IV 
(Merck)) and poured into an Avestin-C3 cell disrupter (Avestin). The cells were broken by 3 
passages through the chilled cell with homogenizing pressures ~30,000 psi. The breaking 
efficiency was > 90% when inspected with a light microscope. Unbroken cells and cell debris 
were removed from the membrane suspension by low-speed centrifugation (10,000 x g in a 
Beckman JA-25.5 rotor for 30 minutes). Membrane was collected using an ultracentrifuge 
(150,000 x g in a Beckman Type 70.1 Ti rotor for 45 minutes) and then resuspended in 
resuspension buffer (10% glycerol, 500 mM NaCl, 50 mM Tris-HCl, pH 8). Membrane was 
rapidly-frozen in liquid nitrogen and stored at -80°C. 
 
2.2.5 Yeast Membrane Solubilisation with SMA Polymer  
2.2.5.1 Preparation of SMA polymer 
Styrene maleic anhydride required hydrolysis to styrene maleic acid (SMA) before use. A 
10% styrene maleic anhydride polymer was prepared by dissolving in 1 M NaOH and stirred 
at room temperature for overnight. The mixture was refluxed for two hours and then 
incubated at 4
o
C for 48 hours. The sample of stock of SMA polymer was stored at -80
o
C until 
it was required. When required, the stock SMA polymer was dialyzed overnight against 50 
mM Tris-HCl, pH 8 using dialysis membranes (3,500 MWCO, Thermo Scientific) to remove 
NaOH before being applied to a solubilisation step. 
58 
 
2.2.5.2 Solubilisation with SMA polymer 
 
Solubilisation with SMA polymer was carried out in the solubilisation buffer I (10% glycerol, 
500 mM NaCl, 2.5% (w/v) SMA, 1% (w/v) DMPC, 50 mM Tris-HCl, pH 8) with a protein 
concentration between 20 - 40 mg/ml. The slurry was stirred for one to two hours at room 
temperature and then centrifuged at 150,000 x g in a Beckman Type 70.1 Ti Rotor for 45 
minutes to remove the unsolubilised materials. The supernatant containing SMALP 
solubilised A2aR (A2aR extracted from cell membranes by SMALP method, not purified yet, 
only the solubilised material) was reserved for further use. 
 
2.2.6 Yeast Membrane Solubilisation with Detergent 
Solubilisation with n-dodecyl-ß-D-maltoside (DDM) was performed in solubilisation buffer 
II (10% glycerol, 500 mM NaCl, 2.5% (w/v) DDM, 0.5% (w/v) Cholesteryl hemi-succinate 
(CHS), 50 mM Tris-HCl, pH 8) with a protein concentration of 20 mg/ml. After incubation 
with slow rotation at 4°C for 2 to 3 hours, the sample was centrifuged at 150,000 x g in a 
Beckman Type 70.1 Ti Rotor for 45 minutes to remove the unsolubilised materials. The 
supernatant containing DDM solubilised A2aR (A2aR extracted from cell membranes by 
DDM method, not purified yet, only the solubilised material) was saved for further use. 
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2.2.7 Purification of A2aR 
There are several purification methods that can be used for A2aR purification, these include 
Immobilized-metal affinity chromatography (IMAC), gel filtration, ion-exchange 
chromatography and affinity methods via an immobilized xanthine ligand.  
 
The first, IMAC was first used for protein purification using the chelating ligand 
iminodiacetic acid (IDA) [119]. IDA was charged with metal ions used for protein 
purification [120]. However, IDA has only three metal-chelating sites results in metal ion 
leaching and leads to low purification yields or impure protein. Nitrilotriacetic acid (NTA) 
has a tetradentate chelating adsorbent site and can be charged with metal ions such as nickel 
ion. NTA binds to four of the six ligand binding sites in the coordination sphere of the nickel 
ion, leaving other two binding sites of nickel ion to bind to His-tagged of protein (Figure 2-3) 
[163]. This method overcomes low purification yields or impure protein. To date, Ni
2+
- NTA 
technology has become one of the most common method for protein purification. 
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Figure 2-3. NTA occupies four of the six ligand binding sites of the nickel ion, leaving two sites free to 
interact with the His tag of protein. 
 
The second, gel filtration, also called size exclusion, separates molecules and proteins 
according to the differences in size. It is a very useful method to separate monomers from 
aggregates for the protein purification. The gel filtration medium is a porous matrix that 
consists of a cross-linked polymer with pores of selected size and packed into the column to 
form a packed bed. Larger molecules migrate faster than smaller ones due to too large to 
enter the pores in the beads, therefore, larger molecules take more direct path through the 
column. The smaller proteins enter the pores in the beads hence take more labyrinthine route 
through the column (Figure 2-4) [12]. 
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Figure 2-4. Gel filtration. Smaller molecules enter the pores in the beads, therefore, migrate slower than 
larger molecules.  
 
The third, ion-exchange, ion-exchange chromatography separates compounds according to 
the net electric charges of protein. The column matrix is a synthetic polymer bound anionic or 
cationic groups. Cationic exchange resins, such as sulphopropyl (strong cationic exchangers) 
and carboxymethyl (weak cationic exchangers), bound anionic group (negative charge) and 
can be used to purify positively charged compounds. Anionic exchange resins, for example, 
quaternary amine (strong anionic exchangers) and diethylaminoethyl (weak anionic 
exchangers), bound cationic group (positive charge) can be used to separate negatively 
charged molecules (Figure 2-5) [12]. The affinity of protein binds to resin is affected by the 
pH (depend on isoelectric point of protein) and the concentration of salt in the buffer, 
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therefore, optimization of purification protocol can be approached by changing the pH or salt 
concentration [12]. 
 
                                                        
Figure 2-5. Ion-exchange. The column matrixcontains anionic or cationic groups. In this example, bound 
cationic group (positive charge), the strongest positive charged compounds are eluted first, followed by 
those with positive charged molecules, negative charged compounds and strongest negative charged 
molecules are eluted last. pH, salt concentration and even temperature all act important roles in controlling 
the separation. 
 
The fourth, affinity methods via an immobilized xanthine ligand, the principle of this method 
is similar to IMAC method: The ligand, in the case of A2aR, Xanthine amine congener (XAC, 
an antagonist of A2aR) was used to bind to the receptor. The A2aR can then be eluted by 
competition elution with other ligands, such as theophylline, an antagonist of A2aR [121,122]. 
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Methods 
2.2.7.1 SMALP Solubilised A2aR Purification Trails 
Several methods were used to develop a protocol for purification of SMALP solubilised 
A2aR. In all cases experiments were carried out at 0 - 4°C to preserve protein integrity. 
 
IMAC method: The supernatant containing the solubilised A2aR was diluted with 80 mM 
imidazole in the resuspended buffer (10% glycerol, 500 mM NaCl, 50 mM Tris-HCl, pH 8), 
so that the mixture had final concentration of 20 mM imidazole in the resuspended buffer. 
The solubilised sample (from 30 g of original culture) was then passed over the 1 ml, 5 ml or 
15 ml of pre-packed His Trap column (GE healthcare) at 4°C overnight, with a flow rate of 1 
ml/min. Alternately, the sample was incubated with 1.5 ml or 15 ml of Ni
2+
-NTA resin 
(Qiagen) with slow rotation at 4°C overnight. The sample was eluted with 20 times column 
volumes of elution buffer (10% glycerol, 500 mM NaCl, 50 mM Tris-HCl, pH 8, plus a linear 
gradient of imidazole up to 500 mM of imidazole). The sample was collected every 0.5 ml. 
 
Gel filtration: The sample was injected into a Superdex 200 10/300 GL column attached to an 
Ä KTA
™ 
purifier FPLC purification system (GE Healthcare) or BioCAD HPLC system. The 
fractions were eluted with gel filtration elution buffer and collected every 0.5 ml (10% 
glycerol, 150 mM NaCl, 50 mM Tris-HCl, pH 8). 
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Ion-exchange: The sample was washed extensively with ion-exchange buffer (10% glycerol, 
100 mM NaCl, 50 mM Tris-HCl, pH 8) before loading onto 3 ml Q Sepharose resin (GE 
Healthcare). The resin was washed with 10 times resin volumes of ion-exchange buffer. The 
receptor was eluted with different concentration of NaCl (from 100 mM to 2 M) in ion- 
exchange buffer. The sample was collected every 0.5 ml. 
 
Affinity methods via an immobilized xanthine ligand: The method has been developed and 
reported in the several publications [26, 121,122]. The experiment was approached according 
to previous publish protocol using synthesized Xanthine amine congener resin (XAC, an 
antagonist of A2aR) [26].  
 
2.2.7.2 Final SMALP Solubilised A2aR Purification Procedure 
A two-step purification process for SMALP solubilised A2aR after numerous of trials (§ 
3.2.4.2) was found to be sufficient. The purification process included IMAC and gel filtration 
step. The supernatant containing the solubilised A2aR was diluted with 80 mM imidazole in 
resuspension buffer (10% glycerol, 500 mM NaCl, 50 mM Tris-HCl, pH 8), so that the 
mixture had final concentration of 20 mM imidazole. The sample was incubated with 1.5 ml 
of Ni
2+
-NTA resin (Qiagen) with slow rotation at 4°C overnight. Typically, 1.5 ml of resin 
was used in 30 g cell pellet of original culture, the resin was washed with 5 times resin 
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volumes of wash buffer (resuspension buffer plus 60 mM imidazole, pH 8) before receptor 
was eluted using the elution buffer (resuspension buffer plus 250 mM imidazole, pH 8) 
within 20 times resin volumes.  
 
The fractions containing A2aR were concentrated using a Vivaspin 20 concentrator (30 kDa 
cut-off, Sigma-Aldrich) and washed extensively with gel filtration elution buffer (10% 
glycerol, 150 mM NaCl, 50 mM Tris-HCl, pH 8) before being injected onto a Superdex 200 
10/300 GL column attached to an Ä KTA
™ 
purifier FPLC purification system (GE 
Healthcare) or BioCAD HPLC. The fractions were eluted with gel filtration elution buffer 
and collected every 0.5 ml (10% glycerol, 150 mM NaCl, 50 mM Tris-HCl, pH 8). 
 
2.2.7.3 Purification of Detergent Solubilised A2aR 
Purification of detergent solubilised A2aR was approached using a three-step purification 
process which included IMAC, ion-exchange and gel filtration [25]. All buffers were 
contained 0.05% DDM and 0.01% CHS. Purification of detergent solubilised A2aR was 
performed as for the SMALP solubilised A2aR based protocol except the following steps 
which were altered: first, all buffers included 0.05% DDM and 0.01% CHS. Second, the 
samples eluted from the IMAC step required an ion-exchange step before being loaded onto 
Superdex 200 10/300 GL. The fractions from IMAC eluted containing A2aR were 
concentrated using Vivaspin 20 concentrator (30 kDa, cut-off) and washed extensively with 
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ion-exchange buffer (10% glycerol, 100 mM NaCl, 50 mM Tris-HCl, pH 8) before loading 
onto a 3 ml Q Sepharose resin (GE Healthcare). The resin was washed with 10 times resin 
volumes of ion-exchange buffer. The receptor was eluted with 250 mM NaCl in ion-exchange 
buffer. The fractions containing A2aR were then concentrated and washed extensively with 
gel filtration elution buffer before being loaded onto Superdex 200 10/300 GL. 
 
2.2.8 SDS-PAGE and Western Blotting 
Unless noted otherwise all work in this section were performed at room temperature. Whole 
cell pellet samples for expression screening were heated at 95°C for 10 minutes in SDS-
PAGE (Laemmli) sample buffer (Table 2-1), and pure receptor samples were incubated with 
sample buffer at 37°C for 15 minutes before being loaded onto the SDS-PAGE gel (Table 2-
2) [123]. Prestained protein marker (range 7-175 kDa, NEB) was used as molecular weight 
marker. The PAGE was run for 50 minutes at 200 volts (V) in SDS-PAGE running buffer (25 
mM Tris-HCl, 192 mM Glycine and 0.1% SDS). The protein was visualised by coomassie 
blue staining (dissolving 0.25 g of coomassie blue in 45 ml methanol, 45 ml water and 10 ml 
glacial acetic acid) for 15~30 minutes and destained in destaining buffer (5:4:1 ratio of 
methanol: water: acetic acid) for one hour to overnight, or used instant blue (Expedeon) and 
destained with water. Alternatively, gel can be visualised by silver staining (Thermo 
scientific) according to the manufacturer’s instructions from Thermo scientific.  
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Components Concentration 
SDS 10% (w/v) 
ß -mercapto-ethanol 10 mM 
Glycerol 20 % (v/v) 
Tris-HCl buffer, pH 6.8 0.2 M 
Bromophenolblue 0.05% (w/v) 
Table 2-1. Recipe of 5x SDS-PAGE sample buffer [123]. 
 
 
 
10% resolving gel 
(volumes) 
Components 
5% stacking gel 
(volumes) 
5.9 ml H2O 3.4 ml 
5 ml 30% (w/v) Acrylamide 0.83 ml 
3.8 ml 
1.5M Tris-HCl buffer, pH 8.8 / 1M Tris-HCl 
buffer,  pH 6.8 
0.63 ml 
0.15 ml 10% (w/v) SDS 0.05 ml 
0.15 ml 10% (w/v) Ammonium persulfate 0.05 ml 
0.006 ml TEMED 0.005 ml 
Table 2-2. Components of 10% resolving gel and 5% stacking gel [123]. 
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For Western blotting, gel was transferred to a nitrocellulose membrane (Sigma-Aldrich) in 
transfer buffer (25 mM Tris-HCl, 192 mM Glycine and 20% methanol) for 60 minutes at 80 
V. The membrane was transferred to blocking buffer (TBST buffer: 10 mM Tris-HCl, pH 7.3, 
100 mM NaCl, 0.2% tween 20, plus 5% non-fat dried milk ) for 1 hour to reduce non-specific 
binding. The membrane was then placed in blocking buffer with 1 : 5,000 diluted 6xHis 
Monoclonal antibody (Clontech) for one hour or with 1 : 250 to 1 : 1,000 diluted rabbit anti-
A2aR receptor antibody (Thermo scientific) for between 1 and 12 hours. The membrane was 
then washed with TBST buffer for 5 minutes and repeated 3 times to remove unbound 
antibody before being placed in blocking buffer with 1 : 10,000 diluted anti-mouse or anti-
rabbit IgG HRP-conjugated (GE Healthcare) for 1 hour. The next step was carried out before 
the bands were visualised using ECL Western blotting detection solution (GE Healthcare) 
and autoradiography film (GE Healthcare) or Gel documentation System (UVItec). 
 
2.2.9 Identification of A2aR 
The band corresponding to the expected mass of A2aR was excised from SDS-PAGE gel and 
then identified by Functional Genomics and Proteomics Laboratory within the School of 
Biosciences at University of Birmingham. The sample was digestion with trypsin before 
identification using Fourier Transform Ion Cyclotron Resonance (FT-ICR) mass 
69 
 
spectrometry. The data were then run a search on Mascot to identify the protein and then 
further analysed using MassLynx software. 
 
2.2.10 Protein Quantitation 
Although there are several methods to quantitate proteins in solution, quantitation of a 
membrane protein is difficult since the lipid membrane and detergents may interfere with the 
assay. To address these three different methods were used to measure protein concentration. 
(1) Ultraviolet (UV) spectrophotometry absorption at 280 nm: This method is a fast and easy, 
however, it is not ideal for membrane proteins. The absorbance maximum in the near UV 
(280 nm) was due to the amino acids with aromatic residues such as Tyrosine and 
Tryptophan [12, 20]. (2) Bicinchoninic acid (BCA) method: This method is a modification of 
the Lowry method improved by Smith et al in 1985 [124]. This method, however, can be 
influenced by the presence of lipid. (3) CBQCA protein quantitation kit: this is a 
commercially available kit which shows a good response in the presence of lipids and 
detergents. It is an ideal method to measure membrane protein concentration. In this project, 
we found CBQCA protein quantitation kit (Invitrogen) does not show interference with lipids, 
DDM and SMA. Therefore, this method is the best way to obtain accurate protein 
concentration in the presence of lipids, DDM and SMA. 
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Methods 
Determining the protein concentration using UV spectrophotometry at 280 nm was based on 
following equation:  
Absorbance (280 nm) = [Protein] (M) x Extinction coefficient (M
-1 
cm
-1
) x pathlength (cm) 
In the case of A2aR, extinction coefficient is 66,850 [125].  
 
BCA assay (Thermo scientific) and CBQCA protein quantitation (Invitrogen) methods were 
performed as described by the manufacturer’s instructions from Thermo scientific and 
Invitrogen. An aqueous solution of bovine serum albumin (BSA) was used as a standard.  
 
2.3 Methods: Characterisation of A2aR 
2.3.1 Radioligand Binding Assays 
A radioligand binding assay is based on the use of a radioactively labelled compound which 
interacts with a receptor. Tritium [
3
H] is the most common isotopes used to label these 
compounds due to its long half-life (12.3 years) [52].  The radioligand binding assays are not 
only used for studying membrane-bound receptor, but also widely used to analyse purified 
receptors.  This tool can also use to analyse the interactions of hormones, neurotransmitters, 
and drugs with the related receptors. There are three main types of information can be given 
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by radioligand binding assays: saturation binding, competitive binding, and kinetics assays 
[52, 126]. 
 
Saturation binding assay  
This assay is used for measuring total binding and non-specific binding at various 
concentrations of the radioligand. The specific binding can be calculated by non-specific 
binding is subtracted from total binding. The maximum binding capability (Bmax) and 
equilibrium dissociation constant (Kd) are calculated from specific binding using Scatchard 
plots [127, 128]. 
 
Competitive binding assay 
The experiment can determine equilibrium binding of a radioligand with a fixed 
concentration at various concentrations of displacing ligand. The data are used to analyse the 
affinity of the receptor for the competitor (displacing ligand) [127, 128]. 
 
Kinetics assay 
The experiment can measure the binding at different times and then used to determine the 
association rate (ligand associating with the receptor) and dissociation rate (ligand 
dissociating from the receptor) constants of radioligand [127, 128]. 
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Method 
All radioligand binding assays were performed using [
3
H]ZM241385, an A2aR antagonist, in 
binding assay buffer (0.5 mM EDTA, 50 mM sodium phosphate, pH 7.4). The assays were 
carried out by Dr. David Poyner (Aston University, UK). For membrane-bound A2aR, the 
assay was performed as described previously [25]. For SMALP/ detergent solubilised or 
purified A2aR (typically at 0.1 mg/ml), the assay was modified for saturation binding analysis 
by incubating the various concentrations of [
3
H] ZM241385 with diluted A2aR for 90 minutes 
at room temperature in the binding assay buffer. For displacement studies, the solubilised 
receptor was incubated with a fixed concentration of [
3
H]-ZM241385 (nominally 1 nM; the 
actual concentration was measured in each experiment) with varying concentrations of 
displacing ligand.  
 
For thermal stability experiments the receptor was pre-incubated at the desired temperature 
for 30 minutes prior to incubation with 1nM [
3
H] ZM241385. Non-specific binding was 
determined in parallel incubations with 1 μM ZM241385. The samples were loaded onto P30 
mini-spin gel filtration columns (Bio-Rad Laboratories Inc.) that had been pre-equilibrated in 
the binding assay buffer and the eluate was collected by centrifugation (3,000 rpm for 4 
minutes). For the displacement and thermal stability experiments, crude SMALP solubilised 
samples were used, rather than purified receptor. Saturation and displacement binding curves 
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were analysed using PRISM Graphpad v4.0, fitting the data to sigmoidal curves with a Hill 
slope constrained to unity. In the displacement studies, Ki values were calculated from IC50’s 
using the Cheung-Prussoff equation. Thermostability curves were fitted to a Boltzmann 
sigmoidal function to calculate the temperature at which binding was reduced by 50% (T½ ).  
 
2.3.2 Circular Dichroism 
Circular dichroism (CD) spectroscopy has been widely used to determine the secondary 
structure of proteins, for example, α-helix, β-sheet, β-turn and polyproline (describe below). 
The different secondary structures of proteins absorb different amounts of right and left 
circularly polarized light providing CD signals [129, 130]. The CD spectrum between the far-
UV region (190 - 260 nm) is a specific region for the peptide backbone and allows the 
identification of secondary structure elements within a protein. By examining the shape CD 
spectra of proteins of known structure, it has been shown that certain features in the spectrum 
correlate with the presence of each secondary structure type (Figure 2-6) [131].  
 
α-helix 
The CD spectrum of α-helix exhibits a double minimum at 208 nm and 222 nm. It also 
presents positive CD signals between 190 nm - 200 nm [130,131].  
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β-sheet 
Unlike α-helix, the CD spectrum of β-sheet is not so well defined. However it is accepted that 
in general β-sheets display a minimum between 216 - 220 nm and a positive peak 
approximately at 195 nm [130,131]. 
 
 β-turn 
The CD spectra of β-turns are quite difficult to define because of it can include numerous 
kinds of turn in a protein. The common shape of β-turn is included a positive peak between 
200 nm and 205 nm and a negative peak between 220 - 225 nm. In addition, it also presents a 
strong negative signal between 180 nm and 190 nm [130,131]. 
 
Polyproline  
The CD spectrum of polyproline is unusual in that it has a positive peak between 225 and 230 
nm [130,131]. 
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                                                                                                                                             [131] 
Figure 2-6. CD spectra of various secondary structure motifs. Each type of secondary structure of protein 
presents different shape. For a protein containing a mix of structures the shape of spectrum is made up of 
the sum of signals from each element. 
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Method 
The protein sample was dialysed using dialysis membrane (14,000 MWCO) against 3 litres of 
10 mM sodium phosphate, pH 8, prior to the CD spectrum was measured. The far-UV (190 - 
260 nm) CD spectrum was recorded in a JASCO J-715 spectrophotometer using 1 mm 
pathlength quartz cuvette. The thermal stability experiments were performed using 1 mm 
pathlength on a JASCO J-810 spectrophotometer fitted with a Peltier heating block. The 
thermal stability experiments involved two methods: The first, monitoring the change in CD 
signals at 222 nm as a function of increasing temperature (0.5°C steps between 25°C and 
95°C). The second, involved recording full wavelength scans between 190 nm and 260 nm 
every 10°C between 25°C and 95°C.  
 
2.3.3 Sedimentation Velocity Analytical Ultracentrifugation 
Sedimentation velocity analytical ultracentrifugation (svAUC) allows the characterisation 
mass of sample in their native state in the solution. The sedimentation velocity experiments 
used in this study separates the molecules by the difference in mass and shape and provides 
information about the solution homogeneity, mass of the sample particle and identifies any 
aggregation [130].  
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Methods 
Receptor sample was equilibrated in 10 mM sodium phosphate, pH 8, prior to analytical 
ultracentrifugation. Velocity experiments were performed using a Beckman Coulter XL-I 
analytical ultracentrifuge and a Ti50 rotor at 40,000 rpm, 4
o
C. The protein concentration 
within the cell was monitored at 280 nm. These data were then analysed using the c(S) and 
c(M) routines implemented within SEDFIT [132]. Parameters for A2aR vbar and solvent 
density and viscosity were calculated using SEDNTERP. The value for vbar is only an 
estimate for the SMALP encapsulated particle as value SMA is not available. 
 
2.3.4 Electron Microscopy  
Receptor sample was equilibrated in 10 mM sodium phosphate, pH 8, and then centrifuged at 
10,000 rpm for 5 minutes to remove any aggregated protein or large particles. 5 µl of the 
mixture was transferred to the carbon side of an electron microscopy grid for 1 minute. The 
sample was stained by incubating in 1% uranyl acetate solution for 45 seconds before the 
excess solution was removed. The electron microscopy (EM) experiment was carried out 
using a JEOL 2011 Transmission electron microscope (TEM). The samples were visualised 
at magnification of 10,000 and 40,000 times.       
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2.4 Methods: Expression and Purification of ZipA 
2.4.1 Plasmid Construction, Escherichia coli Strains and Transformation 
2.4.1.1 Extraction of Escherichia coli Genomic DNA 
ZipA exists as a single copy in the genome of most gram-negative bacteria. In this study, we 
extracted genomic DNA from E. coli strain TOP10 and used it as the template for polymerase 
chain reaction (PCR) to amplify ZipA gene. 
 
Methods 
TOP10 E. coli cells were grown in 5 ml of LB medium at 37°C overnight and then 
centrifuged at 13,000 rpm for 2 minutes in a bench microcentrifuge (Labnet, Model 16M). 
The cell pellet was resuspended in NaCl/EDTA buffer (0.15 M NaCl, 0.1 M EDTA, pH 8.0). 
0.5 mg lysozyme and 0.2 mg RNaseA were added into the sample, and then incubated at 
37°C for 30 minutes. A 25% SDS (w/v) stock solution was added to the sample, so that the 
final mixture had a SDS concentration of 2% (w/v). The sample was incubated at 60°C for 10 
minutes and cooled in a cold water bath to lyse the cells. A 5 M NaCl stock solution was 
added to raise the NaCl concentration to 2 M before adding a mixture of Phenol/CHCl3/IAA 
(Phenol: chloroform: isoamyl alcohol = 25:24:1). The sample was centrifuged at 10,000 rpm 
for 10 minutes using a bench microcentrifuge (Labnet, Model 16M) and added CHCl3/IAA 
(chloroform: isoamyl alcohol = 24:1) to the supernatant. The mixture was centrifuged again 
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at 10,000 rpm for 5 minutes in a bench microcentrifuge (Labnet, Model 16M) and the 
supernatant was kept. Finally, the DNA was precipitated by adding 100% ethanol, followed 
by washing the pellet with 70% ethanol and drying in the air. The dried DNA was then 
resuspended in deionised water for further use. 
 
2.4.1.2 Polymerase Chain Reaction  
The primer sequences (synthesized by Alta biosciences) used to carry out a PCR to amplify 
ZipA gene is described in Table 2-3. 1.25 U Taq DNA polymerase, 0.2 mM dNTPs,  2  mM 
MgCl2, 0.5 mM primers and 1 g genomic DNA which was extracted from previous 
experiment (§ 2.4.1.1) were used in a PCR reaction according to the procedures in the manual 
from Promega. The PCR reaction cycle parameters are shown in Table 2-4. The PCR 
products were examined by 1% agarose gel electrophoresis. 
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Table 2-3: Synthetic oligonucleotides used to amplify ZipA gene. A CACC sequence (underlined) allows 
topoisomerase I to ligate the blunt end PCR product to the pET101/D- TOPO plasmid vector (See Figure 
2-7 and 2-8). 
 
Cycle Step Temperature (°C) Time (minute) 
x1 Initialization 95 2 
 
x30 
Denaturation 95 1 
Annealing 58 1 
elongation 72 1 
x1 Final elongation 72 5 
Table 2-4: The PCR reaction cycle 
 
2.4.1.3 Agarose Gel Electrophoresis  
The 1% (w/v) of agarose solution was prepared by dissolving 0.5 g of agarose in 50 ml of 
1×TAE buffer (40 mM Tris-HCl, 20 mM Acetate, 2 mM EDTA) followed by heating in 
microwave for 1 minute at full power. Ethidium bromide was added to a final concentration 
  
Sequence 
 
Tm(°C) 
 
GC(%) 
 
Forward Primer 
 
5’CACCATGATGCAGGATTTGCGTCT 3’ 
 
67.8 
 
50 
 
Reverse Primer 
 
5’ GGCGTTGTCTTTGACTTCGCG 3’ 
 
67 
 
57.1 
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of 0.5 μg/ml after agarose solution was cooled down to 50°C in a cold water bath. The 
mixture was poured into a mould with a comb and allowed it to cool to room temperature. 
The gel was placed in an electrophoresis tank filled with 1×TAE buffer. The DNA sample 
was mixed with 5×DNA loading buffer (Bioline) before loading into the gel. A HyperLadder 
I (Bioline) was loaded to the gel as a molecular weight marker. The gel was run at 80 V for 
50 minutes and then examined using UV light. 
 
2.4.1.4 Purification of PCR Product from Agarose Gel  
PCR product was purified from agarose gel using a QIA quick gel extraction kit for ligation 
experiment. The kit was designed for DNA size from 70 bp to 10 kb and contains a silica 
membrane assembly for binding of DNA. The impurities such as enzymes, agarose and 
ethidium bromide, were removed during the purification procedure. A purification procedure 
using a QIA quick gel extraction kit was followed the manufacturer’s instructions from 
Qiagen.  
 
2.4.1.5 Ligation Reaction  
The ligation reaction was performed using Champion pET101 Directional TOPO plasmid 
vector which contains a T7 promoter, a 6×His tag at C-terminus and Ampicillin resistance 
gene (Figure 2-7). 
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T7 promoter: bases 209-225 
T7 promoter priming site: bases 209-228 
lac operator (lacO): bases 228-252 
Ribosome binding site (RBS): bases 282-288, 292-296 
TOPO®  cloning site (directional): bases 297-310 
V5 epitope: bases 333-374 
Polyhistidine (6xHis) region: bases 384-401 
T7 reverse priming site: bases 455-474 
T7 transcription termination region: bases 416-544 
bla promoter: bases 845-943 
Ampicillin (bla) resistance gene (ORF): bases 944-1804 
pBR322 origin: bases 1949-2622 
ROP ORF: bases 2990-3181 (complementary strand) 
lacI ORF: bases 4493-5584 (complementary strand)                                       
 
                                                                                                          http//:www.invitrogen.com 
Figure 2-7. Vector map of pET101/D- TOPO. In the pET TOPO
 
vectors, expression of the gene of interest 
under control of T7 promoter. When T7 RNA polymerase is present, it binds to T7 promoter and 
transcribes the gene of interest. T7 RNA polymerase gene is controlled of the lacUV5 promoter, when 
IPTG (inducer) is added that allows expression of T7 RNA polymerase from the lacUV5 promoter. The 
vector contains a 6×His tag for affinity purification of protein of interest and Ampicillin resistance gene as 
selection marker. 
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Topoisomerase I binds to DNA at specific sites (after 5’-CCCTT in one strand). 
Topoisomerase I cleaves the phosphodiester backbone and the energy from the broken 
phosphodiester backbone is used for the formation of a covalent bond between the 3′ 
phosphate of the cleaved strand and tyrosyl residue of topoisomerase I. This phospho-tyrosyl 
bond can be attacked by the 5′ hydroxyl of the original cleaved strand this results in reversing 
the reaction and releasing topoisomerase I. The vector contains a single-stranded GTGG 
overhang on the 5’ end and a blunt end on the 3’ end [98]. Therefore, PCR product contains 
CACC sequence at 5’ end allows topoisomerase I to ligate PCR product to the pET101/D- 
TOPO plasmid vector (Figure 2-8). Figure 2-9 shows a diagram of the ZipA fusion protein 
containing a V5 epitope-tag and a 6 x His-tag in the C-terminal. 
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Figure 2-8. Directional TOPO cloning. The vector contains a single-stranded GTGG overhang on the 5’ 
end and a blunt end on the 3’ end. PCR product contains CACC sequence at 5’ end allowing 
topoisomerase I to ligate PCR product to the vector. 
 
 
Figure 2-9 .Diagram of the ZipA fusion protein, the protein contains a V5 epitope-tag and a 6 x His-tag in 
the C-terminal. 
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Methods 
The 0.5:1 to 2:1 molar ratio of PCR product: vector was used in ligation reaction. The volume 
of vector was 1 μl. The reaction composition was described at Table 2-5. The mixture was 
incubated at room temperature for 5 minutes and stored at 4°C for further use. 
 
Component and final concentration Quantity 
PCR product 0.5 to 4 μl 
Salt solution (0.2M NaCl and 0.01M MgCl2) 1 μl 
Sterile water Added to a final volume of 5 μl 
TOPO vector 1 μl 
Table 2-5. The composition of ligation reaction. 
 
2.4.1.6 Transformation of TOP10 Chemical Competent Cells 
TOP10 chemical competent cells (Invitrogen) were used as a host for plasmids DNA. T7 
RNA polymerase is absent in TOP10 E.coli cell, therefore, the cell is ideal for maintenance 
reproduction and propagation of plasmid DNA. 
 
Methods 
1 to 5 l of ligation products were added to one vial (50 l) of TOP10 chemical competent 
cells and then the mixture was incubated on ice for 30 minutes. The cells were heat-shocked 
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for 30 seconds at 42°C using water bath and then immediately placed on ice 2 minutes. 250 
l of S.O.C. medium (2% Tryptone, 0.5% Yeast extract, 10 mM MgSO4 10 mM NaCl, 2.5 
mM KCl, 10 mM MgCl2 , 20 mM glucose) was added to the sample and incubated at 37°C 
,180 rpm for 1 hour. 20 l to 100 l of mixture was plated onto an LB agar plate containing 
the 100 g/ml Ampicillin at 37°C overnight. 
 
2.4.1.7 Isolation of Recombinant Plasmid DNA  
TOP10 E.coli cell is an excellent candidate for maintenance reproduction and propagation of 
plasmid DNA. Qiagen mini/midi prep extraction kit was used to isolation of plasmid DNA. 
The kit consists of a disposable chromatography column which is used for absorption and 
elution of plasmid DNA. The recombinant plasmid DNA is used for transform into BL21 star 
(DE3) One Shot E.coli cells for protein expression. 
 
Methods 
Selected fresh colonies from previously transformants (TOP10 E.coli cell) were inoculated 
into 5 ml of LB medium containing 100 g/ml Ampicillin and incubated at 37°C, 180 rpm 
overnight. The cultures were used to extract plasmid DNA. The experiment was then carried 
out using a Qiagen mini/midiprep extraction kit according to the manufacturer’s instructions.   
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2.4.1.8 DNA Sequencing 
200 - 500 ng of plasmid DNA isolated from TOP10 E.coli cells were sequenced by 
Functional Genomics and Proteomics Laboratory within the School of Biosciences at 
University of Birmingham. The sample prepared for sequencing was shown at Table 2-6. 
Experiment was carried out using an ABI 3730 Analyser and checked using programme 
BLAST sequence alignment programme [109].  
 
Component Quantity 
Template (plasmid DNA) 200-500 ng 
Primer (used  PCR to amplify ZipA gene) 3.2 pmol 
Deionised water x l 
Terminator Reaction Mix (from Genomics lab) 10 l 
Total volume 20 l 
Table 2-6.The sample prepared for DNA sequence. 
 
2.4.1.9 Transformation of BL21 Star (DE3) One Shot E.coli Cells 
BL21 star (DE3) One Shot E.coli cells (Invitrogen) were used for high level expression of 
genes cloned to vector contains bacteriophage T7 promoter such as pET series. The cells 
contain lysogen of DE3 and carry a chromosomal copy for T7 RNA polymerase gene under 
the control of lacUV5 promoter, therefore, allowing protein expression to be induced by 
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IPTG. OmpT, an outer membrane protease, and lon protease are absent in BL21 star (DE3) 
E.coli cells to reduce heterologous protein degradation. 
 
Methods 
5 - 10 ng of recombinant plasmid DNA containing correct sequence (in 1 to 5 l volume) was 
added to one vial (50 l) of BL21 star (DE3) E.coli cells and incubated on ice for 30 minutes. 
The cells were heat-shocked for 30 seconds at 42°C using water bath and then immediately 
placed on ice. 250 l of S.O.C. medium was added to the cultures and incubated at 37°C, 180 
rpm for 30 minutes. 20 l to 100 l of mixture were plated onto an LB agar plates containing 
100 g/ml Ampicillin at 37°C overnight. 
 
2.4.2 Small-scale Flask Culture  
Selected colonies from successful transformants were inoculated into 5 ml of LB medium 
containing 100 g/ml Ampicillin. The cells were incubated at 37°C overnight with shaking at 
180 rpm. 200 l of 80% glycerol was added to 0.8 ml of the initial culture, and the mixture as 
the glycerol stock can be stored at -80°C. 3 ml of the initial cultures were diluted into 50 ml 
of LB medium containing 100 g/ml Ampicillin. The cultures were grown at 37°C and 180 
rpm until OD600 of 1. A stock IPTG was added into culture to make a final IPTG 
concentration of 0.84 mM, and the cells were grown for another 3 hours. The cells were 
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harvested by centrifuging at 6,000 x g in a Beckman JA-25.5 rotor for 30 minutes, and the 
pellets were washed once with 10 mM Tris-HCl buffer, pH 8. 
 
2.4.3 Large-scale Flask Culture 
The E.coli colonies expressing ZipA protein were inoculated to 5 ml LB medium with 100 
g/ml Ampicillin. The cells were incubated at 37°C and 180 rpm overnight. A 500 ml of LB 
medium containing 0.04% sterile glucose and 100 g/ml Ampicillin was then inoculated with 
5 ml of the initial culture, grown at 37°C and 180 rpm until OD600 of 1. A stock IPTG was 
then added into culture to make a final IPTG concentration of 0.84 mM and the cells were 
grown another 3 hours then harvested by centrifuging at 6,000 x g in a Beckman JA-10 rotor 
for 20 minutes, and the pellets were washed once with 10 mM Tris-HCl buffer, pH 8. 
 
2.4.4 E.coli Membrane Preparation 
E.coli membrane preparation was performed as yeast membrane preparation based protocol 
except the following step which was altered: the homogenizing pressure was 25,000 psi for 
E.coli cells. 
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2.4.5 Solubilisation with SMA and Purification of SMALP Solubilised ZipA 
Solubilisation step was carried out as previously describe in 2.2.5. Purification of SMALP 
solubilised ZipA was performed as purification of SMALP solubilised A2aR based protocol 
(§ 2.2.7.2) with the exception of the following changes. The first, 1.5 ml of resin was used in 
15 g cell pellet of original culture. The second, an additional wash step with 5 times resin 
volumes of wash buffer (resuspension buffer plus 80 mM imidazole, pH 8) was required. 
 
2.4.6 SDS-PAGE and Western Blotting of ZipA 
SDS-PAGE and western blotting was achieved according to previously protocol (§ 2.2.8) 
using 6xHis Monoclonal antibody (Clontech) as the primary antibody. 
 
2.4.7 Identification of ZipA 
The band representing ZipA was excised from SDS-PAGE gel and then submitted to the 
Functional Genomics and Proteomics Laboratory as previously described (§ 2.2.9). 
 
2.4.8 The N-terminal Sequencing of ZipA 
The purified SMALP-ZipA was loaded into SDS-PAGE gel. The Gel was run for 50 minutes 
at 200 volts (V) in SDS-PAGE running buffer and then transferred to Polyvinylidene fluoride 
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(PVDF) membrane. The PVDF membrane was stained with coomassie blue and a band at 
~52 kDa was excised from PVDF membrane. The sample was identified by Alta Biosciences 
at University of Birmingham. The system used for the N-terminal protein sequencing 
chemistry first devised by Edman. The equipment used by the laboratory is an Applied 
Biosystems Procise 494HT machine. 
 
2.4.9 FtsZ Protein Preparation 
FtsZ protein used for the interaction experiments between FtsZ and ZipA was kindly 
provided by Dr. Raul Pacheco-Gomez (University of Birmingham, UK). FtsZ protein was 
also purified following the protocol described below [133]. Expression plasmid for FtsZ 
protein was kindly provided from Dr. Raul Pacheco-Gomez.  
 
2.4.9.1 FtsZ Protein Expression 
Plasmid DNA was transformed to BL21 star (DE3) E.coli cell was previously describe in 
2.4.1.9. The cells were plated onto an LB agar plate containing the 100 g/ml Ampicillin at 
37°C overnight. Selected colonies from the successful transformation experiment were 
inoculated to 5 ml LB medium with 100 g/ml Ampicillin. The cells were incubated at 37°C 
and 180 rpm overnight. A 500 ml of LB medium containing 100 g/ml Ampicillin and 0.04% 
sterile glucose was inoculated with 5 ml of the initial culture, grown at 37°C and 180 rpm 
until OD600 of 0.4. A stock IPTG was then added into culture to make a final IPTG 
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concentration of 0.84 mM and allowed cells to grow for another 3 hours. The cells were 
harvested by centrifuging at 6,000 x g in a Beckman JA-10 rotor for 20 minutes, and the 
pellets were washed once with 10 mM Tris-HCl buffer, pH 7.9.  
 
2.4.9.2 FtsZ Protein Purification 
All work involving protein purification was carried out at 0 - 4°C. Typically 10 g of cells 
were suspended in 50 ml ice-cold lysing buffer (50 mM Tris-HCl, pH 7.4, 2 mM EDTA, 
0.2% protease inhibitor cocktail set IV (Calbiochem)) and poured into an Avestin-C3 cell 
disrupter. E.coli cells were broken by 3 passages through the chilled cell. Unbroken cells and 
cell debris were removed from the membrane suspension by low-speed centrifugation 
(10,000 x g in a Beckman JA-25.5 rotor for 30 minutes). The membrane fraction was 
removed using an ultracentrifuge (150,000 x g in a Beckman Type 70.1 Ti Rotor for 45 
minutes). A 30% ammonium sulfate (16.6 g/100 ml of extract) was then slowly added to the 
supernatant with stirring for 20 minutes. The ammonium sulphate precipitate was collected 
using a centrifugation (20,000 x g in a Beckman JA-25.5 Rotor for 15 minutes) and 
resuspended in buffer A (50 mM Tris-HCl, pH 7.9, 50 mM KCl, 1 mM EDTA, 10% 
glycerol). The sample was dialysed using dialysis membrane (3,500 MWCO, Thermo 
Scientific) overnight against 3 x 1 litre of buffer A.  
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The dialysed ammonium sulphate fraction was loaded to Q Sepharose resin (GE Healthcare) 
with slow rotation for 1 hour. Typically, 3 ml of resin was used in 1 litre of original culture. 
The resin was washed with 5 times resin volumes of buffer A before the protein was eluted 
with 250 mM KCl in buffer A. Fractions of 2 ml were collected and examined by SDS-
PAGE. The eluted fractions containing pure FtsZ were mixed. Further purification steps 
where then used to remove contaminating acetate kinase activity [133, 134]. A 20% 
ammonium sulfate (11 g/100 ml of extract) was added to mixture containing FtsZ with 
stirring for 20 minutes. The ammonium sulphate precipitate was collected using 
centrifugation (20,000 x g in a Beckman JA-25.5 rotor for 15 minutes) and resuspended in 
buffer A. The sample dialyzed overnight against extensive buffer A. The further ion- 
exchange chromatography was then carried out following the same procedure previously 
described. The fractions containing pure FtsZ were concentrated using a Vivaspin 20 
concentrator (30 kDa cut off, Sigma-Aldrich) and washed extensively with 50 ml of buffer A. 
The FtsZ protein can be stored at -80°C for more than 1 year. 
 
2.4.10 Protein Quantitation 
ZipA and FtsZ protein quantitation were carried out according to previously described (§ 
2.2.10). 
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2.5 Methods: Characterisation of ZipA 
2.5.1 Circular Dichroism and Sedimentation Velocity Analytical Ultracentrifugation 
CD and svAUC of ZipA were carried out according to previously protocol (§ 2.3.2 and 
2.3.3). 
 
The Interaction Experiments Between FtsZ and ZipA 
The sections from 2.5.2 to 2.5.7 described the methods used to characterise the FtsZ-ZipA 
interaction. 
 
2.5.2 Right Angle Light Scattering 
The dynamics of FtsZ polymerisation, steady state and depolymerisation could be measured 
by Right-Angle Light-Scattering assay (RALS). The experiment was performed according to 
the preliminary work developed by Mukherjee and Lutkenhaus [135]. This study showed that 
FtsZ polymerisation reached steady state within the first minute of the reaction, the length of 
steady state was proportional to the GTP concentration. FtsZ depolymerisation followed this 
steady state as a result of GTP hydrolysis by FtsZ [135]. In the presence of ZipA protein, the 
dynamics of FtsZ polymerisation, steady state and depolymerisation could be changed and it 
provides us the information about the size of FtsZ polymer affected by ZipA.  
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Methods 
11 M FtsZ and appropriate ZipA were incubated at 25°C for 10 minutes in polymerization 
buffer (50 mM MES, pH 6.5, 50 mM KCl, and 10 mM MgCl2) to give a final volume of 100 
l. The sample was placed into a 0.3 cm path length fluorescence cuvette. The experiments 
were performed using a Perkin Elmer LS50B spectrofluorimeter. The excitation and emission 
wavelengths were set at 500 nm, and the excitation and emission slit widths were set at 2.5 
nm. A baseline was collected for 2 minutes before 0.2 mM GTP was added to the sample. 
 
2.5.3 Linear Dichroism 
Linear dichroism (LD) is a spectroscopic technique that can be used for studying on the 
orientations of biomolecules in ordered arrays [115]. For example, it has been used to study 
of oriented peptide in liposomal membrane [136]. Linear dichroism is defined as the 
difference in absorbance of light polarized parallel and perpendicular to an orientation axis 
[115]. LD spectrum can be obtained by modifying circularly polarised light of CD 
spectropolarimeter to linearly polarised light by the addition of a quarter wave plate or by 
modifying the phase of the lock-in amplifier [133].  
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Methods 
11 M FtsZ and appropriate ZipA were incubated at 25°C for 10 minutes in polymerisation 
buffer (50 mM MES, pH 6.5, 50 mM KCl, and 2.5 mM MgCl2) to give a final volume of 90 
l. The experiments were performed at room temperature using a Jasco J-715 
spectropolarimeter adapted for LD spectroscopy. The sample was then placed into a quartz 
capillary Couette cell which induces long assemblies to align by applying a shear flow 
(generated by spinning the capillary). The experiment was carried out with a rotation (7 V) 
and a blank (non-rotation) was subtracted from each sample measured. Data were recorded 
using an interval scan measurement programme. The wavelength range was set between 190 
nm and 350 nm with a scanning speed of 200 nm/min and data pitch of 0.5 seconds.  
 
2.5.4 GTPase Assay 
The inorganic phosphate (Pi) released from enzymatic reactions can be determined by a 
spectrophotometric method. This method is based on the conversion of 2-amino-6-mercapto-
7-methylpurine riboside (MESG) to ribose 1-phosphate and 2-amino-6-mercapto-7-
methylpurine by an enzymatic reaction leading to a shift in the wavelength of maximum 
absorbance from 330 nm to 360 nm [138]. Purine nucleoside phosphorylase (PNP) uses Pi 
released from the action of FtsZ on GTP to convert MESG to ribose 1-phosphate and 2-
amino-6-mercapto-7-methylpurine leading to an increase in the absorbance at 360 nm. The 
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increase in the absorbance at 360 nm can thus be used to quantitate Pi. The assay can 
therefore be used to determine the GTPase activity of FtsZ produced when the FtsZ monomer 
forms FtsZ polymers [133]. It also allows the measurement of the catalytic activity of FtsZ in 
the presence/or absence of ZipA (Figure 2-10).  
 
 
Figure 2-10. Schematic diagram for measuring the catalytic activity of FtsZ in the presence/or absence of 
ZipA. Pi is released from GTP hydrolysis catalysed by FtsZ. PNP uses Pi to convert MESG to ribose 1-
phosphate and 2-amino-6-mercapto-7-methylpurine results in shift in the wavelength of maximum 
absorbance from 330 nm to 360 nm. The change in absorption at 360 nm allows quantification of Pi and 
thus determine the catalytic activity of FtsZ in the presence/or absence of ZipA. 
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 Methods 
The experiment was performed using an EnzChek®  Phosphate Assay Kit (Invitrogen) based 
on manufacturer’s instructions from Invitrogen. The sample was prepared as described in 
Table 2-7. The mixture was incubated at 25°C for 10 minutes and placed into a 0.5 cm 
cuvette. The experiment was carried out using a Jasco V-550 spectrometer at room 
temperature, and the wavelength was set up at 360 nm. The Abs360 was zeroed before adding 
0.2 mM GTP into the sample.  
 
Compound Final concentration 
dH2O x 
MES pH 6.5 50 mM 
KCl 50 mM 
MgCl2 2.5 mM 
MESG 0.4 mM 
PNP 1 U/ml 
FtsZ 11 µM 
ZipA Appropriate 
 Table 2-7.The components for GTPase assay. 
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2.5.5 Sedimentation Assay  
A previous study has described that a sedimentation assay can be used for determining the 
effect of the FtsZ co-protein YgfE on FtsZ polymerisation [113,137]. The FtsZ polymers can 
be selectively sedimented to form a pellet leaving unincorporated monomers in the solution.  
 
Methods 
A protocol for sedimentation assay was similar to published protocol [139]. The samples 
were prepared as described in Table 2-8. 250 μl mixture containing FtsZ and/or ZipA was 
made up in the polymerisation buffer and then incubated at 25°C for 10 minutes. 2 mM GTP 
was added to the sample immediately before centrifugation. Experiments were carried out at 
20
o
C using a rotor TLA 100.2 in Beckman Coulter XL-I analytical ultracentrifuge at 80,000 
rpm for 10 minutes. 125μl of supernatant was collected and the remainder was carefully 
removed. The pellet was resuspended in 250 μl of polymerisation buffer. 20 μl of samples 
were then taken for analysis by SDS-PAGE gel. 
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Compound Sample 1 Sample 2 Sample 3 Final 
concentratio
n 
dH2O + + + x 
MES pH 6.5 + + + 50 mM 
KCl + + + 50 mM 
MgCl2 + + + 2.5 mM 
FtsZ Not added + + 11 µM 
ZipA + Not added + Appropriate 
GTP + + + 2 mM 
   Table 2-8. Table 2-7.The components for sedimentation assay. 
 
2.5.6 Electron Microscopy  
The proteins were centrifuged at 10,000 rpm for 5 minutes to remove any aggregation protein 
or large particles. 100 μl reactions containing 11 µM FtsZ with appropriate ZipA were made 
up in the polymerisation buffer and then incubated at 25°C for 10 minutes. 0.2 mM GTP was 
added to the mixture immediately before 5 µl of the mixture was transferred to the carbon 
side of carbon-coated copper grids for 1 minute. The sample was stained by incubating in 1% 
uranyl acetate solution for 45 seconds before the excess solution was removed. The 
experiment was carried out using a JEOL 2011 Transmission electron microscope (TEM). 
The samples were visualised at magnification of 10,000, 30,000 and 50,000. 
101 
 
2.5.7 Reconstitution of FtsZ-ring Inside A GUV 
SMA polymer can be removed from purified SMALP solubilised protein by decreasing pH or 
adding MgCl2, the process we termed ―de-SMALP‖. However, reducing pH can destabilise 
encapsulated proteins. De-SMALP allows protein to be inserted to the different model system 
such as GUVs for further studies.  
 
GUVs are large vesicles with diameters of 5 μm ~300 μm that can to be visualised using 
optical microscopy [8]. The bilayer can be labelled with rhodamine 6G were prepared by 
following published protocol allowing GUVs to be seen by confocal microscope [140,141]. 
 
Methods 
A stock of MgCl2 was added to the purified SMALP solubilised ZipA to give a final MgCl2 
concentration of 50 mM. The sample was then dialysed overnight against polymerisation 
buffer using dialysis membrane (14,000 Molecular weight cut-off, MWCO) that allowed the 
SMA to exit the sample. The protein can be stored at 4°C for further use.  
 
A 10 mg/ml of lipid mixture contains 40% of DMPC and 60% of egg phosphocholine (PC), 
were dissolved in methanol. Methanol was evaporated in a fume cabinet under the air current 
then resuspended lipid with a final concentration of 10 mg/ml in 10 M rhodamine 6G by 
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vigorous vortexing. Small drops of the mixture was placed on a 4 cm diameter Teflon disc 
and allowed to dry. The films were then hydrated by covering them with 5 ml of the 
polymerisation buffer and incubated at 37°C for 3 hours. GUVs were suspended by gentle 
pipetting to form a turbid layer. 50 μl ~100 μl of GUVs were removed from this layer and 
used for further experiments. 
 
The de-SMALP ZipA and FtsZ were prepared in the polymerisation buffer to give a final 
protein concentration of 3.3 M (or in the absence of de-SMALP ZipA) and 11 M, 
respectively. The 67.5 μl of protein sample in the polymerisation buffer were added into 
GUVs to make up a final volume of 135 μl, the sample was mixed by gentle pipetting and 
then incubated at 37°C for 15 minutes. GTP was added into the sample to give a final 
concentration of 2 mM, and then the reaction was observed immediately by Nikon A1R 
Inverted Confocal microscope at 60 times magnification, the samples were observed for up to 
30 minutes.  
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CHAPTER 3: Expression and Purification of A2aR 
3.1 Introduction 
GPCRs are the largest family of membrane proteins, and these proteins represent, 
pharmaceutically, the most important receptors in human biology. Research on drugs that 
target GPCRs currently accounts 40% of all spending drugs discovery [2]. However, 
structural characterisation of GPCRs has been limited by problems with protein expression, 
solubilisation, purification, and preservation of activity in vitro.  
 
SMALP, SMA/lipid particle, is a novel nano-reagent that enables a quick and easy 
purification of membrane proteins without adding any detergent. The preliminary protocol for 
solubilising and purifying bacterial membrane proteins using this method was recently 
developed by Knowles et al. [49]. These data showed SMALP can stabilise the bacterial 
membrane protein forming thermostable and soluble nanoparticles suitable for biophysical 
studies [49]. In this study, the SMALP method was applied for the first time to the 
purification of a GPCR (human adenosine 2a receptor, A2aR) directly from the cell 
membranes. 
 
Earlier studies have shown that A2aR has been successful expressed in Pichia pastoris, and it 
was solubilised and purified with detergent [25]. However, the yield of pure receptor was   
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low and detergents had been shown to hamper further structural characterisation as it disturbs 
the interplay between conformational states within the GPCR. In this project, we have used 
the same expression plasmid used in the previous studies in order to compare the SMALP 
with the detergent method [25]. 
 
3.2 Results 
3.2.1 Expression Screening of A2aR 
The A2aR expression plasmid consisted of a 10xHis-tag in the N-terminal that enabled 
detection of A2aR expression by Western blotting using anti-His-tagged Monoclonal 
antibody. A band at 83 kDa was observed from all transformants including the negative 
control (the sample only containing plasmid without the A2aR gene) (Figure 3-1, data not 
shown for negative control). Previous Pichia pastoris studies have shown that this represents 
non-specific binding to the AOX1 gene product (Dr. Mohammed Jamshad, personal 
communication). A second band at 58 kDa was observed in most of transformants. However, 
this was considerably heavier than the calculated value of A2aR (47 kDa). Anomalous 
migration of membrane proteins on SDS-PAGE is a well-known phenomenon [142, 143], so 
to ascertain whether this band represented A2aR, two samples, sample 7 and 8 were chosen 
for an A2aR specific radioligand binding assay. Both samples showed the specific binding to 
[
3
H]ZM241385, with sample 8 showing better binding capability (Bmax ~9.5 pmol/mg) than 
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sample 7 (Bmax at fmol/mg level). Therefore, sample 8 was chosen for the further 
experiments.   
 
 
Figure 3-1. Western blotting of an SDS-PAGE using anti-His-tagged antibody for A2aR expression 
screening. Two bands were found on the blot. A band at 83 kDa was observed from all transformants 
including negative control. This could be non-specific binding with AOX1. The other band at 58 kDa was 
observed from most of transformants, this band could be A2aR.  Sample 7 and 8 were chosen for specific 
radioligand binding assay (since they had the strongest signal on the band of 58 kDa). Sample 8 showed 
higher binding capability (Bmax~9.5 pmol/mg).  
 
3.2.2 Large-scale Protein Expression 
Obtaining a high protein yield is essential for biophysical and structural analysis of A2aR. 
Two cultures systems were investigated in this study, the flask culture and the bioreactor 
culture. However, it was found that the bioreactor produced higher biomass (typically 110 g 
of yeast cells per litre) and hence greater yields. To enhance this yield further a modified 
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bioreactor protocol was implemented using a mixture of 60% sorbitol and 40% methanol for 
induction leading to biomasses of up to 160 g wet weight per litre. This compared favourably 
with the bioreactor culture using solely methanol and at 30°C for induction which obtained 
an average of ~130 g wet weight per litre. Comparing to the flask culture (with average ~16 g 
of cell was obtain from one litre culture), the bioreactor culture produced up to 10 times more 
biomass. Unfortunately, the radioligand binding assays showed low Bmax value on the 
membrane preparation using a mixture of sorbitol and methanol for induction (Bmax at 
fmol/mg level). The bioreactor culture inducted using solely methanol at 30°C showed a Bmax 
value of 3.8 pmol/mg.  
 
The bioreactor cultures (using methanol and at 22°C for induction) and flask cultures (using 
methanol and at 22°C for induction) had a similar Bmax value ~ 9.5 pmol/mg. Given the high 
production of sample from the bioreactor cultures it was decided that only bioreactor cultures 
provided sufficient samples for functional and structural analysis, therefore, the bioreactor 
cultures were used for large-scale protein expression with the induction conditions utilising 
methanol at 22°C. Table 3-1 shows A2aR expression results by different culture methods and 
conditions. 
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Culture methods Bmax (pmol/mg) 
 
Yeast cells obtained 
(g/litre culture) 
Bioreactor cultures 
(using methanol at 22°C for 
induction) 
 
9.5 
 
110 
Bioreactor cultures 
(using a mixture of sorbitol and 
methanol at 22°C for induction) 
 
Only at fmol/mg level 
 
160 
Bioreactor cultures 
(using methanol at 30°C for 
induction) 
 
3.8 
 
130 
Flask cultures 
(using methanol at 22°C for 
induction) 
 
9.5 
 
16 
Table 3-1. A2aR expression results using different culture methods and induction conditions. Bioreactor 
cultures gave much higher production than flask culture, and using methanol at 22°C for induction showed 
the highest Bmax (green colour). 
 
 
3.2.3 A Comparison of SMA Solubilisation with Detergent Solubilisation  
So far, solubilisation membrane protein using SMA polymer has only been applied to the 
protein from bacterial cells by adding SMA and exogenous lipid into membrane sample [49]. 
SMA had until this point not been used to solubilise a protein from yeast. The first 
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observation during the experiment showed that SMA successfully solubilised the yeast 
membranes. The data showed yeast membrane sample became clearer after adding SMA. In 
addition, smaller pellet after centrifugation of the processed membrane when compared to the 
control without SMA added (Figure 3-2).  
 
 
Figure 3-2. (A) The figure showed yeast membrane sample became clearer after adding SMA. (B) The 
figure showed a smaller pellet in the SMA solubilisation sample after being centrifuged at 150,000 x g.  
 
Previously, n-dodecyl-ß-D-maltoside (DDM) has been shown to solubilise A2aR from cell 
membrane preparations [25, 26, 122]. In order to compare the solubilisation efficiency 
between SMA and detergent, experiments were carried out using both SMA and DDM.  In 
addition, two types of SMA experiments were carried out with and without exogenous lipid 
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(1,2-Dimyristoyl-sn-Glycero-3-Phosphocholine, DMPC) (Table 3-2). These experiments 
were devised to examine whether the SMA method could be used for membrane protein 
solubilisation in its native environment. In each case, the solubilisation was monitored using 
radioligand binding assay. These data showed that there was no decrease in the Bmax value 
upon SMA extraction from the yeast membranes, indicating that the SMA method preserves 
the function and hence structure of A2aR. There was also a two fold increase in Bmax value 
achieved by the addition of DMPC during the course of solubilisation by SMA. The 
comparison between SMA and DDM solubilisation indicated DDM solubilisation sample had 
a slightly higher Bmax value (13.6 pmol/mg) than SMA solubilisation sample (9.6 pmol/mg), 
but Kd data showed SMA solubilisation had higher affinity (12 nM) than DDM solubilisation 
sample (43 nM). 
 
Solubilisation condition Bmax (pmol/mg) 
 
Kd (nM) 
 
2.5% SMA with 1% DMPC 9.6 12 
2.5% SMA only 4.8 12 
2.5% DDM with 0.5% CHS 13.6 43 
Table 3-2. A2aR solubilisation experiments performed using different conditions. These data showed that 
adding DMPC during solubilisation by SMA results in a two fold increase in Bmax value. DDM 
solubilisation showed a little higher value in Bmax, but it also showed larger kd value (lower affinity).  
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3.2.4 Purification of A2aR 
3.2.4.1 SMALP Solubilised A2aR Purification Trails 
The IMAC method was chosen to purify SMALP solubilised A2aR due to its simplicity and 
high specificity to the target protein. There were two different methods allowed protein to 
load onto IMAC resin. The first, involved applying the samples into a pre-packed column by 
passing the sample over the column with a flow rate of 1 ml/min (column loading). The 
second, involved loading samples by adding the sample directly onto the resin followed by 
mixing by slow rotation (batch loading). The data indicated a significant difference between 
column loading and batch loading method. Column loading (15 ml of resin) led to end yield 
of less than 0.2 mg of protein per litre bioreactor culture (Figure 3-3). In contrast batch 
loading of resin (15 ml of resin) produced and end yield of > 3.5 mg of protein per litre 
bioreactor culture (Figure 3-4). However, this method also yielded samples with significant 
contamination by other proteins. To resolve this, elutions were then applied onto ion- 
exchange resin or XAC affinity resin to attempt to increase purity.  
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Figure 3-3. Silver stained of SDS-PAGE gel showed the very low binding efficiency using column loading 
method for SMALP solubilised A2aR. Lane 1 to 5: elution with 250 mM imidazole. Lane 6: wash with 60 
mM imidazole. Lane 7: Flow through: the materials did not bind to the resin.  
 
 
Figure 3-4. Silver stained of SDS-PAGE gel showed the improved binding efficiency using batch loading 
method for SMALP solubilised A2aR. Lane 1to 4: elution with 250 mM imidazole.  
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The data from the ion-exchange chromatography experiment showed no improvement in the 
purity of A2aR (Figure 3-5, lane 2). Moreover, the receptor required higher concentration of 
NaCl (1M) for elution, indicated that the large negative charge of SMALP solubilised A2aR 
interacted strongly the positively charged resin.    
 
                                   
Figure 3-5. Purification of SMALP solubilised A2aR using ion-exchange method. Silver stained SDS-
PAGE gel showed the purification using ion-exchange method did not improve the purity of protein. Lane 
1: IMAC elution. Lane 2: Ion-exchange elution: the protein was eluted in a high concentration of NaCl 
(1M).  
 
Synthesised XAC resin (XAC, an antagonist of A2aR) was also used as an affinity resin to 
improve the purity of A2aR. However, the data showed the purification using XAC resin 
caused a serious aggregation problem (Figure 3-6). Most of proteins were aggregated and the 
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radioligand binding assay also showed a low Bmax value (0.5 nmol/mg) for purified SMALP-
A2aR purified via this method.  
 
Figure 3-6. Purification of SMALP solubilised A2aR using synthesized XAC resin. Silver stained SDS-
PAGE gel showed the purification using XAC resin caused a serious aggregation problem. Most of 
proteins were aggregated. Lane 1: Flow through: the materials did not bind to the resin. Lane 2: wash with 
resuspended buffer (10% glycerol, 500 mM NaCl, 50 mM Tris-HCl, pH 8). Lane 3-9: elutions with 
resuspended buffer plus 20 mM theophylline.  
 
 
3.2.4.2 Final SMALP Solubilised A2aR Purification Procedure 
Previous study has shown that reducing the volume of IMAC resin used in the purification 
can have an effect on the purity of the final product (Dr. Eva Hyde, personal communication). 
To address the issues of purity in this project, a smaller volume (1.5 ml) of IMAC resin was 
used for the first stage of purification. Data from this purification showed a substantial 
increase in purity of the A2aR with a resulting increase in Bmax. The protein yield was > 1.6 
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mg (calculated from all eluted fractions) per litre of bioreactor culture after the IMAC 
purification stage, with a high degree of purity (Figure 3-7). 
 
Figure 3-7 (A) 
 
Figure 3-7 (B)                            
Figure 3-7. Silver stained SDS-PAGE gel showing the increased purification efficiency by IMAC method 
(small volume of resin and batch loading method). (A) Lane 1: yeast crude membrane .Lane 2:SMALP 
solubilised materials. (B) Lane 1: wash with 60 mM imidazole. Lane 2 to 7: elution with 250 mM 
imidazole. These two figures showed the good purification efficiency by this simple SMALP purification 
method. 
 
115 
 
Silver stained SDS-PAGE gel showed the receptor from IMAC elutions except eluted 
fraction 1 (Figure 3-7, lane 2) was already substantially pure, but radioligand binding assay 
only showed approximately half of theoretical Bmax (21.3 nmol/mg, § 4.2.1). To improve 
Bmax, the receptors from IMAC elutions (Figure 3-7, lane 3 to 7) were further purified by gel 
filtration Superdex 200 10/300 GL column to remove any aggregated protein or small 
peptides (Figure 3-8) (Figure 3-9). The radioligand binding assay for the gel filtered sample 
showed a Bmax of 20.1 nmol/mg, close to the theoretical Bmax value of 21.3 nmol/mg. These 
data suggest purified SMALP-A2aR from two-step purification process had reached 
homogeneity and retained its functionality. The final protein yield was ~0.55 mg from one 
litre bioreactor culture (~ 0.1 mg of A2aR can be obtained from one litre flask culture) after 
this two-step purification process. Table 3-3 shows a summary of purification results by 
different purification methods. 
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Figure 3-8. Gel filtration of A2aR. The data showed some aggregation protein was eluted before the major 
protein (A2aR) was eluted. The fractions of different peak were then examined by silver stained SDS-
PAGE gel (Figure 3-9). The experiments were carried out using a Superdex 200 10/300 GL column 
attached to an Ä KTA
TM 
FPLC purification system. A flow rate was set at 1 ml/min. Absorbance 
measurements were recorded at 280 nm.  
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Figure 3-9. Silver stained SDS-PAGE gel for the purification of SMALP solubilised A2aR using gel 
filtration. The gel showed the major peak (Figure 3-8) was A2aR. Lane 1: the protein from major peak. 
Lane 2: the fraction from aggregated peak. 
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Purification methods Results 
IMAC method by column loading (1 ml of 
resin) 
Very low yield, can not be detected by 
silver stained SDS-PAGE gel 
IMAC method by column loading (5 ml of 
resin) 
Very low yield, can not be detected by 
silver stained SDS-PAGE gel 
IMAC method by column loading (15 ml of 
resin) 
Very low yield, only showed very slight 
band on silver stained SDS-PAGE gel 
IMAC method by batch loading (1.5 ml of 
resin) 
Showing a good purification efficiency 
IMAC method by batch loading (15 ml of 
resin) 
Low purity 
Ion-exchange method Did not improve the purity. Requires a 
very high concentration of NaCl to elute 
XAC resin Serious aggregation problem 
Gel filtration Removes aggregation protein to improve 
the purity of protein 
Table 3-3. A summary for the purification results of SMALP solubilised A2aR by different purification 
methods. The results showed that using two-step purification process including IMAC and gel filtration 
(green colour) can obtain the best purification result. 
 
3.2.4.3 Purification of Detergent Solubilised A2aR 
DDM solubilised sample required the use of a three-step purification process to reach 
homogeneity [25]. We observed in increased level of impurities after the IMAC stage was 
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applied to the detergent sample compared to the SMALP solubilised sample (1.5 ml resin, 
batch loading, Figure 3-10).  
 
 
 
Figure 3-10.  Silver stained 10% SDS-PAGE gel of DDM solubilised A2aR by IMAC method. Lane 1 to 7: 
elution with 250 mM imidazole. Lane 8: wash with 60 mM imidazole. The elutions (lane 1 to 6) were 
mixed and further purified by ion-exchange column. 
 
Hence, it was necessary to use ion-exchange column before loading to gel filtration Superdex 
200 10/300 GL column. Figure 3-11 and Figure 3-12 showed DDM solubilised A2aR after 
ion-exchange and gel filtration step. The protein reached homogeneity after three-step 
purification process and the final protein yield was ~ 0.5 mg per litre bioreactor culture ( ~ 
0.1 mg of A2aR can be obtained from one litre flask culture). Table 3-4 is the purification 
table for purified A2aR by SMALP and detergent methods. 
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Figure 3-11.Silver stained SDS-PAGE for the purification of DDM solubilised A2aR using ion-exchange.  
Lane 1 to 6: the protein was eluted with 250 mM NaCl. Lane 7: the protein was washed with 100 mM 
NaCl. Lane 8: Flow through: the materials did not bind to the resin. The elutions (lane 1 to 4) were mixed 
and further purified by gel filtration.  
 
 
Figure 3-12. Silver stained SDS-PAGE gel for the purification of DDM solubilised A2aR using gel 
filtration. The purified A2aR was approached by a three purification step. Only single band was observed 
on the gel.  
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Purification step Total 
protein 
(mg) 
Specific binding  
(Bmax, pmol/mg) 
Total 
A2aR 
(pmol) 
Relative 
yield 
(%) 
Purification 
(fold) 
Solubilised 
materials 
2835 9.6 27216 100 1 
IMAC eluate 1.61 9300 14973 55 968 
Gel filtration 
eluate 
0.55 20100 11055 40.6 2093 
Table 3-4 (A) 
Purification step Total 
protein 
(mg) 
Specific binding 
(Bmax,pmol/mg) 
Total  
A2aR 
(pmol) 
Relative 
yield 
(%) 
Purification 
(fold) 
Solubilised 
materials 
2420 13.6 32912 100 1 
IMAC eluate 3.82 4500 17190 52.2 330 
Q Sepharose eluate 1.51 10200 15402 46.7 750 
Gel filtration eluate 0.50 18200 9100 27.6 1338 
Table 3-4 (B) 
 
Table 3-4. (A) Purified SMALP-A2aR (B) Purified DDM-A2aR.. Assuming 1 litre yield of A2aR 
purification. Calculating from 0.5 litre bioreactor culture. The purification was carried out as described in 
the materials and methods section. Protein concentration was determined with CBQCA protein 
quantitation method. Specific binding was the Bmax value of radio-ligand binding assay using [
3
H] 
ZM241385. Total A2aR was calculated by total protein × specific binding. Relative yield was calculated by 
total A2aR of each step ÷ total A2aR at solubilised materials. Purification (fold) was calculated by specific 
binding of each step ÷ specific binding at solubilised materials. The data showed on this table were 
representative data. Data varies for each preparation, but the final relative yields were always between 
30~40.6% for SMALP sample and 25~35% for DDM sample.  
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3.2.5 Receptor Identification and Western Blotting Analysis 
A band at 34 kDa is an intact A2aR  
The purified A2aR (for both of SMALP and DDM solubilised samples) ran in SDS-PAGE 
gels was incubated at 37°C before being loaded into SDS-PAGE gel due to membrane 
proteins can aggregate in SDS at temperatures over 50°C [147]. The gel showed a single 
band with an apparent molecular mass of 34 kDa. This is less than the predicted molecular 
weight of 47 kDa, and that observed in a previous paper [25]. This could be some membrane 
proteins bind to more SDS than water soluble protein [142, 143]. To demonstrate that the 
anomalous migration resulted from atypical running behaviour, rather than from proteolysis, 
we used FT-ICR mass spectrometry and Western blotting to identify and analyse the proteins. 
The band at 34 kDa was cut from SDS-PAGE gel stained by silver staining, and digested 
with trypsin before the fragments were identified by FT-ICR. Three peptides were found 
which were cross referenced with the human proteome. The protein was identified as human 
adenosine 2a receptor. (Table 3-5).  
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Peptide Fragments Peptide Sequence Peptide Location 
(amino acid) 
Peptide Location 
1 YNGLVTGTR 112-120 Intracellular loop 2 
2 QMESQPLPGER 210-220 Intracellular loop 3 
3 SHVLRQQEPFK 305-315 Cytoplasmic 
domain 
Table 3-5. Three Peptide fragments identified by FT-ICR. Purified A2aR was determined by SDS-PAGE 
following stained with silver stain, a band was cut at ca. 34 kDa, for trypsin digestion before identified by 
FT-ICR. The data were then run a search on Mascot to identify the protein and carried out the further 
analysis using MassLynx software. Peptide location (amino acid) represents the location of this peptide, 
for example, 112-120 represents this peptide located from 112 to 120 amino acid residue of A2aR protein. 
 
Furthermore, Western blotting analysis using both the anti-A2aR antibodies and the anti-His- 
tagged antibodies as a primary antibody, both showed a single band at 34 kDa. The positive 
result with the anti-A2aR antibodies indicated that the C-terminus of A2aR was also intact as 
this antibody bound at the C-terminus of A2aR (Figure 3-13, data only shown purified DDM-
A2aR). The positive result with the anti-His-tagged antibodies indicated that the N-terminus 
of A2aR was also intact as this antibody bound at the N-terminus of A2aR (Figure 3-14). 
These data added to the results of the specific radioligand binding assay provide strong 
evidence that the purified A2aR had retained is an intact, functional A2aR.   
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Figure 3-13.Western blotting of purified DDM-A2aR. The pure receptor was analysed by Western blotting. 
Only one band was observed on blot. The primary antibody was anti-A2aR antibody with 1: 500 dilutions 
and the secondary antibody used anti-rabbit IgG HRP-conjugated with 1: 10,000 dilutions. The anti-A2aR 
antibody bound close to the C-terminus of A2aR, therefore, indicating that the C-terminus of A2aR was 
intact. 
 
                                                        
                          (A)                                                             (B) 
Figure 3-14.Western blotting of purified SMALP and DDM A2aR  
(A) The purified SMALP-A2aR (B) The purified DDM-A2aR. The pure receptor was analysed by Western 
blotting using an anti-His-tagged antibodies as primary antibody. Only one band was observed on both 
blots. The anti-His-tagged of A2aR bound close to the N-terminus, therefore, the presence of a band 
indicates that the N-terminus of both purified SMALP and DDM A2aR were intact. The primary antibody 
was anti-His-tagged antibody with 1: 5,000 dilutions and the secondary antibody was anti-mouse IgG 
HRP-conjugated with 1: 10,000 dilutions.  
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3.3 Discussion 
Previous published data showed bacterial membrane proteins, PagP and bR can be 
incorporated into SMALP. These proteins preserve their folded state and activity in SMALP. 
Here, we have applied SMALP to more difficult protein, A2aR, a GPCR. To date, one of the 
major challenges in the study of GPCRs has been the problem of obtaining a large amount of 
soluble and functional of protein. This is, in general, due to difficulties in purification, low 
expression of receptor and difficulty in maintaining the native environment around the 
protein. We have shown A2aR can be expressed in Pichia pastoris in bioreactor culture 
system allowing the production of around 10 times higher cell density compared to flask 
cultures. Approximately 0.5 mg of purified A2aR was produced from a litre bioreactor 
culture, a sufficient quantity for initial functional and structural studies. 
 
During purification of the receptor, it was found that the SMA solubilisation material 
produced a higher better Bmax when DMPC was added. It is possible that DMPC makes this 
disk structure larger, and hence more native lipids can surround the protein to stabilise A2aR, 
or DMPC directly stabilise A2aR. Whatever the mechanism, however, this investigation 
indicates that the lipid is vital importance for preserve receptor functionality. A similar result 
was also observed in DDM solubilisation A2aR indicating that the presence of CHS (an 
analogue of cholesterol), also results in higher Bmax values during the solubilisation and 
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purification process [122]. These observations are consistent with demonstrations that 
membrane protein activity is preserved to a higher degree in the correct lipid environment. 
 
Experiments also showed that purification process of SMALP solubilised A2aR is improved 
by loading sample to a small amount of resin as a slurry rather than loading on resin in situ in 
a column. This may reflects a decreased on-rate for the interaction between the SMALP and 
the resin. Previous studies on the purification of membrane proteins with His-tagged have 
also shown that batch loading provides better yield than column loading [122]. Our 
experiments, remarkably also shown that even a single purification step (IMAC) provides 
SMALP-A2aR that is potentially pure enough for many further analytical studies. 
Conventionally, purifications of GPCRs and other membrane proteins take a much larger 
number of steps [25, 122]. For example, unlike purified SMALP-A2aR, purified DDM-A2aR 
needs three-step purification process to approach homogeneity [25]. An additional 
purification step (ion-exchange) was needed to remove the contamination by other proteins to 
produce a preparation with a Bmax value close to the theoretical Bmax value. The purification 
table (Table 3-4) shows the relative yield decreased by increase purification step. Therefore, 
it is important to reduce the number of purification steps to increase the final relative yield.  
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In addition to purify SMALP solubilised A2aR using IMAC and gel filtration methods, we 
also attempted to use synthesised XAC affinity resin. However, this resin caused a serious 
aggregation problem, but the reason is still not clear. Additionally, ion-exchange method 
seems not suitable for SMALP due to the negative charge of polymer. 
 
FT-ICR mass spectrometry, Western blotting and radioligand binding assay showed the band 
at 34 kDa is an intact and functional A2aR. Overall, we have shown that SMALP provides us 
several advantages for A2aR purification. The first, the protein can be solubilised by SMA 
without any detergent added. The second, quicker method to obtain pure protein than 
detergent solubilised sample. The third, low cost, SMA polymer is much cheaper than DDM, 
and simple purification process also decrease the cost of research.  
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CHAPTER 4: Characterisation of A2aR 
 
4.1 Introduction 
In order to maintain GPCRs in a native-like membrane environment for their structural and 
functional studies, these proteins must be isolated in detergent micelles or inserted into a 
model system such as liposomes or bicelles. However, no single system has been universally 
satisfactory for use with all techniques used to characterise membrane proteins. In addition, 
sometimes, maintaining the protein in detergent micelles or a model system requires careful 
control of experimental conditions within narrow limits, for example, bicelles are very 
sensitive to solution conditions, and the temperature is defined by the lipid combinations 
[46,144]. It is therefore often a requirement to use the different systems for different 
functional and structural studies of a membrane protein. In the chapter 3, we have shown that 
we have successfully applied SMALP to purify A2aR.  In this chapter, we characterise 
purified SMALP-A2aR using the radioligand binding assay and several biophysical 
techniques to show that the SMALP solubilisation process has not affected the receptor 
structure or function. Additionally, we show that a range of commonly used bioanalytical 
methods are not disrupted by the SMALP system. 
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The radioligand binding assay is used to analyse A2aR bound to its cognate ligands to prove 
whether the protein has maintain its activity or pharmacological properties during the 
solubilisation and purification steps. The biophysical tool, circular dichroism (CD), is then 
used to provide the information about whether SMALP solubilisation has altered the 
secondary structure of the protein, and its folded state. The oligomerisation state of protein is 
then monitored by sedimentation velocity analytical ultracentrifugation (svAUC). 
Additionally, we compare these experiments with detergent solubilised A2aR that provide the 
information whether SMALP offers improved stability over detergent. 
 
4.2 Results 
4.2.1 Radioligand Binding Assays 
Purified SMALP-A2aR is fully functional 
The binding capability (Bmax) of the purified SMALP-A2aR (Table 4-1) was studied by 
radioligand binding assay using [
3
H] ZM241385. The value obtained in this study was close 
to the theoretical value of 21.3 nmol/mg for a fully active A2aR. The theoretical Bmax value of 
pure A2aR (with a predicted molecular weight of 47 kDa), was calculated by assuming a 1:1 = 
A2aR: [
3
H] ZM241385 molar binding ratio, this gave theoretical Bmax value of 21.3 nmol/mg. 
We have also shown that the affinity constant (Kd) of ZM241385 was comparable to previous 
study [25]. 
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A2aR preparation Bmax (pmol mg
-1
) pKd 
(–log Kd) 
Yeast membrane 9.5 8.11 ± 0.18 
SMALP solubilised material 9.6 - 
IMAC eluate 9300 - 
Gel filtration eluate 20100 8.42 ± 0.16 
Table 4-1. Bmax and pKd of purified SMALP-A2aR from membrane preparation to gel filtration eluate. The 
values represented here are the mean values of 2 or 3 determinations. Bmax and Kd/pKd values were 
obtained by saturation binding of [
3
H]-ZM 241385. The resulting binding curves were fitted to a single site 
model using PRISM Graphpad v4.0. 
 
To confirm that the binding profile of SMALP solubilised A2aR was not significantly 
different from that observed in the native membranes (compared to previous report) [25]. 
SMALP solubilised A2aR was pharmacologically characterised using a range of cognate 
ligands including ZM241385, theophylline, XAC (Xanthine amine congener) and NECA (N-
ethylcarboxamidoadenosine), which have various affinity and efficacy, in competition 
radioligand binding assays (Table 4-2 and Figure 4-1). These data showed that SMALP 
solubilised A2aR is still able to bind these ligands with affinities near to that of A2aR in native 
membranes.  
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Ligands pKi Ki Ki  (crude, A2aR membrane) [25] 
ZM241385 9.47  ± 0.25 0.38nM 3.3 ± 0.6 nM 
XAC 6.55 ± 0.16 280 nM 43.9 ± 0.4 nM 
NECA 4.82 ± 0.67 15 μM 1.3 ± 0.3 μM 
Theophylline 4.35 ± 28 47 μM 35.3 ± 1.9 μM 
Table 4-2 Affinity values for several different ligands binding to SMALP solubilised A2aR. 
This table compares the Ki and the pKi values (-log(Ki)), in comparison to the Ki values for the same 
ligands on the A2a receptor expressed in Pichia pastoris membranes as reported by Fraser [25]. Values 
reported here are the mean values ± s.e.m, and n (number of repetitions) =3. 
 
 
 
Figure 4-1. Displacement of 1nM [
3
H]-ZM241385 from SMALP solubilised A2aR by unlabelled 
ZM241385, NECA, theophylline and XAC. Representative data from an experiment repeated in triplicate. 
Each point is the mean value ± s.e.m. 
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Detergents often strip away the lipids from the receptor making membrane proteins unstable. 
It is therefore important to investigate whether SMALP offers a more stable environment 
than detergents. A preliminary report by Knowles et al. showed that SMALP can exert a 
stabilising effect on membrane proteins [49]. If, as we propose, the SMALP maintains a 
native-like membrane environment around A2aR, then it may be expected that the stability of 
the protein should be enhanced compared to A2aR solubilised in detergents. To address this, 
experiments that involved incubating A2aR at elevated temperatures for a set time (30 
minutes) were carried out. The samples were then cooled on the ice and the retention of 
ligand binding activity was measured. This experiment showed that there were observable 
differences between the two solubilisation methods. The SMALP solubilised A2aR 
maintained ligand binding competency after exposure to higher temperatures than that 
observed for DDM solubilised A2aR (T½  for SMALP of 49.93 ± 1.19 vs 44.40 ± 0.27 for 
DDM, n=3, P<0.05, Students t) (Figure 4-2). Whatever the mechanism, however, in contrast 
to DDM solubilised A2aR, it is clear that the SMALP protects the protein more effectively 
from exposure to elevated temperatures. 
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Figure 4-2. Thermostability of SMALP or DDM solubilised A2aR. Receptors solubilised with either 
SMALP or DDM were incubated for 30 minutes at the indicated temperature and the amount of [
3
H] 
ZM241385 bound was determined. Binding is expressed as % of [
3
H] ZM241385 bound at 20
o
C. Points 
are means ± s.e.m of three experiments. 
 
4.2.2 Circular Dichroism Studies 
CD spectrum of purified SMALP-A2aR shows that the receptor is a well folded protein  
A far-UV region (195 - 260 nm) CD spectrum of purified SMALP-A2aR revealed a high -
helix content (negative signal at 208 and 222 nm) indicating a well folded protein (positive 
signal between 190 - 200 nm) (Figure 4-3, A), it was consistent with the known structure of 
A2aR, the class A GPCRs with high α-helical component [25, 57]. The CD data suggest that 
A2aR maintains a native folded structure within SMALP. Purified DDM-A2aR also showed a 
high -helix component, consisting with the report by Fraser (Figure 4-3, B) [25]. 
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Figure 4-3 (A) CD spectrum of purified SMALP-A2aR 
 
Figure 4-3 (B) CD spectrum of purified DDM-A2aR 
Figure 4-3. Both of purified SMALP-A2aR and purified DDM-A2aR showed that preserved the high α-
helical content in their secondary structure, indicating a well-folded receptor, consists with the known 
structure of A2aR [25, 57]. CD data were collected using a JASCO J-715 spectropolarimeter. CD spectra 
were collected using a 1 mm path length cuvette and averaged over 8 scans in the far-UV domain. Spectra 
acquired were corrected for the buffer signal. Protein concentrations for purified SMALP/detergent A2aR 
were 0.05 mg/ml. 
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The effects of increasing temperature on the secondary structure of purified SMALP/ DDM 
A2aR were also studied using CD (Figure 4-4). The results showed a clear gradual decrease in 
amplitude of the CD signal at the wavelengths that correlate to -helix content. Surprisingly, 
for both samples (SMALP and detergent), the CD signal had not completely changed to that 
of a random coil even at 95
o
C (the CD spectrum of a random coil protein is characterised by 
an intense negative band at 200 nm and a positive band at 218 nm, sometimes, it accompanies 
with a very weak negative band at 235 nm [133]). This indicates that A2aR conformation was 
relatively resistant to thermal denaturation compared to that generally observed for globular 
proteins from mesotherms. Comparison of the thermal denaturation of purified 
SMALP/DDM A2aR showed a slight difference between the two samples when the 
temperature was increased to 95°C. However, the majority of the α-helical secondary 
structure still maintained.  
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Figure 4-4 (A). CD study of the thermal stability of purified SMALP-A2aR   
 
Figure 4-4 (B). CD study of the thermal stability of purified DDM-A2aR 
Figure 4-4. CD spectra of the thermal stability experiment for the purified SMALP/DDM A2aR. The CD 
intensity (in mdegs) of the spectra increase with increasing temperature from 25
o
C to 95
o
C, (spectra 
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measured at intervals of 10
o
C). Even at the maximum temperature measured (95
o
C), significant secondary 
structure remains in both samples. CD data were collected using a JASCO J-810 spectropolarimeter. CD 
spectra were collected using a 1 mm path length cuvette and averaged over 8 scans in the far-UV region 
(from 195 to 260 nm). Spectra acquired were corrected for the buffer signal. Protein concentrations for 
purified SMALP/DDM A2aR were 0.03 mg/ml. 
 
Moreover, the negative signal at 222 nm (characteristic of α-helical motifs)  also suggests that 
both purified SMALP/DDM A2aR were still folded at 95°C even CD intensity of the spectra 
increase with increasing temperature at 222 nm (Figure 4-5). Taken together these data 
indicate that at least at the level of secondary structure there is no difference in thermal 
stability of the two preparations. 
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Figure 4-5. CD thermal study of purified SMALP-A2aR and DDM-A2aR monitored at 222nm showed their 
unfolding profiles. The data suggest both samples still maintained of their secondary structure at 95°C 
even though larger values at 222 nm (less negative) were observed at lower temperatures. CD data were 
collected using JASCO J-810. CD spectra were collected using a 1 mm path length cuvette and averaged 
over 8 scans at 222 nm. Spectra acquired were corrected for the buffer signal. Protein concentrations for 
purified SMALP/DDM A2aR were 0.03 mg/ml. 
 
4.2.3 Sedimentation Velocity Analytical Ultracentrifugation 
Given the size of the SMALP, it is possible that more than one receptor could be 
encapsulated into the particle. To address this issue, sedimentation velocity analytical 
ultracentrifugation (svAUC) was used to probe the oligomerisation of the protein in the 
particle (Figure 4-6). SEDFIT analysis of these data using the c(M) model produced an 
intense peak at 91 kDa, this is likely to be a A2aR encapsulated in SMALP accompanied by 
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two minor peaks at 16 and 51 kDa. The first minor peak (16 kDa) had the molecular masses 
close to the data from equivalent svAUC experiments carried out on free SMA (16 kDa). This 
peak is also commonly observed in other SMALP purifications (Dr. Tim Dafforn, personal 
communication). The other minor peak (51 kDa) is likely to be empty SMALP, however, this 
peak had a different molecular mass peak to that from equivalent svAUC experiments carried 
out on other SMALP purifications, such as purified SMALP-ZipA (data shown in 6.2.2). This 
different behaviour could be the empty SMALP since it has been suggested that SMALP may 
contains different lipid components within different conditions, for example, yeast and 
bacterial cell membranes have different lipid components. The intense higher molecular peak 
can therefore be attributed to the presence of purified SMALP-A2aR (91kDa).  
 
An approximate measure of the mass of the encapsulated A2aR can then be determined by 
subtraction of the mass of the empty SMALP, which yields a mass of approximately 40 kDa. 
However, this mass does not complete match the expected theoretical size of 47 kDa. This 
might due to a different volume of lipid between empty SMALP and purified SMALP-A2aR, 
therefore, resulting in this shifting.               
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Figure 4-6. A SEDFIT c(M) deconvolution of Sedimentation Velocity Analytical ultracentrifugation data 
collected on purified SMALP-A2aR showing the presence of 3 peaks corresponding to SMA (16 kDa), the 
empty SMALP (51 kDa) and A2aR encapsulated in SMALP (91 kDa). Data were collected on a Beckman 
XL-I proteome lab at 40,000 rpm with the migration of the particles being monitored by scanning the cells 
at 280 nm. 
 
4.2.4 Electron Microscopy  
It has been shown that purified SMALP-PagP has a nanodisk structure with diameter of 11.2 
±1.4 nm [49]. A2aR is a 7 transmembranes protein which is larger than PagP, additionally, the 
lipid component in the yeast cell membrane is different to that of bacterial cell membranes. It 
is possible that the purified SMALP-A2aR should be a nanodisk structure and it may have 
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different dimensions compared to purified SMALP-PagP. TEM is the best way to visualise 
purified SMALP-A2aR. TEM micrograph of purified SMALP-A2aR (×40,000) showed 
purified SMALP-A2aR was a nanodisk structure (Figure 4-7). This nanodisk structure had a 
diameter approximately 20 ± 2.5 nm, it suggests SMALP is highly flexible which can be 
incorporated with the different size of proteins. 
 
 
 
Figure 4-7. TEM micrograph of uranyl acetate stained purified SMALP-A2aR (×40, 000) showed purified 
SMALP-A2aR is a nanodisk structure. This nanodisk structure has a diameter approximately 20 ± 2.5 nm 
Selected areas were photographed at ×40,000. Scale bar represents 100 nm. The experiment was carried 
out using a JEOL 2011 transmission electron microscope. The sample was stained with 1% uranyl acetate 
solution.  
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4.3 Discussion 
Numerous systems have been developed for studying membrane proteins that claim to 
maintain them in a native-like membrane environment, but all have drawbacks (described in 
the chapter 1). In the chapter 3, we have addressed the purification results of A2aR using 
SMALP method.  In this chapter, we have shown the subsequent studies for the purified 
SMALP-A2aR that confirms that the protein has both structure and activity. 
 
Radioligand binding assays showed purified SMALP-A2aR is fully functional. In addition, 
SMALP solubilised A2aR was pharmacologically characterised using a range of ligands 
including ZM241385, theophylline, XAC and NECA, these data showed that SMALP 
solubilised A2aR is still able to bind to these ligands and the affinities are near A2aR in the 
native membrane. Subsequent CD study showed purified SMALP-A2aR is a well folded 
protein. Taken together these data confirm that A2aR maintain its native activity and structure 
during the solubilisation and purification using SMALP method. svAUC data showed 
purified SMALP-A2aR is mainly monomeric. In addition, TEM data indicated SMALP is 
flexible due to the size of purified SMALP-A2aR is obviously different from purified 
SMALP-PagP. Therefore, SMALP system could be incorporated with more different 
architectures of proteins. 
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The thermal stability experiments using radioligand binding assay and CD showed the 
different results. The radioligand binding assay showed SMALP solubilised A2aR maintains 
higher activity open exposure to elevated temperature than DDM solubilised A2aR, but CD 
data indicated that at least at the level of secondary structure there is no difference in thermal 
stability between SMALP and DDM samples. The reason for this difference could either be 
due to differences in the methods used or an indication that loss of activity is not 
accompanied by a change in secondary structure. The samples used for radioligand binding 
assay were incubated at elevated temperatures for 30 minutes, and then placed on the ice. 
However, the samples used for CD thermal stability were heated at elevated temperatures for 
a minute and measure the signal continuously. These data indicated, upon cooling, SMALP 
sample returns to an active conformation, and hence SMALP offers a better thermal stable 
environment than detergent. This may mean that the SMALP protein is protected from some 
kind of aggregation compared to the DDM solubilisation. This is backed up by the lack of a 
CD signal difference as aggregation can sometimes occur without significant unfolding of the 
protein [145]. 
 
Overall, SMALP provides a novel method for membrane protein study which might be 
suitable for most analytical study tools. Furthermore, SMALP offers more thermal stable 
environment than detergent. Purified SMALP-A2aR is fully functional and well-folded. 
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Therefore, SMALP may offer a solution to obtain ―native‖ GPCRs crystal structure in the 
future.   
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CHAPTER 5: Expression and Purification of ZipA 
 
5.1 Introduction 
The previous chapter showed how SMALP could be used to purify a mammalian protein with 
7 transmembrane helices from a yeast expression system. In this chapter we showed how the 
same system can be used to purify a protein with a completely different architecture from a 
different expression system. It is hoped that the results from this study will demonstrate the 
wide applicability of this technique. 
 
Cell division is a critical process for all living organism by which a cell divides into two or 
more daughter cells. In E.coli cells, there are at least 15 proteins involved in cell division. 
One of these proteins, FtsZ, is the first protein appears at the division site, it is an essential 
protein for bacterial cell division and it forms FtsZ-ring. Another cell division protein, FtsZ-
interacting protein A (ZipA), is an integral inner-membrane protein contains a single 
transmembrane domain. ZipA is located in a FtsZ-ring structure at division site, and fulfils an 
essential role on the assembly and function of FtsZ-ring. In fact, it has been found that cells 
depleted of ZipA can grow, but can not divide [100].  
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However, the mechanism of how ZipA interact with FtsZ is not clear. This is because, as with 
most membrane proteins, it is difficult to maintain protein in native-like environment to 
preserve its native structure and function. Therefore, in this study, we purified ZipA using 
SMALP system to maintain the protein in a native-like membrane environment. 
 
In this chapter, we showed the results of the expression and purification of ZipA using 
expression plasmid in an E. coli host to obtain the purified SMALP-ZipA. The purification 
progress was monitored by SDS-PAGE gels, and the identification of ZipA was confirmed by 
FT-ICR mass spectrometry. Moreover, we also showed the data for the expression and 
purification of FtsZ. These two proteins will be used for subsequent FtsZ-ZipA interaction 
experiments (describe in the chapter 6).   
 
5.2 Results 
5.2.1 Plasmid Construction, Escherichia coli Strains and Transformation 
5.2.1.1 Extraction of Escherichia coli Genomic DNA 
Genomic DNA was extracted from TOP10 E. coli cells. The concentration of DNA was 
determined by absorbance at 260 nm. The quality of DNA can be determined by the ratio of 
Abs 260/Abs 280 (Table 5-1). This ratio should be located between 1.8 and 2.0 (If the ratio is 
below 1.8, it represents the sample is protein contamination; the ratio is over 2.0, it represents 
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the sample is RNA contamination). Table 5-1 showed that the concentration and quality of 
sample 1 was better than sample 2, thus sample 1 was diluted 100 times by deionised water, 
and then used for further experiments. 
 
 Concentration (ng/l) A260/A280 
Sample 1 5008.3 1.88 
Sample 2 4768.8 1.69 
Table 5-1. Genomic DNA extraction. Sample 1 showed a higher concentration and better quality than 
sample 2. The DNA concentration and the ratio of A260/A280 of were measured using a NanoDrop ND -
1000 spectrophotometer and blanked using water. 
 
5.2.1.2 Polymerase Chain Reaction  
Table 5-2 showed the different conditions used for PCR to amplify ZipA gene. The results 
were determined by 1% agarose gel (Figure 5-1). One strong band was observed at 
approximately 1,000 bp, it was close to full length of fusion ZipA gene (984 bp). The other 
band, shown on the bottom of the gel (less than 200 bp), could be a product of primer self- 
annealing, frequently observed from PCR reaction (Dr. Jet Lee, personal communication). 
The results showed the sample 4 has the weakest reaction (lower concentration of MgCl2, 
higher primer concentration), and other samples showed the similar results. Sample 2 and 3 
were chosen for further experiments due to they showed the strongest signal for the band ~ 
1,000 bp, and the weakest signal for the small size band (a band less than 200 bp). A band ~ 
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1,000 bp was cut and purified using a QIA quick gel extraction kit. The concentration and 
quality of the purified DNA was measured by absorbance at 260 nm and 280 nm (Table 5-3). 
 
Components Sample 1 Sample 2 Sample 3 Sample 4 Sample 5 Sample 6 
H2O .45 l 29.45 l 26.45 l 30.15 l 27.85 l 24.85 l 
10 × reaction 
buffer 
10 l 10 l 10 l 10 l 10 l 10 l 
MgCl2 
(1, 2, 4 mM) 
2 l 5 l 8 l 2 l 5 l 8 l 
dNTP (0.2 mM) 1 l 1 l 1 l 1 l 1 l 1 l 
Forward Primer 
(0.5-1 mM) 
1 l 1 l 1 l 2 l 2 l 2 l 
Reverse Primer 
(0.5-1 mM) 
1.3 l 1.3 l 1.3 l 2.6 l 2.6 l 2.6 l 
Genomic DNA 
(0.1g) 
2 l 2 l 2 l 2 l 2 l 2 l 
Taq polymerase 
(1.25 U) 
0.25 l 0.25 l 0.25 l 0.25 l 0.25 l 0.25 l 
Table 5-2. The six different conditions used to PCR reaction. The reactions were applied different 
concentration of primer and MgCl2. Sample 2 and 3 (blue colour) showed the best results and were chosen 
for further experiments. 
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Figure 5-1. 1% agarose gel electrophoresis showed the results of PCR reaction. M represents molecular 
marker. Sample 2 and 3 were chosen for further experiments. The band ~1000 bp expected ZipA gene was 
purified using a QIA quick gel extraction kit.  
 
 
 Concentration (ng/l) A260/A280 
Sample 2 20 1.95 
Sample 3 12 1.91 
Table 5-3. The concentration and the ratio of A260/A280 of purified DNA. PCR products were purified 
from 1% agarose gel using a QIA quick gel extraction kit. The DNA concentration and the ratio of 
A260/A280 of were measured using a NanoDrop ND -1000 spectrophotometer and blanked using water. 
The results showed sample 2 has higher concentration, and was then diluted to 3 or 18 ng/l used for 
following ligation experiment.  
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5.2.1.3 Ligation, Transformation and Extraction of Plasmid DNA 
3 ng and 18 ng of purified DNA from PCR reaction were used in ligation reaction. The 
reactions were transformed into TOP10 E.coli cells, and the cells were cultured on LB agar 
plate containing the 100 g/ml Ampicillin. All LB agar plates showed a large number of 
colonies after incubated at 37°C overnight, indicating that the ligation and transformation 
reactions were successful. Twelve single colonies were chosen for purification of plasmid 
DNA.  Figure 5-2 showed a 1% agarose gel of purified plasmid DNA, sample  3, 4, 5, 6, 9, 10 
and 12 showed the size of ~5,000 bp, they are smaller than expected (vector + ZipA gene ~ 
6,737 bp ). This could be the result of the plasmid DNA being circular, therefore, it ran faster 
than expected compared to linear DNA ladder (Dr. Jet Lee, personal communication). These 
samples were then sequenced and the data showed the plasmid DNA (sample 3, 4, 5, 6, 9, 10 
and 12) contain ZipA gene. Sample 1, 2, 7 and 8 showed the size of ~ 4000 bp, and the 
sequencing data revealed these samples did not contain ZipA gene, therefore, these samples 
might only contain a vector. Sample 11 showed large size ~ 10,000 bp, it could be multi ZipA 
gene included in plasmid. 
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Figure 5-2. 1% agarose gel of purified plasmid DNA. Sample 3, 4, 5, 6, 9, 10 and 12 (red arrow) showed 
the size of ~5,000 bp, smaller than expected, more commonly observed from circular of plasmid DNA. 
The sequence data confirmed these samples contain ZipA gene.  
 
5.2.2 Expression Screening and Small-scale of Protein Purification 
The plasmid containing ZipA gene was then transformed to BL21 star (DE3) One Shot E. 
coli cells for ZipA protein expression. A large number of colonies were observed after 
incubated at 37°C overnight on LB agar plate containing the 100 g/ml Ampicillin. 3 
colonies (including negative control) were chosen for expression screening. The ZipA fusion 
protein has a 6xHis-tag in the C-terminal, therefore, we examined ZipA expression by 
Western blotting using anti-His-tagged monoclonal antibody (Figure 5-3). The blotting 
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showed the band at ~ 52 kDa in all samples (apart from negative control, the sample only 
contains vector without ZipA gene). The positive band showed on SDS-PAGE gel was close 
to the previous report of ZipA by Hale and de Boer [100]. Therefore, we conclude a band at ~ 
52 kDa was ZipA. Sample 2 showed the strongest signal at 52 kDa than the other samples. 
Therefore, we chose this sample for the further experiments. 
 
 
Figure 5-3. Western blotting using anti-His-tagged antibody for ZipA protein expression screening. The 
fusion ZipA protein has a 6xHis-tag in the C-terminal enables examined ZipA expression by Western 
blotting using anti-His-tagged Monoclonal antibody. A band showed at ~ 52 kDa was observed at all 
samples (lane 1 and 2), excluding negative control (N). Sample 2 showed the strongest signal on this band, 
and was chosen for the further experiments. The cell pellets were mixed with 1x SDS-PAGE sample buffer 
and then incubated at 95°C for 10 minutes. 20 µl of mixture were then loaded onto the 10% SDS-PAGE 
gel and then transferred to a nitrocellulose membrane. The primary antibody was used anti-His-tagged 
Monoclonal antibody with 1: 5,000 dilutions and the secondary antibody was used anti-mouse IgG HRP-
conjugated with 1: 10,000 dilutions. 
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The solubilisation of bacterial cell membrane used the same protocol as for yeast membrane. 
Adding SMA into bacterial membrane resulted in the solubilisation of most of the 
membranes hence less material transferred in the pellet than observed for yeast (data not 
shown). These data suggest that SMA has better solubilised efficiency on bacterial 
membranes than for yeast. The solubilised samples were then purified by using Ni
2+
-NTA 
resin. A band at ~52 kDa with strong signal was observed in the elution fractions (with 250 
mM imidazole) (Figure 5-4). This suggests this protein binds strongly to Ni
2+
-NTA and is 
likely to be our fusion ZipA protein (with 6xHis tag at its C-terminus). Furthermore, the size 
of this protein showed on the SDS-PAGE gel was close to previous report [100]. Therefore, 
we conclude this protein is our ZipA. These cells which have successfully expressed ZipA 
were saved as glycerol stock for large-scale ZipA protein expression and purification. 
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Figure 5-4. Small scale of ZipA purification. Lane 1: wash with 60 mM imidazole. Lane 2 to 6: eluted with 
250 mM imidazole. The band at ~52 kDa is likely to be ZipA protein, the size is close to previous report 
[100].  
 
5.2.3 Large-scale of Protein Expression and Purification 
Purified SMALP-ZipA is approached by a simple two-step purification process 
On average, approximately 3.5 ~ 4 g of E.coli cells were obtained from a litre of flask 
culture. The membranes prepared from these cells were then solubilised by SMALP method. 
Most of membranes were solubilised and remained in the solubilised fractions (supernatant). 
The solubilised materials containing ZipA protein were then purified to homogeneity by a 
two-step purification process similar to A2aR purification process, this including the use of 
IMAC and gel filtration methods. 
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The first step was to use IMAC method, and the data showed a very good purification 
efficiency for SMALP solubilised ZipA using this method. Silver stained SDS-PAGE gel 
showed the proteins from IMAC elutions (Figure 5-5, lane 5 to 8) were already substantially 
pure, however, two weak bands (at ~28 kDa and ~ 80 kDa) also showed on the gel. 
Therefore, the elutions were further purified by gel filtration column to remove these 
contaminating proteins, improving purity of protein (Figure 5-6 and 5-7).  
 
Figure 5-5. Purification of ZipA using IMAC method. The fractions were analysed by SDS-PAGE gel and 
silver staining. Lane 1 (from the left of the gel): Flow through: the materials that did not bind to the resin. 
Lane 2: first wash with 60 mM imidazole. Lane 3 and 4: second wash with 80 mM imidazole. Lane 5 to 8: 
elute with 250 mM imidazole.  
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Figure 5-6. Gel filtration of ZipA. The IMAC elutions were loaded into gel filtration column. The progress 
was monitored by absorbance at 280 nm. The data showed a few larger proteins (observed at 80 kDa on 
SDS-PAGE gel) was eluted before the major protein, ZipA was eluted. The fractions containing ZipA were 
mixed and then examined by SDS-PAGE gel (Figure 5-7). The experiments were carried out using a 
Superdex 200 10/300 GL column attached to an Ä KTA
TM  
FPLC purification system. A flow rate was set 
at 1 ml/min. 
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Figure 5-7. SDS-PAGE gel for the purification of ZipA using gel filtration. The IMAC elution was loaded 
to gel filtration Superdex 200 10/300 GL column to remove aggregation protein to reach homogeneity. The 
fractions containing ZipA were examined by SDS-PAGE gel. Only single band was observed at ca. 52 
kDa. This showed that the protein has reached homogeneity after a two-step purification process.  
 
5.2.4 Protein Identification and Western Blotting Analysis  
A band at 52 kDa is an intact ZipA 
The band observed at ~52 KDa was larger than calculated molecular weight (fusion ZipA: 
38.7 kDa). This protein has been shown before to migrate aberrantly in SDS-PAGE gel [100]. 
To confirm a band at ~52 kDa is our purified SMALP-ZipA. FT-ICR mass spectrometry was 
applied to the band cut from SDS-PAGE gel (Figure 5-7), the sample was digested with 
trypsin to produce several short segments for FT-ICR mass spectrometry experiment. Five 
peptides fragments were identified which were cross referenced with the bacterial proteome 
and the protein was identified as FtsZ-interacting protein A (Table 5-4). These peptides are 
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found in the different domain of ZipA protein (highly charged region: amino acid from 29 -
85, P/Q domain: 86 - 185, and globular domain: 186 - 328).  
 
 
Peptide 
Fragments 
Peptide Sequence Peptide 
Location 
(amino acid) 
1 SKRDDDSYDEDVEDDEGVGEVR 46-67 
2 VNHAPANAQEHEAARPSPQHQYQPPYASAQPR 70-92 
3 RHLSPDGSGPALFSLANMVKPGTFDPEMKPGTFDPEMK 230-259 
4 LMLQSAQHIADEVGGVVLDDQR 283-305 
5 LREYQDIIR 312-321 
Table 5-4. The identification of ZipA was using FT-ICR mass spectrometry. A band at ca. 52 kDa was cut 
from instant blue stained 10% SDS-PAGE gel for trypsin digestion before identified by FT-ICR mass 
spectrometry. Five peptides fragments are found in the different domain of ZipA protein including highly 
charged region, P/Q domain and globular domain). Peptide location (amino acid) represents the location of 
this peptide, for example, 46-67 represents this peptide located from 46 to 67 amino acid residue of ZipA 
protein. 
 
Additionally, in order to demonstrate purified SMALP-ZipA is intact, the purified protein 
was analysed by Western blotting using anti-His-tagged antibody and N-terminus 
sequencing. Western blotting using anti-His-tagged antibody can be used for determining 
159 
 
whether C-terminus of ZipA is intact due to anti-His-tagged antibody bound to C-terminus of 
ZipA. Only one band showed on the blot, it suggests the C-terminus of ZipA is intact (Figure 
5-8). The N-terminus sequencing of purified SMALP-ZipA showed a sequence was found at 
N-terminus of protein, namely M-M-Q-D-L corresponds to the N-terminus of ZipA. 
Therefore, it indicates the N-terminus of ZipA is intact, too. Taken together these data, we 
conclude a band showed on SDS-PAGE gel at ~52 kDa is an intact ZipA.  
 
 
 
Figure 5-8. Western blotting of purified SMALP-ZipA. The purified SMALP-ZipA obtained from a simple 
two-step purification process was analysed by Western blotting. Only one band was observed at 52 kDa. 
This concludes the C-terminus of ZipA is intact due to anti-His-tagged antibody bound to C-terminus of 
ZipA. 20 µl of mixtures (proteins and loading buffer) were loaded onto the 10% SDS-PAGE gel and then 
transferred to a nitrocellulose membrane. The primary antibody was used anti-His-tagged Monoclonal 
antibody with 1: 5,000 dilutions and the secondary antibody was used anti-mouse IgG HRP-conjugated 
with 1: 10,000 dilutions.  
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5.2.5 FtsZ Protein Expression and Purification  
An initial sample of FtsZ protein used in FtsZ-ZipA interaction experiments was kindly 
provided from Dr. Raul Pacheco-Gomez. However, the protein was insufficient to complete 
the whole project. Therefore, we also purified FtsZ protein used for FtsZ-ZipA interaction 
experiments.  
 
5.2.5.1 Expression Screening of FtsZ 
The FtsZ expression plasmid was obtained from Dr. Raul Pacheco-Gomez (University of 
Birmingham). The plasmid was transformed to BL21 star (DE3) One Shot E.coli cells for 
FtsZ protein expression. A large number of colonies were observed after incubated at 37°C 
overnight on LB agar plate containing the 100 g/ml Ampicillin. Six colonies (including one 
sample for negative control, without adding IPTG for the induction) were chosen for 
expression screening. The SDS-PAGE gel showed a strong band at ~40 kDa appeared on all 
samples apart from negative sample (Figure 5-9), it is consistent with previous report [133]. 
Therefore, we conclude FtsZ protein was successfully expressed in BL21 star (DE3) One 
Shot E.coli cells. 
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Figure 5-9 .Over-expression of FtsZ. The gel showed a strong band ~40 kDa, the size of this protein 
consists with previous report for FtsZ protein. We conclude a band at ~40 kDa is FtsZ. Lane 1, 3, 4, 5 and 
6: the samples added IPTG. Lane 2: the sample did not add IPTG. The cells grew at 37°C and until OD600 
of 0.4. A stock IPTG was then added into culture to make a final IPTG concentration of 0.84 mM for the 
protein induction. The cell pellets were mixed with 1xSDS-PAGE sample buffer and then incubated at 
95°C for 10 minutes. 20 µl of mixture were then loaded onto the 10% SDS-PAGE gel.  
 
5.2.5.2 Large-scale FtsZ Expression and Purification 
The colonies which have been shown successfully expressed FtsZ protein were then used in 
large-scale protein expression and purification. Unlike A2aR and ZipA, FtsZ is a cytoplasmic 
protein and hence the membrane fraction was removed for the purification of FtsZ. Figure 5-
10 showed a SDS-PAGE gel of the FtsZ fractions eluted from the ion-exchange column (Q 
Sepharose). FtsZ was eluted at 250 mM KCl (Figure 5-10, lane 1 to 6), and the gel showed 
FtsZ was already substantially pure, and approximately 25 - 30 mg of FtsZ was obtained from 
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one litre culture. Purified FtsZ was stored at -80°C at least a year and showed no loss of 
polymerisation or GTPase activities. Moreover, freezing and thawing FtsZ up to five times 
did not affect activity. 
 
 
Figure 5-10. 10% SDS-PAGE of FtsZ fractions eluted from ion-exchange column (Q Sepharose). Lanes 1-
6 :elution, FtsZ was eluted at 250 mM KCl. The elution showed a major single band with little or no 
contamination.  
 
5.2.5.3 Activity Test for FtsZ  
In order to study the interaction between FtsZ and ZipA we must first establish that FtsZ is 
active. The easiest and quickest way is to measure FtsZ polymerisation activity using a right 
angled light scattering (RALS) experiment (§ 2.5.2). Figure 5-11 showed a rapid increase in 
light scattering that was known to occur within the first minute of the reaction after adding 
GTP. The large light scattering signal was sustained for several minutes, and then decreased. 
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This is consistent with previous observations that FtsZ undergoes rapid polymerisation and 
reaches a steady state. The length of steady state was proportional to the GTP concentration. 
While we added 0.2 mM of GTP into the sample and the length of steady state maintain about 
5 minutes. A rapid decrease in the light scattering suggests FtsZ depolymerisation happened 
as GTP depletion due to GTP hydrolysis. This is consistent with previous reports of FtsZ 
polymerisation [133]. The data suggest the FtsZ protein we purified is active. 
 
 
Figure 5-11. Light scattering assay for polymerisation of FtsZ. Data showed a rapid increase in light 
scattering occurred within the first minute of the reaction after adding GTP. The light scattering signal 
decreased while GTP depletion due to GTP hydrolysis. This suggests that FtsZ undergoes rapid 
polymerisation and reaches a steady state, and then FtsZ is depolymerised as GTP is depleted. These data 
suggest the purified FtsZ is active. The experiment was performed using a Perkin Elmer LS50B 
spectrofluorimeter. Data were collected every second at room temperature in a 0.3 cm path length 
fluorescence cuvette (typically with 100 μl volume) The excitation and emission wavelengths were set at 
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500 nm, and the excitation and emission slit widths were set at 2.5 nm. A baseline was collected for 150 
seconds before 0.2 mM was added to the sample. 
 
5.3 Discussion 
The ZipA genetic construct was designed to attach a 6xHis at C-terminus of protein enabling 
the use of the same purification protocol as A2aR to purify ZipA. On average, it took 5 ~6 
working day to obtain a purified ZipA from the expression step to the purification step, and 
10 ~ 11 working day for obtaining a purified A2aR. Therefore, this single transmembrane 
membrane protein (ZipA) is easier to be obtained comparing to A2aR. The purified SMALP-
ZipA showed a size at ~52 kDa on the SDS-PAGE gel. This is much larger than expected 
size 38.7 kDa. This atypical running behaviour, we also observed on A2aR and has described 
in section 3.2.5. To confirm the identity of the protein in the band, FT-ICR mass 
spectrometry experiments were carried out showing the presence of peptides throughout the 
ZipA sequence.  
 
Additionally, the protein was analysed by Western blotting using anti-His-tagged antibodies 
proving that the C-terminus of ZipA is intact. However, this fusion ZipA protein does not 
have any tag in the N-terminus. Therefore, we used N-terminus sequencing to determine 
whether the N-terminus of ZipA is intact. The data showed a sequence that consists with the 
N-terminus sequence of wild type ZipA. These data demonstrate SMALP system can be 
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applied to an integral inner-membrane protein with a significantly different architecture to 
those so far purified using SMALP.   
 
In conclusion, in this chapter, we have proved that SMALP can be used to produce ZipA 
using the same protocol as well as A2aR. In the future, this protocol could be used for many 
other membrane proteins to be an universal method for membrane protein study. 
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CHAPTER 6: Characterisation of ZipA 
 
6.1 Introduction 
ZipA is a protein involved in bacterial cell division that contains a single transmembrane 
domain that has been shown to be involved in stabilisation of FtsZ-ring [110,111]. However, 
the FtsZ-ZipA interactions have not been that well studied due to the difficulty of purifying 
and handling ZipA (which is a membrane protein). In the previous chapter, we used the novel 
SMALP system to produce ZipA, now we use a range of techniques to characterise purified 
SMALP-ZipA and also study the FtsZ-ZipA interaction.  
 
First of all, we use CD to determine the secondary structure of purified SMALP-ZipA, and its 
folded state. We also use svAUC to monitor the oligomerisation state of purified SMALP-
ZipA. Moreover, we address the FtsZ-ZipA interaction via RALS assay, sedimentation assay, 
LD, GTPase assay and TEM. These data provide the information about the protein-protein 
interactions and allow us to build a model to describe how ZipA affect FtsZ polymers during 
the cell division. Furthermore, we attempt to reconstitute ZipA and FtsZ into a GUV to create 
an artificial FtsZ-ring inside a GUV. This could provide us a new route to understand the 
mechanism of cell division in vitro and in particular how the division machinery alters 
membrane morphology. 
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6.2 Results 
6.2.1 Circular Dichroism  
CD spectrum of purified SMALP-ZipA presents a native folded protein  
To date, the full structure of ZipA has not been solved. However, the crystal structure exists 
of C-terminal of ZipA shows both -helices and -sheets character [105]. The remaining 
parts of the protein are made up of a single -helices transmembrane domain and a region 
that is predicted to be unstructured [99]. From these data we can predict that ZipA consists of 
-helices, -sheets and extensive unstructured region from its sequence of amino acids.  
 
Our CD data showed purified SMALP-ZipA consists of -helices (29%), -sheets (35%) and 
36% unfolded of secondary structure (Figure 6-1). Additionally, the CD signal at 190 nm is 
lower than that expected for a folded protein, representing the protein was not fully folded (a 
folded protein should present a positive signal at 190 nm, Dr. Tim Dafforn, personal 
communication). This correlates with the presence of an unstructured region in the purified 
SMALP-ZipA and is consistent with the predicted structure of ZipA.  
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Figure 6-1. CD spectrum of purified SMALP-ZipA. The CD data showed purified SMALP-ZipA consists 
of -helices, -sheets and unstructured region, consists with the predicted structure of ZipA. It suggests 
purified SMALP-ZipA maintained its native secondary structure after solubilisation and purification steps. 
CD data were collected using a JASCO J-715. CD spectra were collected using a 1 mm path length cuvette 
and averaged over 8 scans in the far-UV domain. Spectra acquired were corrected for the buffer signal. 
Protein concentration of purified SMALP-ZipA was 0.05 mg/ml. 
 
6.2.2 Sedimentation Velocity Analytical Ultracentrifugation 
svAUC data shows purified SMALP-ZipA is mainly monomeric 
In the chapter 4, sedimentation velocity analytical ultracentrifugation was shown to have 
potential utility for monitoring oligomerisation of proteins in SMALP (Figure 6-2). SEDFIT 
analysis of data from a sample of purified SMALP-ZipA using the c(M) model produced an 
intense peak at 78 kDa, that is likely to be a ZipA encapsulated in SMALP, accompanied by 
two minor peaks at 10 and 30 kDa. The first minor peak (10 kDa) is likely to be free SMA 
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(10 kDa) and the other minor peak (30 kDa) is likely to be empty SMALP. This second peak 
has the molecular mass different from equivalent svAUC experiments carried out on purified 
SMALP-A2aR (§ 4.2.3). This could be the result of these protein-free SMALP having 
different components of lipids as they were derived from E.coli membranes, rather than the 
yeast cell membrane used in the previous study in the chapter 4.  
 
The intense higher molecular peak can therefore be attributed to the presence of purified 
SMALP-ZipA. An approximate measure of the mass of the encapsulated ZipA can then be 
determined by subtraction of the mass of the empty SMALP, which yields a mass of 
approximately 48 kDa. However, this does not completely match the expected size of ZipA 
(38.7 kDa) The difference is likely to result from either a variance in the amount of lipid 
maintained in the protein free SMALP and protein loaded SMALP, or perhaps the presence 
of a mixed population containing dimeric and monomeric ZipA. Although it is clear that even 
if there is some dimeric contaminant, it constitutes only a small proportion of the sample. 
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Figure 6-2. A SEDFIT c(M) deconvolution of sedimentation velocity analytical ultracentrifugation data 
collected on purified-SMALP-ZipA showing the presence of 3 peaks corresponding to SMA (10 KDa), the 
empty SMALP (30 KDa) and ZipA encapsulated in SMALP (78 KDa). Data were collected on a Beckman 
XL-I proteome lab at 40,000 rpm with the migration of the particles being monitored by scanning the cell 
at 280 nm. 
 
6.2.3 Electron Microscopy  
It has been shown that purified SMALP-PagP and purified SMALP-A2aR are nanodisk-like 
structures. TEM micrograph of purified SMALP-ZipA (×30, 000) (×50, 000) showed purified 
SMALP-ZipA was also in a nanodisk structure (Figure 6-3). Moreover, on average, the 
structure of purified SMALP-ZipA (17.5 ± 2.5 nm) was a little smaller than purified SMALP-
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A2aR (20 ± 2.5 nm). It is probably that ZipA only contains a single transmembrane domain, 
and it is a smaller protein (38.7 kDa) than A2aR (47 kDa). 
                              
(A) TEM of purified SMALP-ZipA (×30, 000) 
                               
(B) TEM of purified SMALP-ZipA (×50, 000) 
 
Figure 6-3. (A) TEM micrograph of purified SMALP-ZipA (×30, 000) showed purified SMALP-ZipA was 
a nanodisk structure. On average, the structure of purified SMALP-ZipA was a little smaller than purified 
SMALP-A2aR. Selected areas were photographed at ×30,000. Scale bar represents 100 nm. (B) TEM 
micrograph of purified SMALP-ZipA (×50, 000). Selected areas were photographed at ×50,000. Scale bar 
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represents 50 nm. The experiments carried out using a JEOL 2011 transmission electron microscope. The 
samples were stained with 1% uranyl acetate solution.  
 
The Interaction Experiments Between FtsZ and ZipA 
The sections from 6.2.4 to 6.2.9 described the methods used to characterise the FtsZ-ZipA 
interaction. 
 
6.2.4 Right Angle Light Scattering 
RALS signal of FtsZ polymerisation is significant increased in the presence of ZipA   
Changes in RALS signal reflect the changes in the size distribution of particles in a sample. 
In this study, we used RALS to study the dynamics of FtsZ polymerisation in the presence or 
absence of ZipA. According to the previous publish protocol, the buffer used for FtsZ 
polymerisation should contain a concentration of 10 mM MgCl2, at pH of 6.5.  However, 
SMA polymer is pH-sensitive leading to precipitation at pH <6.5. In addition the polymer is 
precipitated by high concentrations of MgCl2. Therefore, before we study the interaction of 
SMALP-ZipA with FtsZ, we have to investigate if purified SMALP-ZipA is stable in the 
assay buffer (10 mM MgCl2, pH 6.5).  
 
However, our initial studies showed the purified SMALP-ZipA was affected by 10 mM 
MgCl2 (Figure 6-4). The RALS signal of purified SMALP-ZipA in 10 mM MgCl2 continually 
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increased suggesting that the purified SMALP-ZipA particle was dissociated leading to the 
formation of SMA polymer precipitate. To address this, we decreased the concentration of 
MgCl2 to 2.5 mM and determined if this still affects the purified SMALP-ZipA. The data 
showed, in this low concentration of MgCl2, the RALS signal was very steady suggesting that 
the purified SMALP-ZipA was stable in the lower concentration of MgCl2.  
 
Figure 6-4. The effect of Mg
2+
 concentration on purified SMALP-ZipA. 
Purified SMALP-ZipA was in 50 mM MES buffer pH 6.5, 50 mM KCl and 2.5 mM MgCl2 (green), 5 mM 
MgCl2 (red) or 10 mM MgCl2 (blue) to which 0.2 mM GTP was added.  Data were collected every second 
at room temperature in a 0.3 cm path length fluorimeter cuvette (typically with 100 μl volume). The 
excitation and emission wavelengths were set at 500 nm, and the excitation and emission slit widths were 
set at 2.5 nm. The experiment was performed using a Perkin Elmer LS50B spectrofluorimeter. A baseline 
was collected for 60 seconds before the GTP was added to the sample. 
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Moreover, we also investigated if purified SMALP-ZipA is affected by pH. The data showed 
the purified SMALP-ZipA was stable at pH 6.5 and 7, but started to be unstable while pH 
was decreased to 6  (Figure 6-5).  
 
 
Figure 6-5. The effect of pH on purified SMALP-ZipA. 
The experiment was started by adding into the sample. Purified SMALP-ZipA in 50 mM MES buffer pH 6 
(red), 6.5 (blue) or 7 (green), 50 mM KCl and 2.5 mM MgCl2 to which 0.2 mM GTP was added. Data were 
collected every second at room temperature in a 0.3 cm path length fluorimeter cuvette (typically with 100 
μl volume). The excitation and emission wavelengths were set at 500 nm, and the excitation and emission 
slit widths were set at 2.5 nm. The experiment was performed using a Perkin Elmer LS50B 
spectrofluorimeter. A baseline was collected for 60 seconds before GTP was added into the sample. 
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Furthermore, we determined whether the FtsZ polymerisation is affected by the concentration 
of MgCl2 (Figure 6-6). The data showed the RALS signal of FtsZ polymerisation became 
smaller and a cycle of FtsZ polymerisation also became shorter while the MgCl2 was decrease 
to 2.5 mM, consists with previous reports [133,137]. However, given that 10 mM MgCl2 can 
affect the structural integrity of the purified SMALP-ZipA, the assay conditions were chosen 
with 2.5 mM of MgCl2 as compromise between FtsZ polymerisation and SMALP integrity. 
 
Figure 6-6. The effect of Mg
2+
 concentration on FtsZ polymerisation  
FtsZ was in 50 mM MES buffer pH 6.5, 50 mM KCl and 10 mM MgCl2 (red) / 2.5 mM MgCl2 (blue).  
Data were collected every second at room temperature in a 0.3 cm path length fluorimeter cuvette 
(typically with 100 μl volume). The excitation and emission wavelengths were set at 500 nm, and the 
excitation and emission slit widths were set at 2.5 nm. A baseline was collected for 2 minutes before 0.2 
mM of GTP was added to the sample. The experiment was performed using a Perkin Elmer LS50B 
spectrofluorimeter. A baseline was collected for 120 seconds before GTP was added into the sample. 
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Previously study has shown FtsZ polymerisation to be sustained at lower pH condition, such 
as pH of 6 [133]. Our previous study (Figure 6-5), however, showed the requirement for the 
assay buffer have to be a pH over 6.5 to allow the SMALP structure to be stable. It meant we 
had to study the effect of increasing pH on FtsZ polymerisation (Figure 6-7). These data 
showed FtsZ polymerisation was decreased (shorter and smaller) by increasing pH. At pH 6, 
the RALS reached a maximum value of 34 units and then it took approximately 500 seconds 
to return to a value of 0 units. At pH 6.5, the RALS reached a maximum value of 23 units and 
then it took approximately 400 seconds to return to a value of 0 units. This (at pH 6.5) only 
represents a slight loss in activity and is thought to be permissible in this study, and pH 6 can 
affect the structural integrity of the purified SMALP-ZipA, therefore, the assay conditions 
were chosen at at pH 6.5 for studying FtsZ-ZipA interaction experiments. 
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Figure 6-7. The effect of pH on FtsZ polymerisation  
FtsZ was in 50 mM MES buffer pH 6 (red), 6.5 (blue) or 7 (green) 50 mM KCl and 2.5 mM MgCl2. Data 
were collected every second at room temperature in a 0.3 cm path length fluorimeter cuvette (typically 
with 100 μl volume). The excitation and emission wavelengths were set at 500 nm, and the excitation and 
emission slit widths were set at 2.5 nm. A baseline was collected for 2 minutes before 0.2 mM of GTP was 
added to the sample. The experiment was performed using a Perkin Elmer LS50B spectrofluorimeter. A 
baseline was collected for 120 seconds before GTP was added into the sample. 
 
Figure 6-8 showed the RALS data of FtsZ polymerisation in the presence of different 
concentrations of ZipA. In the absence of ZipA, the RALS reached a maximum value of 20 
units and then it took approximately 400 seconds to return to a value of 0 units. In the 
presence of ZipA, the RALS reached a maximum value of 50 units. More interestingly, the 
signal did not come back to zero even after 30 minutes. In the presence of more ZipA, the 
maximum of RALS increased to approximately 110 units. These data suggest that in the 
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presence of ZipA, the size of FtsZ polymers become larger and it takes much longer for FtsZ 
polymers dissociate back to FtsZ monomers.   
 
 
Figure 6-8. The effect of ZipA on FtsZ polymerisation  
FtsZ was in 50 mM MES buffer pH 6.5, 50 mM KCl and 2.5 mM MgCl2 in the presence of different 
concentration of ZipA. Data were collected every second at room temperature in a 0.3 cm path length 
fluorimeter cuvette (typically with 100 μl volume). The excitation and emission wavelengths were set at 
500 nm, and the excitation and emission slit widths were set at 2.5 nm. The experiment was performed 
using a Perkin Elmer LS50B spectrofluorimeter. A baseline was collected for 120 seconds before 0.2 mM 
was added into the sample. 
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6.2.5 Sedimentation Assay 
FtsZ polymerisation can also be measured using sedimentation assay. FtsZ polymers can be 
selectively pelleted over the monomer by centrifugation due to its heavier mass, the resulting 
pellet can then be analysed using SDS-PAGE gel. To test the effect of the purified SMALP-
ZipA on FtsZ polymerisation, the sedimentation assay was carried out using the conditions 
described in 6.2.4. The importance of reducing Mg
2+
 ions in SMALP solutions was again 
underlined by data that showed a strong ZipA band in the pellet of samples containing 10 
mM MgCl2 (Figure 6-9). However, the majority of purified SMALP-ZipA remained on the 
supernatant when the concentration of MgCl2 was decreased to 2.5 mM MgCl2 (Figure 6-9).  
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Figure 6-9. The effect of Mg
2+
 concentration on purified SMALP-ZipA using sedimentation assay 
The SDS-PAGE gel showed the effect of MgCl2 on purified SMALP-ZipA was decreased to minimum by 
decreasing the concentration of MgCl2. Supernatant (S) and pellet (P). 3.3 μM ZipA was in polymerisation 
buffer (50 mM MES pH 6.5, 50 mM KCl, and 10 or 2.5 mM MgCl2) and 2 mM GTP. 2 mM GTP was 
immediately added to the sample to make up a final volume of 250 μl before centrifugation at 80,000 rpm 
for 10 minutes. 125 μl of supernatant was collected and the pellet was resuspended in 250 μl of 
polymerisation buffer. The protein samples were mixed with 5xSDS-PAGE sample buffer. 20 µl of 
mixture were then loaded onto the 10% SDS-PAGE gel.  
 
Similar experiments to those mentioned above were also carried out to determine whether the 
FtsZ polymers sedimentation assay is affected by the concentration of MgCl2 (Figure 6-10). 
These data showed fewer FtsZ polymers were found in the pellet sample when the MgCl2 
concentration was decreased to 2.5 mM. Although FtsZ polymers were decreased at the lower 
concentration of MgCl2 (2.5 mM), but it does not significantly affect the study on FtsZ-ZipA 
interaction.  
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Figure 6-10. The effect of Mg
2+
 concentration on FtsZ polymerisation using sedimentation assay 
The SDS-PAGE gel showed the FtsZ polymerisation was decreased by decreasing MgCl2 to 2.5 mM (less 
FtsZ found in the pellet). Supernatant (S) and pellet (P). Supernatant (S) and pellet (P). 3.67 μM FtsZ was 
in polymerisation buffer (50 mM MES pH 6.5, 50 mM KCl, and 10 or 2.5 mM MgCl2) and 2 mM GTP. 2 
mM GTP was immediately added to the sample to make up a final volume of 250 μl before centrifugation 
at 80,000 rpm for 10 minutes. 125 μl of supernatant was collected and the pellet was resuspended in 250 μl 
of polymerisation buffer. The protein samples were mixed with 5xSDS-PAGE sample buffer. 20 µl of 
mixture were then loaded onto the 10% SDS-PAGE gel.  
 
When the polymerisation of FtsZ in the presence of ZipA was eventually carried out, these 
data showed more FtsZ polymers were found in the pellet in the presence of ZipA (Figure 6-
11). This confirms that ZipA binds to FtsZ and suggests that ZipA promotes FtsZ 
polymerisation due to increase the number of FtsZ polymers found in the pellet.  
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Figure 6-11. Sedimentation assay for polymerisation of FtsZ in the presence or absence of ZipA 
The SDS-PAGE gel showed ZipA promotes FtsZ polymerisation and thus more FtsZ polymers were found 
in the pellet. Supernatant (S) and pellet (P). Lane 1 and 2 (from the left), negative control, where represent 
μM ZipA was in polymerisation buffer (50 mM MES pH 6.5, 50 mM KCl, and 2.5 mM MgCl2 ) and 2 mM 
GTP . Lane 3 and 4, positive control, represent μM FtsZ was in polymerisation buffer and 2 mM GTP. 
Lane 5 and 6, experimental, represent ZipA and FtsZ was at 3.3 μM and 11μM, respectively, in 
polymerization buffer and 2 mM GTP. 2 mM GTP was immediately added to the sample to make up a 
final volume of 250 μl before centrifugation at 80,000 rpm for 10 minutes. 125 μl of supernatant was 
collected and the pellets were resuspended in 250 μl of polymerisation buffer. The protein samples were 
mixed with 5xSDS-PAGE sample buffer. 20 µl of mixture were then loaded onto the 10% SDS-PAGE gel.  
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6.2.6 GTPase Assay 
Previous studies have shown that FtsZ polymerisation is triggered by the presence of GTP, 
once GTP is depleted, the FtsZ polymers are disassociated [133]. In order to determine 
whether ZipA affects the GTPase activity of FtsZ, we used GTPase assay to examine the 
GTPase activity of FtsZ in the presence of different concentrations of ZipA. The experiment 
was started by adding 0.2 mM GTP into the sample. The data were transferred to the 
percentage of Pi released at any given time (100% represent the complete hydrolysis of GTP 
to GDP) (Figure 6-12). These data showed ZipA does not affect the GTPase activity of FtsZ, 
and this result is consistent with the observation by Haney et al and Liu et al [107, 146]. 
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Figure 6-12. The effect of ZipA on the GTPase activity of FtsZ.  
The Pi was released from the enzymatic conversion of GTP to GDP catalysed by FtsZ in the presence or 
absence of ZipA. The data showed ZipA does not affect the GTPase activity of FtsZ. The assay was 
performed by measuring Abs 360 between the substrate (MESG) and its products (ribose 1-phosphate and 2-
amino-6-mercapto-7-methlpurine). The experiment was carried out using a Jasco V-550 spectrometer at 
room temperature, and the wavelength was set up at 360 nm. The Abs 360 was zeroed before adding 0.2 
mM GTP into the sample. Data were collected every 1 second for 1800 seconds in a 0.5 cm path length 
cuvette. The data were transformed to the percentage of Pi released at any given time (100% represent the 
complete hydrolysis of GTP to GDP). 
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6.2.7 Linear Dichroism  
LD spectroscopy can be used to study the orientations of biomolecules in ordered arrays 
[114]. LD gives information about the spatial orientation of subunits of a system with respect 
to the orientation axis as well as the specific binding of ligands. LD experiments can be 
performed in systems that are intrinsically oriented or systems that can be oriented using 
external forces. LD has been previously used to detect FtsZ polymers as well as the 
orientation of chromophores within FtsZ fibres [113]. FtsZ polymerises upon GTP addition 
which means that the monomers (globular) are invisible to LD, however, when GTP is added 
to the solution, FtsZ forms the FtsZ polymers and these polymers can be oriented and have a 
large aspect ratio which LD spectrum can record.  
 
In this section, we have used LD to examine the structure of the FtsZ polymers in the 
presence or absence of ZipA. The data presented here show that the LD signal at 211 nm in 
backbone region (190 to 260 nm) decreased in the presence of ZipA (Figure 6-13, A). These 
data suggest that either the FtsZ polymers have decreased in length or have become more 
curved upon addition of ZipA since in both cases a reduction in the LD signal would be 
obtained and therefore do not align as well as FtsZ polymers in the absence of ZipA.  
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We have also analysed if there was any change of the orientation of chromophores within the 
FtsZ polymers in order to get an insight of the possible mechanism of FtsZ protofilament 
formation and/or FtsZ protofilament/ZipA interaction. Examination of the LD region from 
240 to 290 nm, which has been previously studied to report the orientation of GTP bound to 
FtsZ [133]. Figure 6-13 (B) showed the LD spectra of FtsZ in the absence or presence of 
increasing amounts of ZipA and it provides an insight into the possible mechanism of the 
GTP reorientation. The data showed a very slight difference in one of the guanine transitions 
(long axis) at ~250 nm from positive to negative when ZipA is present. This change is likely 
to be a reorientation of the guanine in the GTP due to the protofilaments lateral associations 
when ZipA is present. 
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 Figure 6-13(A) LD signal at 211 nm in backbone region 
   
       
Figure 6-13 (B) Region from 240 to 290 nm 
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Figure 6-13 LD spectra of FtsZ protofilaments in the presence or absence of ZipA.  
Increasing concentrations of ZipA (FtsZ :ZipA =1:0.15(red), FtsZ :ZipA =1:0.3(green) were added to FtsZ 
protofilaments (to a final concentration of FtsZ 11 M). The samples were incubated at 25°C for 10 
minutes in polymerization buffer (50 mM MES, pH 6.5, 50 mM KCl, and 2.5 mM MgCl2 ) to give a final 
volume of 90 l. (A) In the presence of increasing concentrations of ZipA, the LD backbone signal 
decreased. (B) The data showed a very slight difference in one of the guanine transitions (long axis) at 
~250 nm from positive to negative when ZipA is present. The data were collected using a Jasco J-715 
spectropolarimeter adapted for LD spectroscopy. The experiment was carried out with a rotation (7 V) and 
a blank (non-rotation) was subtracted from each sample measured. Data were recorded using an interval 
scan measurement programme. The wavelength range was set between 190 nm and 350 nm with a 
scanning speed of 200 nm/min and data pitch was set 0.5 seconds.  
 
 
6.2.8 Electron Microscopy  
The effect of ZipA on FtsZ polymerisation was directly visualised by TEM. 0.2 mM GTP 
was added into the sample immediately before the sample was transferred to the carbon side 
of grid. The TEM data showed that in the absence of ZipA, FtsZ formed numerous straight or 
curved single protofilaments (Figure 6-14, A). In the presence of ZipA, the TEM micrograph 
showed these straight or curved protofilaments trended to bundle together (Figure 6-15, B), it 
suggests that ZipA promoted the bundling of FtsZ protofilaments. 
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      (A)                                                                                       (B) 
Figure 6-14. The effect of ZipA on FtsZ polymerisation. (A) In the absence of ZipA, FtsZ formed a lot of 
straight or curved single protofilaments. The length of these protofilaments was various. (B) In the 
presence of ZipA, these straight or curved protofilaments trended to bundle together. 100 μl reactions 
contained 11 µM FtsZ with or without 3.3 µM ZipA were made up in the polymerization buffer and then 
incubated at 25°C for 10 minutes. 0.2 mM GTP was added to the mixture immediately before 5 µl of the 
mixture was transferred to the carbon side of grid for 1 minute. The sample was stained by washing 1% 
uranyl acetate solution for 45 seconds. The experiment was carried out using a JEOL 2011 transmission 
electron microscope (TEM). Selected areas were photographed at ×10,000. Scale bar represents 0.2 μm. 
 
6.2.9 Reconstitution of FtsZ-ring Inside A Giant Unilamellar Vesicle 
SMA polymer can be removed from pure SMALP solubilised protein by decreasing pH or 
adding MgCl2, the process we termed ―de-SMALP‖. The protein can be inserted to the mimic 
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membrane system such as giant unilamellar vesicles (GUVs), one type of liposomes. This 
could allow us to create an artificial FtsZ-ring inside a GUV and then provide us a new route 
to understand the mechanism of cell division in vitro and in particular how the division 
machinery alters membrane morphology. These large vesicles with diameters of 5 μm ~300 
μm have the advantage of being easily visualised using optical microscopy. Moreover, 
labelling GUVs with rhodamine 6G that allows GUVs to be seen by fluorescence confocal 
microscopy. It was decide that using the low pH method for the de-SMALP may destabilise 
protein. Therefore, we carried out the de-SMALP by adding 50 mM MgCl2. CD data showed 
the de-SMALP ZipA inside a labelled GUV still maintained its native secondary structure 
(Figure 6-15).  
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Figure 6-15. CD spectrum of de-SMALP ZipA inside a labelled GUV.  
The CD data showed de-SMALP ZipA inside a GUV still maintained its native secondary structure during 
de-SMALP and reconstitution into a labelled GUV step. The de-SMALP ZipA was added into labelled 
GUV, mixed by gentle pipetting and then incubated at 37°C for 15 minutes. CD data were collected using 
JASCO J-715. CD spectra were collected using a 1 mm path length cuvette and averaged over 8 scans in 
the far-UV domain. Spectra acquired were corrected for the buffer signal.  
 
FtsZ was then added into labelled GUVs in the presence or absence of de-SMALP ZipA. The 
samples were then observed by confocal microscope. In the absence of ZipA, the 
photographs of confocal microscope showed the most of GUVs presented a shape which is 
like an ―onion‖ (Figure 6-16, A and B). In the presence of ZipA, the most of GUVs were 
changed to many irregular shapes. Unfortunately, we did not observe any the structure is like 
a ―ring‖ (Figure 6-16, C and D). 
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(A) (B)            
                     
 
 
        (C)                                                                    (D) 
Figure 6-16. Confocal microscope of reconstitution of FtsZ-ring Inside a GUV. The ZipA (de-SMALP) 
and FtsZ were prepared in the polymerisation buffer to give a final protein concentration of 3.3 µM and 11 
µM, respectively.(A) and (B), GUVs only contained 11 µM FtsZ. (C) and (D), GUVs contained 11 µM 
FtsZ and 3.3 µM ZipA. The 67.5 μl of proteins in the polymerisation buffer were added into GUVs to 
make up a final volume of 135 μl, the sample was mixed by gentle pipetting and then incubated at 37°C for 
15 minutes.  GTP was added into the sample to give a final concentration of 2 mM, and then the 
reaction was observed immediately by Nikon A1R Inverted Confocal microscope at 60 times 
magnification. 
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6.3 Discussion 
In this chapter, we have shown the biophysical characterisation of purified SMALP-ZipA 
using a range of techniques including CD, svAUC, RALS assay, LD, GTPase and TEM. CD 
data showed purified SMALP-ZipA consists of -helices, -sheets, it is consistent with its 
predicted structure. Moreover, the data also indicates that purified SMALP-ZipA contains a 
significant amount of unfolded structure, it is consistent with the presence of a P/Q domain 
which is predicted to be a largely unfolded polypeptide [99]. We also used svAUC to monitor 
the oligomerisation state of purified SMALP-ZipA. The data suggest that purified SMALP-
ZipA is mainly monomeric (intense peak at 78 kDa). Taking the CD and svAUC data 
together, the purified SMALP-ZipA maintains its native structure at least at the level of 
secondary structure and it is mainly monomeric. 
 
The FtsZ-ZipA interactions were then studied by various biophysical tools. These data 
showed ZipA affects the polymerisation of FtsZ but without affecting the GTPase activity of 
FtsZ. Data from LD studies showed that the presence of ZipA reduces the LD signal from the 
FtsZ fibres. This could be because the ZipA is disrupting the FtsZ, making it less long and 
hence less able to align. However, the results from sedimentation experiments showed 
different levels of FtsZ in the pellet with or without ZipA showing that this is not the case. 
Another possibility would be that the ZipA has changed the shape of the polymers making 
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them less linear. Examination of the TEM pictures suggest that this may be the case as more 
convoluted structures are observed in the FtsZ + ZipA experiments. This information is 
enough to begin to build a model to describe how ZipA affect FtsZ-ring during the cell 
division (see chapter 7).  
 
Furthermore, we also attempt to reconstitute of FtsZ-ring inside a GUV. The experiment 
involved a process we termed ―de-SMALP‖, and then inserted ZipA into a GUV. Importantly, 
CD data shows no significant difference between SMALP-ZipA and de-SMALP ZipA inside 
a GUV. Studies of the effect of FtsZ polymerisation on the structure of GUVs containing 
ZipA showed the significant changes in morphology, indicating that a simple preliminary in 
vitro cell division system may have been reconstituted. However, we do not observe any the 
structure is like a ―ring‖. Therefore, the conditions of this experiment will require further 
development in the future.  
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 CHAPTER 7: General Discussion, Conclusions and Future Work 
7.1 General Discussion 
Since the first membrane protein structure was solved in 1985, it has become possible to 
obtain atomic level structural information for membrane proteins. However, for the past 26 
years, the production and study of membrane proteins has been limited by the ability to 
produce sufficient quantities of pure membrane protein. In particular the absence of a simple 
and universal protocol for extracting membrane proteins from the native membrane 
environment while at the same time maintaining their native structures and functions has 
been a real problem. This insufficiency has limited the study of the human biology and 
pharmaceuticals development as membrane proteins are central to a wide range of biological 
processes such as signal transduction, molecular transport, and respiration [129].   
 
The main reason membrane protein is difficult to extract is their low solubility in water, 
which leads to instability and loss of activity. Most conventional methods require the use of 
detergent as an extraction agent from the cell membranes which often leads to the striping of 
lipids from the protein and, as result, alteration of its activity. To address this problem, 
several model systems including the use of liposomes, amphipols, nanodiscs, and bicelles 
have allowed studying membrane proteins in vitro in a native-like membrane environment. 
All these current systems, however, have drawbacks and each of these methods require the 
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use of detergents to extract proteins from the cell membrane, and hence the striping away of 
their native lipids. In addition, no single method has been universally satisfactory for its 
posterior biophysical study and characterisation. It is therefore crucial to develop a novel 
system which can be used to produce membrane proteins, ideally keeping them in their native 
environment without adding any detergents as well as being suitable for most techniques used 
to characterise membrane proteins.  
 
SMALP, a novel method to study membrane proteins, has been reported in this thesis. This 
method has been successfully previously used to study two naturally abundant bacterial 
membrane proteins, PagP and bR [49]. In this project, we have demonstrated that SMALP 
can be used for studying more challenging membrane proteins, such as A2aR. We have 
showed for the first time that the SMALP system can be used to extract A2aR directly from 
Pichia pastoris cell membranes. The SMALP method performed equally well when 
compared to an existing detergent method (as it can be concluded from the radioligand 
binding assay results, data shown in the chapter 3). In pharmacological studies, the data 
showed that SMALP solubilised A2aR can bind to a number of small molecule ligands with 
native-like affinities, it demonstrates that SMALP maintains an environment similar to the 
native membrane. In addition, our industrial collaborator has demonstrated that SMALP can 
be used to solubilise membrane proteins directly from a mammalian cell membrane. It is 
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therefore clear that SMALP has applications across a wide range of expression systems 
(bacterial, yeast and mammalian cells). Another advantage of the SMALP system is that it is 
simple to use. The protocol that we have developed only requires adding SMA polymer (also 
supplied with the extra lipids) to extract the protein from the cell membrane. The downstream 
experiments do not require addition of extra polymer or lipids to maintain this condition. 
Other systems often require careful control of the experimental condition during the 
purification and subsequent analytical studies. For example, maintaining micelles require 
careful control the concentration to ensure that it is kept above CMC [8, 20], however, that is 
not the case if SMALP was to be used. 
 
Continuing the comparison with detergent based preparation, one of the advantages of the 
SMALP system is that, in some cases, it leads to a reduction in the number of purification 
steps required to produce pure protein (2 versus 3 for A2aR). It is a good thing to decrease the 
number of purification steps when purifying a protein, especially for the low abundance 
protein such as GPCR as each step potentially decreases yield. We have also showed that 
SMALP can provide a more thermostable environment than detergent as suggested by the 
study of its thermal stability using radioligand binding assays. Figure 7-1 shows a model of a 
purified SMALP-A2aR.  
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Figure 7-1. Model of a purified SMALP-A2aR 
Cartoon shows the formation of purified SMALP-A2aR SMA polymer and DMPC are added into cell 
membranes containing A2aR. The final SMALP-A2aR is obtained after subsequent purification steps. 
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Moreover, we have also used this novel method to study the bacterial membrane protein 
ZipA, which is involved in bacterial cell division. We have characterised and studied ZipA 
protein and its interaction with FtsZ protein, which forms a ring in the inner membrane of 
bacteria that recruits approximately 15 auxiliary proteins including ZipA. ZipA was purified 
using the same protocol to purify A2aR demonstrating the universal nature of the SMALP 
method. The secondary structure of the purified SMALP-ZipA was characterised using CD, 
and the size was studied by svAUC. These data combined showed that the purified SMALP-
ZipA maintained its native structure and it is mainly monomeric. Analysis of the FtsZ-ZipA 
interaction, showing that SMALP is complementary with several commonly used protein 
analysis methods including RALS assay, sedimentation assay,  LD, GTPase assay and TEM.  
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In RALS assay, the signal was increased while FtsZ polymerisation (Figure 7-2, A). In the 
presence of ZipA, the signal has been shown a significant increase, this because ZipA induce 
the bundling of FtsZ polymers and thus produce the larger FtsZ polymers (Figure 7-2, B) 
[110,111]. 
 
 
Figure 7-2 Schematic representation of the possible mechanism of FtsZ-ZipA interaction (A) Without 
ZipA, the signal is increased while FtsZ polymerisation. (B) In the presence of ZipA, ZipA induce 
bundling of FtsZ polymers and thus the signal has been shown a significant increase.  
 
The sedimentation assay showed that FtsZ was presented in the pellet when GTP was added 
to FtsZ monomers indicating the formation of FtsZ polymers. In the presence of ZipA, more 
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intense band corresponding to the approximate molecular weight of FtsZ was observed in the 
SDS-PAGE gel of the pellet sample, suggesting that ZipA induces the bundling of FtsZ 
polymers. In addition, ZipA was also observed in the pellet, confirming that ZipA bound to 
FtsZ polymers. Figures 7-3 shows a schematic representation of the possible mechanism.  
 
 
Figure 7-3. Schematic representation of the sedimentation assay performed on (A) in the absence of ZipA, 
FtsZ was presented in the pellet when GTP was added to FtsZ monomers indicating the formation of FtsZ 
polymers and (B) in the presence of ZipA, more FtsZ protein observed in the SDS-PAGE gel of the pellet 
sample, suggesting that ZipA induces the bundling of FtsZ polymers. 
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The LD data showed that the backbone far-UV signal decreased when increasing the 
concentration of ZipA which was added to FtsZ polymers. These data could be interpreted as 
three distinct possibilities:  (1) ZipA makes the FtsZ polymers more flexible or curved; (2) 
the FtsZ polymerisation is reduced by ZipA (the polymers become shorter); (3) a 
combination of both. Figure 7-4 shows a schematic representation of these possible 
mechanisms. However, taking all the data together (RALS, sedimentation assay, LD and 
TEM) together, it is more likely to be the FtsZ polymers becoming more flexible or curved in 
the presence of ZipA. 
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Figure 7-4. In the presence of increasing concentrations of ZipA, the backbone far-UV LD signal 
decreases. This indicates three possibilities (1) ZipA makes the FtsZ polymer more flexible or curved (2) 
the FtsZ polymerisation is reduced by ZipA or (3) a combination of both.  
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Overall, ZipA not only induces the bundling of FtsZ polymers, but also makes the polymers 
more flexible or curved (Figure 7-5). These data corroborates our previous results and agree 
with previous studies [107,110-112]. Our studies showed FtsZ can form FtsZ polymers, 
however, these polymers are more rigid in the absence of ZipA.  In the presence of ZipA, 
these FtsZ polymers must be very flexible in order to form the FtsZ-ring. The data presented 
here support this mechanism and the biological role of this type of interaction.  
 
 
 
 
Figure 7-5. ZipA not only induces bundling of FtsZ polymers, but also makes the polymers more flexible 
or curved. 
 
7.2 Conclusions 
The first aim of this project was to develop the SMALP method in order to use it with more 
challenging membrane proteins, such as G-protein coupled receptors. Our study has been 
successful and it has produced pure and active A2aR without adding any detergent, the first 
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time that a GPCR has been purified in this way. Moreover, the results presented here show 
SMALP can impart added stability to the protein. The second aim of this project was to use 
SMALP to produce ZipA. This was successful and the resulting sample has been used to 
study the FtsZ-ZipA interaction, providing more information into the role of ZipA and FtsZ 
during the cell division. These results have significant implications for future membrane 
proteins providing a simple protocol to produce pure and active proteins in their native lipid 
environment for future studies. Table 7-1 shows a summary of the advantages and 
disadvantages of using SMALP method. 
 
 
 
 
 
Advantages 
 
Provide a native lipid environment 
Maintain lateral pressure 
Size homogeneity 
The protein can be extracted directly from the membrane without adding 
any detergent  
It is simple and easy to use 
Disadvantages It is affected by the magnesium concentration 
Table 7-1: The advantages and disadvantages of SMALP 
 
7.3 Future Work 
The very promising results obtained from this project have allowed us to demonstrate that 
SMALP can be used to produce membrane proteins. Further analytical and biophysical 
studies on the samples have the potential to gain a very important insight into these proteins. 
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Subsequent to the completion of this study, the methods pioneered in this project have been 
successfully applied to the purification of more than 10 membrane proteins. It would be 
important, however, to use SMALP solubilisation proteins in structural determination studies, 
such as crystallography. In addition, the attempt to reconstruct the FtsZ-ring inside a GUV 
presented in this project has shown some very promising results, however, it does not achieve 
our main aim, to see the ring inside a GUV, it still requires amending experiment protocol to 
approach it in the future. 
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CHAPTER 9: Appendices 
 
A2aR Protein Wild Type Sequence (412 Amino Acid Residues) 
MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPF
AITISTGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICW
VLSFAIGLTPMLGWNNCGQPKEGKNHSQGCGEGQVACLFEDVVPMNYMVYFNFFACVLVP
LLLMLGVYLRIFLAARRQLKQMESQPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHII
NCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKA
AGTSARVLAAHGSDGEQVSLRLNGHPPGVWANGSAPHPERRPNGYALGLVSGGSAQESQG
NTGLPDVELLSHELKGVCPEPPGLDDPLAQDGAGVS 
 
ZipA Protein Wild Type Sequence (328 Amino Acid Residues) 
MMQDLRLILIIVGAIAIIALLVHGFWTSRKERSSMFRDRPLKRMKSKRDDDSYDEDVEDDEG
VGEVRVHRVNHAPANAQEHEAARPSPQHQYQPPYASAQPRQPVQQPPEAQVPPQHAPHPAQ
PVQQPAYQPQPEQPLQQPVSPQVAPAPQPVHSAPQPAQQAFQPAEPVAAPQPEPVAEPAPVM
DKPKRKEAVIIMNVAAHHGSELNGEALLNSIQQAGFIFGDMNIYHRHLSPDGSGPALFSLAN
MVKPGTFDPEMKDFTTPGVTIFMQVPSYGDELQNFKLMLQSAQHIADEVGGVVLDDQRRM
MTPQKLREYQDIIREVKDANA 
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